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The number and types of diagnostic ions obtained by infrared multiphoton 
dissociation (IRMPD) and collision induced dissociation (CID) were evaluated for 
supercharged peptide ions created by electrospray ionization of solutions spiked with m-
nitrobenzyl alcohol.  IRMPD of supercharged peptide ions increased the sequence 
coverage compared to that obtained by CID for all charge states investigated.  
Multiply charged, N-terminally derivatized peptides were subjected to electron 
transfer reactions to produce singly charged, radical species. Upon subsequent “soft” 
CID, highly abundant z-type ions were formed nearly exclusively, which yielded 
simplified fragmentation patterns amenable to de novo sequencing methods.  
Furthermore, the simplified series of z ions were shown to retain labile phosphoric acid 
moieties.  
Infrared multiphoton dissociation (IRMPD) was implemented in a novel dual 
pressure linear ion trap for rapid “top-down” proteomics. Due to secondary dissociation, 
IRMPD yielded product ions in significantly lower charge states as compared to CID, 
thus facilitating more accurate mass identification and streamlining product ion 
assignment. This outcome was especially useful for database searching of larger proteins 
(~29 kDa) as IRMPD substantially improved protein identification and scoring 
 viii
confidence. Also, IRMPD showed an increased selectivity towards backbone cleavages 
N-terminal to proline and C-terminal to acidic residues (especially for the lowest 
precursor charge states).  
Ultraviolet photodissociation (UVPD) at 193 nm was implemented on a linear ion 
trap mass spectrometer for high-throughput proteomic workflows. Upon irradiation by a 
single 5 ns laser pulse, efficient photodissociation of tryptic peptides was achieved with 
production of a, b, c, x, y, and z sequence ions, in addition to immonium ions and v and w 
side-chain loss ions. The factors that influence the UVPD mass spectra and subsequent in 
silico database searching via SEQUEST were evaluated.  
193 nm ultraviolet photodissociation (UVPD) was employed to sequence singly 
and multiply charged peptide anions. Upon dissociation by this method, a-/x-type, 
followed by d and w side-chain loss ions, were the most prolific and abundant sequence 
ions, often yielding 100% sequence coverage. LC-MS/UVPD analysis using high pH 
mobile phases yielded efficient characterization of acidic peptides from mitogen-
activated protein kinases. 
 ix
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Proteomics is the study of the structures and functional interplay of proteins in 
cells. By fully characterizing proteins and their extensive network of post-translational 
modifications (both qualitatively and quantitatively), scientists would have a better 
understanding and approach for developing new therapeutics that target cellular disease. 
Mass spectrometry (MS) has increasingly become the analytical method of choice in the 
field of proteomics in recent years due to significant advances in instrumentation, 
sampling techniques, and data interpretation algorithms. Although there have been 
tremendous inroads, there still remain many unresolved limitations in fully characterizing 
cellular proteomes. This dissertation aims at advancing the development of novel tandem 
mass spectrometry techniques (MS/MS and MSn), a vital component of proteomic 
analysis, to increase the diagnostic content of MS/MS spectra, improve automated 
analysis, decrease experimental duty cycles, and overall furthering the field of proteomics 
by developing methods to maximize the characterization of proteins. 
 
1.2 Tandem Mass Spectrometry for Proteomics 
Large scale, “bottom-up” characterization of cellular proteomes has been 
enormously successful1 and continues to improve due to ongoing innovation in the areas 
of mass spectrometric instrumentation, tandem mass spectrometry (MSn) techniques, 
sampling, separations, and bioinformatics. Typical high-throughput, bottom-up 
workflows consist of proteins being extracted from cells, enzymatic digestion, separation 
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of the resulting peptides, and then online analysis by MS and MS/MS. Database search 
algorithms are then employed to correlate MS/MS spectra with sequence and ultimately 
the parent protein. Four of the most popular algorithms, SEQUEST,2 MASCOT,3 
OMSSA,4 and X! Tandem,5 were recently compared,6 and each algorithm yielded 
acceptable and similar results for a complex human protein sample. In terms of MS 
instrumentation, the introduction of the Orbitrap7, 8 and hybrid linear ion trap (LIT)-
Orbitraps9, 10 have afforded significantly better mass accuracy and resolution (i.e., a 
resolving power of ~80,000 – 100,000 at  m/z of around 1000)7, which has greatly 
increased selectivity in database searching for bottom-up experiments. Recent 
innovations in quadrupole-time-of-flight instruments have yielded similar high 
performing mass accuracy and resolution measurements.11, 12 Also, the analysis times of 
mass spectrometers continue to decrease. The newly released dual-pressure linear ion trap 
(Velos),13 for example, has decreased cycle times two-fold by technological advances 
that eliminate prescans and allow faster scan rates in a low pressure trap.  This 
improvement significantly increased the experimental duty cycle over more traditional 
trapping instruments, resulting in more protein identifications and a deeper depth of 
analysis into the proteome.13 
While the most common proteomics technique for protein analysis uses the 
“bottom-up” mass spectrometry strategy,14, 15 the “top-down” strategy (an alternative to 
the bottom-up approach) relies on fragmentation of intact protein ions in the gas phase 
(i.e., no enzymatic digestion). Although more challenging,  top-down methods offer 
certain benefits over the bottom-up approaches including the elimination of enzymatic 
digestion procedures, access to contextual post-translational modification (PTM) 
information, and direct knowledge about the molecular weights of the intact proteins.16-18 
To date, top-down proteomic applications have mainly been undertaken on FT-ICR 
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instruments,16 which can resolve highly charged product ions created  upon collision 
induced dissociation (CID),19-21 electron capture dissociation (ECD),22-24 infrared 
multiphoton dissociation (IRMPD),25 or ultraviolet photodissociation (UVPD)26 of the 
intact proteins. Top-down applications utilizing various hybrid instrument platforms such 
as the linear ion trap (LIT)/FT-ICR,17 LIT/time-of-flight,18, 27 and LIT/orbitrap28 that 
allow physical separation of the ion activation and mass analysis steps have gained 
momentum. Recently, some inroads in top-down proteomics have been achieved using 
cheaper, faster, and more robust quadrupole ion trap instruments.12-18 For instance, 
McLuckey and coworkers have shown successful protein  identification by dissociation 
of whole proteins by CID followed by gas-phase ion/ion reactions undertaken to convert 
multiply charged product ions into singly charged ions for easier product ion 
assignment.29-32 Other groups have reported top-down protein analysis in quadrupole ion 
traps by combining electron transfer dissociation (ETD) with other ion/ion reactions33 or 
by using extended ETD periods.34  Although these ion trap techniques have shown 
substantial promise in the identification of proteins, they generally require relatively long 
activation/reaction times (up to 300 ms)34 or require greater abundances of precursor ions 
than conventional CID.33  Some of the resulting singly charged product ions that are 
useful for protein identification may also have m/z values beyond the  range of a typical 
quadrupole ion trap (i.e., greater than m/z 2000) due to the subsequent proton transfer 
reactions.33 Regardless if one uses the bottom-up or top-down strategy, the activation 
method of choice is critical to the success of the analysis, and more importantly, both 
strategies can be used in a complementary fashion to achieve the most complete 




1.2.1 Protein/Peptide Product Ion Nomenclature 
To gain sequence information and to pinpoint modified amino acid residues in 
proteomics experiments, ions are fragmented into smaller diagnostic product ions. These 
fragmentation patterns can then be analyzed with automated algorithms to identify and 
characterize the peptide(s)/proteins(s) of interest. For any given activation method, the 
most important outcome succeeding dissociation is the generation of product ions that 
can be predicted. That is, for any given sequence, the peptide will fragment along the 
backbone and/or at the amino residues specifically and reproducibly. To simplify the 
interpretation of these fragmentation patterns, nomenclature was proposed and was 
accepted throughout the mass spectrometry and proteomics communities. This general 










































Figure 1.1 Peptide/Protein Fragmentation Nomenclature  
 
The main products formed from all activation methods described in this dissertation are 
contained within this general nomenclature scheme. The ions are labeled by the specific 
cleavage site along the backbone and to which termini (N or C) the product contains. 
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Internal fragments, those that contain no termini, have no assigned nomenclature since 
they are generally produced with low frequency and abundance, which is true for almost 
all activation methods. Numbers are assigned to each product ion based off how many 
residues from the termini a particular cleavage occurs. Dissociation by thermal activation 
generally yield cleavages at N-C(O) bonds along the backbone producing b- and y-type 
products. In contrast, dissociation by higher-energy photons and collisions more often 
yield higher abundances of fragment ions from Cα-C(O) cleavages, which produce a/x 
ions. Lastly c- and z- type ions are generated from N- Cα backbone cleavage, and are 
generally the result of activation methods that utilize radical-directed mechanisms. 
Depending on the tandem MS method, losses of side-chain moieties from these product 
ions can occur at high frequencies and abundances. These losses occur from secondary 
dissociation mechanisms and specifically for high-energy activation methods; thus, a 
more detailed discussion for these ions will be discussed in section 1.2.2.4 of the 
Introduction (Vacuum Ultraviolet Photodissociaiton). 
 
1.2.2 MSn Methods  
For successful protein identification, both bottom-up and top-down approaches 
rely on the collection of informative tandem mass spectra that critically depend on the 
activation technique used. In recent years there have been many advances in activation 
technology, but there still remains no universal method that can successfully and 
efficiently analyze all proteins and their peptide constituents.  The activation methods 




1.2.2.1 Collision-Induced (Activated) Dissociation 
Collision-induced dissociation (CID) is the gold standard MS/MS method. It 
essentially is the default activation method for almost all modern, commercial mass 
spectrometers. CID fragments precursor ions by accelerating them into a neutral gas 
(often Helium or Nitrogen) by applying an electrical potential. Some portion of the 
kinetic energy of the accelerated ions is then converted to internal energy thus causing 
dissociation from collisional heating. In most modern MS instruments used in proteomic 
workflows, these low-energy CID conditions (eV collisions) are employed in which 
dissociation occurs upon vibrational excitation generating b- and y-type product ions. 
Past mass spectrometers such as magnet sector instruments have employed high-energy 
(keV) CID conditions where the production of a-type, internal, and side-chain loss ions 
are frequent and abundant. However, this technique is not commonplace in modern 
proteomic analysis aside from TOF-TOF instruments.  
Low-energy CID is an established, sensitive, and robust method, and when used 
to dissociate tryptic peptides, consistently identified the most peptides of complex protein 
mixtures as compared to other activation methods.35, 36 Because of this, CID is the most 
common method used for sequencing peptides and identifying PTMs.37 Uninformative 
labile neutral losses for both unmodified and modified peptides, however, remain a 
consistent problem for CID. Also, since internal energy is randomized prior to 
dissociation, collisional heating preferentially cleaves the backbone at specific residues 
(e.g., proline, histidine, glutamic acid, and aspartic acid) due to their lability, thus limiting 
the overall sequence coverage for certain peptides and essentially all top-down analysis. 
Another downfall of CID in ion traps, is the low mass cutoff (LMCO) problem, which 
arises due to an experimental incompatibility between the AC waveform used for CID 
and the radio frequency (rf) trapping voltage. This limitation prevents trapping and 
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detection of informative, low m/z product ions such as small b and y ions as well as 
immonium ions, the latter which are particularly useful in determining the amino acid 
composition of unknown peptides. Furthermore, these lower m/z diagnostic ions are 
important for automated sequencing algorithms and can be useful for the rapid 
determination of modified amino acids (e.g., phosphorylated, acetylated, and methylated 
residues).38-40 Recently, however, higher-energy C-trap dissociation (HCD), a form of 
CID that allows smaller m/z product ions to be detected, has been implemented on the 
newest hybrid Orbitraps and has yielded comparable results to that of low-energy CID for 
complex biological samples.10, 41 This new technique shows promise in both bottom-up 
and top-down proteomic applications, but its full exploitation has yet to be fully realized. 
 
1.2.2.2 Infrared Multiphoton Dissociation 
Infrared multiphoton dissociation (IRMPD) is another tandem MS method that 
has been successfully implemented in FT-ICR, time-of-flight, and quadrupole ion trap 
instruments.25, 42-58 Much of the appeal of IRMPD in quadrupole ion traps is related to the 
broader m/z trapping range possible compared to conventional CID.  This stems from the 
ability to reduce the rf trapping voltage during ion activation, an option that is detrimental 
for CID due to the decrease in energy deposition associated with lower rf trapping 
voltages.57 Also, because all ions are continuously irradiated during the activation period, 
IRMPD can promote secondary dissociation of primary product ions and thus lead to 
formation of a more diverse array of diagnostic ions compared to CID. 57, 59 Due to the 
substantial competition between IR energization and collisional cooling that occurs at 
typical operating pressures of quadrupole ion traps (~1 mtorr), IRMPD has had limited 
implementation in quadrupole ion trap instruments. Several methods have been explored 
to combat the low IRMPD efficiencies of larger peptides. For example, the Glish group 
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developed thermally-assisted IRMPD (TA-IRMPD),57 which involved heating the bath 
gas in the ion trap to increase the internal energies of ions, and have also improved 
dissociation efficiencies from simply focusing the laser.60 Our group has pursued peptide 
derivatization strategies to increase the photoabsorptivity of ions and/or decrease their 
critical energies for dissociation, 58, 61-63 the supercharging of ions prior to activation,64 
and more recently the utilization of a dual pressure linear ion trap.65  
Efficient top-down proteomics using IRMPD in quadrupole ion traps has 
remained largely unexplored. Due to the inherent lower pressures of FT-ICR and linear 
ion trap/time-of-flight mass analyzers, both McLafferty and Siu have used these 
instruments in conjunction with IRMPD for successful top-down analysis.25, 66   In both 
of these prior studies, the dominant IRMPD pathways involved cleavages of the protein 
backbone on the C-terminal side of glutamic and aspartic acid residues as well as on the 
N-terminal side of proline residues.25, 66 
 
1.2.2.3 Electron Transfer/Capture Dissociation 
Electron-based dissociation techniques such as electron capture dissociation 
(ECD)22 in FT-ICR instruments and electron transfer dissociation (ETD)67 in ion traps 
have shown to be particularly promising for characterization of post-translational 
modifications (PTMs)44, 67-73 and for increasing peptide sequence coverage.35, 74 Both 
methods involve the reaction of multiply charged cations with either low-energy 
electrons (ECD) or radical anions (ETD), leading to an exothermic electron attachment 
process that may also cause complementary c- and z-type backbone cleavages that retain 
labile PTMs such as phosphorylation and glycosylation. In more mechanistic detail, 
electron capture/transfer dissociation requires the migration of an H atom to a carbonyl 
group in the peptide backbone prior to cleavage of an N-Cα bond and production of 
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complementary c and z• ions.22, 67 This process is thought to involve rearrangement and 
transfer of α-carbon radicals to backbone carbonyls, initiating a free radical reaction 
cascade.75 To a lesser extent an H atom can be transferred to an amide nitrogen, thus 
generating a/y fragments.67 For peptides of lower charge, however, these electron-based 
methods yield charge-reduced radicals from the precursor as the most abundant products 
with low yields of c and z products.74, 76 Recently, both the Coon and McLuckey groups 
have implemented supplemental collisional activation (i.e. low-energy CID) of charge-
reduced peptide radicals after the electron transfer reaction (ETcaD), thus affording 
significantly improved peptide sequence coverage for lower charged precursor ions.76-78  
Both ETD and ECD are promising new alternatives to CID for sequencing peptides. 
 
1.2.2.4 Vacuum Ultraviolet Photodissociation 
Vacuum ultraviolet photodissociation (UVPD) is another emerging activation 
method suitable for energizing and dissociating peptides. UVPD, which typically uses an 
excimer laser operated at a wavelength of 193 or 157 nm, delivers high-energy photons 
(6.4 or 7.9 eV) that can excite peptides to higher electronic states and/or promote access 
to other types of fragmentation pathways  such as Cα-C(O) bond cleavages, resulting in a 
+ 1 or x + 1 radical ions that may further undergo secondary dissociation into even 
electron a, x, d, w, v, and/or Y products through losses of  CO and various amino acid 
side-chains.79, 80 This secondary dissociation process is illustrated in Figure 1.2. The 























































Figure 1.2 The main ions created upon UVPD of peptide cations. Dashed arrows 
indicate indirect pathways to other secondary product ions.  
 
UVPD at 193 nm of peptides was first performed in the 1980’s,81-84 but 
experiments were limited to a few selected peptides on FTICR mass spectrometers. A 
recent renaissance in the use of short wavelength (157 and 193 nm)85-90 ultraviolet 
photodissociation (UVPD) coupled mainly to TOF instruments has occurred due to the 
ultrafast (nanosecond) activation timescales and the rich tandem mass spectrometric 
information obtained (i.e., more types of backbone and side-chain loss ions are observed 
compared to traditional activation methods). There have been noteworthy inroads in the 
implementation of MALDI-TOF-MS with UVPD for high-throughput proteomic 
workflows,32 although inefficient ion activation has hindered the analysis of the lowest 
abundance proteins/peptides,86 coupled with the typical need for ~2000 spectral averages 
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(~40 s) for each spectrum.80, 85 The rich dissociation observed upon UVPD motivated our 
interests in implementing this activation technique in trapping instruments for high-
throughput proteomic experiments.  
 
1.3 Overview of Chapters 
With all the innovations in tandem mass spectrometry that have helped advance 
the field of proteomics, there are still vast improvements that can be made to further the 
depth of knowledge about cellular proteomes. The body of work in this dissertation has 
sought to develop new methods and/or improve existing techniques to expand MSn 
technology to its furthest potential.  
In chapter 3, diagnostic ions obtained by IRMPD and CID were evaluated for 
supercharged peptide ions created by electrospray ionization of solutions spiked with m-
nitrobenzyl alcohol. IRMPD of supercharged peptide ions increased the sequence 
coverage compared to that obtained by CID for all charge states investigated.  
Chapter 4 utilized electron transfer reactions to produce singly charged, radical 
species from multiply charged, N-terminally derivatized peptides. Upon subsequent 
collision activation (MS3), fragmentation patterns amenable to de novo sequencing were 
produced from a simplified series of z-type ions.   
IRMPD was implemented in a novel dual pressure linear ion trap for rapid “top-
down” proteomics in chapter 5. Due to secondary dissociation, product ions in 
significantly lower charge states were produced, thus facilitating more accurate mass 
identification and streamlining product ion assignment. This outcome was especially 
useful for database searching as IRMPD substantially improved protein identification and 
scoring confidence.  
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 In chapter 6, UVPD at 193 nm was employed for high-throughput proteomic 
workflows. Upon irradiation by a single 5 ns laser pulse, efficient photodissociation was 
achieved yielding diagnostic fragmentation behavior from several complementary 
product ion types. The factors that influence the UVPD mass spectra and subsequent in 
silico database searching via SEQUEST were evaluated.  
The results in chapter 7 highlighted the utility of 193 nm UVPD for sequencing 
singly and multiply charged peptide anions. Upon dissociation by this method, a-/x-type, 
were the most prolific and abundant sequence ions, often yielding 100% sequence 
coverage. LC-MS/UVPD analysis using high pH mobile phases yielded efficient 
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Experimental Methods  
 
2.1 Mass Spectrometry 
All mass spectrometric analysis in the chapters herein utilized electrospray 
ionization (ESI) and ion trap mass spectrometers. ESI is the most commonly used 
ionization technique in proteomics research due to its ability to gently ionize 
peptides/proteins without extensive degradation and denaturing. To achieve ionization, a 
high voltage of approximately 2 – 5 kilovolts is applied to a sample solution inside a 
narrow capillary; upon sufficient flow, a charged spray is formed containing the ionized 
analyte of interest. ESI generates ions that are multiply charged, which is advantageous 
since the most successful ion activation methods yield the most informative 
fragmentation information from multiply charged precursor ions. The majority of the 
work herein focuses on the development of novel ion activation methods that either 
provide more extensive and diagnostic fragmentation patterns for proteomic analysis, 
lowers the activation times and improves the duty cycle of LC-MS/MS experiments, 
and/or yield more easily interpreted MS/MS patterns that may be useful for automated 
spectral interpretation algorithms. The mass spectrometric instrumentation utilized in this 
body of work is described in detail in the subsequent sections. 
 
2.1.1 Thermo Electron LTQ Ion Trap Mass Spectrometer 
Peptides were analyzed using a modified Thermo Fisher (San Jose, CA) LTQ 
two-dimensional linear ion trap mass spectrometer. Pulsed-Q Dissociation (P-QD), a 
 
19
form of CID, was performed on the LTQ with a q value of 0.7 and an activation time of 
0.1 ms.  
Direct infusion nanoESI experiments utilized an online setup using a conductive 
mini microfilter assembly from IDEX Health and Science (Oak Harbor, WA) coupled to 
a New Objectives uncoated PicoTip® nanoESI emitter (Woburn, MA), which was 
operated at an ESI voltage of 2 kV. Peptides diluted to 10 µM were directly infused by a 
syringe pump at 300 nL/min. 
 
2.1.2 ThermoFinnigan LCQ Ion Trap Mass Spectrometer 
Supercharged tryptic peptides were analyzed using a modified ThermoFinnigan 
LCQ Deca XP three-dimensional quadrupole ion trap mass spectrometer equipped with a 
Synrad 50-W continuous wave CO2 laser.
1 Radiation at 10.6 μm was introduced into the 
quadrupole ion trap through a 5 mm hole drilled into the ring electrode. For certain 
tryptic peptides, the He bath gas pressure was reduced during laser dissociation 
experiments to allow for greater fragmentation efficiencies. A higher q value of 0.25 was 
used for CID experiments to afford more efficient ion activation at the expense of a more 
limited m/z trapping range. For all charge states, the CID voltage or IR irradiation time 
was adjusted to cause dissociation of approximately 100% (if possible) of the precursor 
ions.  
 
2.1.3 Thermo Electron LTQ Velos Ion Trap Mass Spectrometer 
Proteins were analyzed using a modified LTQ Velos, which is a differentially 
pumped dual pressure linear ion trap (Thermo Fisher, San Jose, CA).2 The high pressure 
cell was operated at nominally 4.7 mTorr, and the low pressure cell at nominally 0.3 
mTorr. Protein ions are accumulated in the high pressure cell for more efficient trapping 
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and isolation, and were then transferred to the low pressure cell where m/z analysis was 
performed in zoom scan mode. The automatic gain control (AGC) was set to 500, and the 
ESI voltage to 4.5 kV. Sheath and auxiliary nitrogen gas flow rates were 0.12 L/min and 
0.3 L/min, respectively. The heated capillary temperature was maintained at 200ºC. 
IRMPD experiments were performed in both the high and low pressure cells using a 
Synrad 50 W continuous wave CO2 laser (model 48-5; Mukilteo, WA) operated at full 
power (~50 W). Laser radiation at a wavelength of 10.6 μm was introduced into the linear 
ion trap via a modified back plate containing a ZnSe window.3 The precursor m/z was 
placed at a q-value of 0.1 for all IRMPD experiments, and irradiation times ranged from 
5.0 – 18.0 ms. CID experiments were performed in the high pressure cell to maximize 
dissociation efficiencies. Standard parameters (q-value of 0.25 and activation times of 30 
ms) were used for all CID experiments. All spectra were generated from 20 – 34 averages 
of three microscans.  
 
2.2 Liquid Chromatography 
For complex proteomic samples, often a separation step is required prior to mass 
spectrometric analysis. This step reduces ion suppression because the complex mixture of 
analytes is dispersed in time which prevents saturation of the electrospray, and increases 
the richness of the proteomic data. Most commonly, peptide/protein mixtures are 
separated via reversed phase - high performance liquid chromatography (RP-HPLC), 
which is then easily coupled online to ESI-MS/MS instrumentation. The HPLC flow rate 
is a critical parameter to the success of LC-MS/MS and can be divided into three 
commonly used flow rate scales - analytical (mL flow rates), capillary (µL flow rates), 
and nano (nL flow rates). The lower the flow rate, the more sensitive the LC-MS/MS 
method is in terms of total ion intensity; however, these low flow rate regimes are often 
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not robust and require specialized instrumentation. The HPLC instrumentation and 
parameters that were utilized in the chapters herein are described in the subsequent 
sections.  
 
2.2.1 Hitachi L-7000 HPLC 
Samples containing 10 μM digested protein were injected (10 μL) onto a 
Symmetry300 reversed-phase C18 analytical column (Waters, Milford, MA) (2.1  50 
mm, 3.5 m packing) with a matched guard column (2.1  10 mm, 3.5 m packing). 
Eluents consisted of 0.2% formic acid in water (A), and 0.2% formic acid in acetonitrile 
(B). Gradient elution was performed as follows: 95% (A) for 2 minutes followed by a 
linear gradient to 40% (A) over 60 minutes at a flow rate of 0.300 mL/min. Data-
dependent aquisition was used for all LC-MSn analysis with the first scan event being a 
full mass spectrum at a m/z range of 400 – 2000, and subsequent events consisting of 
ETD, CID, and ETcaD of the one or two most abundant peaks. A normalized collision 
energy of 35% was used for all LC-CID-MS analysis.  
 
2.2.2 Dionex Ultimate 3000 cap/nano HPLC 
Liquid chromatography was performed using a Dionex UltiMate 3000 system 
(Sunnyvale, CA) using a capillary flow splitter. An Agilent ZORBAX 300SB-C18 
capillary column (Santa Clara, CA) (150 × 0.3 mm, 5 µm particle size) was used for all 
separations. The column temperature was kept constant at 40°C.  Eluent A consisted of 
0.1% formic acid in water and eluent B 0.1% formic acid in acetonitrile. A linear gradient 
from 5% eluent B to 40% eluent B over 65 min at 5 µL/min was used. Injections of 
approximately 1 µg (20 picomoles) were used for the digested BSA sample and 10 µg for 
the HT-1080 lysate sample.  
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Liquid chromatography using high pH eluents was carried out using a Dionex 
UltiMate 3000 system (Sunnyvale, CA) with an Agilent ZORBAX 300Extend-C18 
capillary column (Santa Clara, CA) (150 × 0.3 mm, 3.5 µm particle size).  Eluent A was 
composed of 10 mM piperidine (~pH 11.5) in water and eluent B 10 mM piperidine (~pH 
11.5) in acetonitrile. A 65 min linear gradient from 5% eluent B to 40% eluent B was 
used at a flow rate of 4 µL/min. The mitogen-activated kinase mixture was injected at 
approximately five picomoles of tryptic digest per protein. 
 
2.3 Chemicals 
Myoglobin and cytochrome c from equine (Equus caballus) heart, bovine (Bos 
Taurus) carbonic anhydrase, bovine serum albumin, bovine ubiquitin, bovine -SI-
casein, proteomics grade trypsin, and all other reagents and peptides were purchased from 
Sigma-Aldrich (St. Louis, MO). The peptides DRVYIHPFHLVIH, YRPPGFSPFR, 
KRPPGFSPFR, ASHLGLAR, DRVYIHPFHLVIH, TSTEPQpYQPGENL, HCKFWW, 
GNHWAVGHLM, and DAEFRHDSGYEVHHEK were purchased from BACHEM 
(King of Prussia, PA). The phosphorylated peptides RQpSVELHSPQSLPR, KRpTIRR, 
TRDIYETDYpYRK and NRVpYIHPF were purchased from from AnaSpec (San Jose, 
Ca), and immobilized TPCK trypsin beads were obtained from Pierce Biotechnology, 
Inc. (Rockford, IL). KAKAA and RAAAA were synthesized by Bio Basic (Ontario, 
Canada). All solvents were purchased from Fisher Scientific (Fairlawn, NJ). 
 
2.4 Protein Preparation 
For TPCK trypsin bead digestion, proteins were digested with 100 μL 
immobilized TPCK trypsin beads in 50 mM ammonium bicarbonate incubated for 18 
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hours at 37 °C. After digestion, the excess beads were discarded and the remaining tryptic 
peptides were diluted prior to analysis.  
Proteins with disulfide linkages were reduced by adding a 10-fold molar excess of 
dithiothreitol (DTT) (100 µL of 1.0 mM DTT) to 10 nmoles of BSA (10 µL of 1.0 mM 
protein), which was buffered to a pH of ~8.4 with ~4 µmoles ammonium bicarbonate. 
Solutions were then incubated for one hour at 40 ˚C after which alkylation was performed 
by adding 4.0 µL of 1.0 M iodoacetamide (buffered to a pH of ~8.0 with ~20 µmoles 
ammonium bicarbonate). This solution was incubated at ambient temperature for 45 
minutes in the dark followed by subsequent quenching by the addition of excess DTT. 
For enzymatic digestion, 5.0 µL of 1.0 mg/mL trypsin in 1.0 mM HCl was added to the 
reduced/alkylated solution followed by incubation at 37˚C for 16 hours. 
 HT1080 cells were suspended in low-salt buffer (10 mM Tris-HCl, 10 mM KCl, 
1.5 mM MgCl2, pH 8.0) to swell, and were then lysed by dounce homogenization. The 
whole cell lysate was centrifuged at 1000 × g to clarify the soluble lysate and to remove 
the insoluble pellet. Soluble lysate (2 mg/mL protein) was denatured by addition of 2,2,2-
trifluoroethanol (TFE) to 50% (vol/vol) and reduced with 15 mM DTT at 55 ˚C for 45 
min. Following reduction, the proteins were alkylated with 55 mM iodoacetamide at 
room temperature for 30 min. The sample was diluted in digestion buffer (50 mM Tris-
HCl, 2 mM CaCl2, pH 8.0) to a final TFE concentration of 5% (vol/vol). Trypsin was 
added to a 1:50 (enzyme:protein) concentration (w/w), and the sample was incubated at 
37˚C for 5 hrs.  The digestion was quenched with 1% formic acid and sample volume 
was reduced to 20 μl by centrifugation under reduced pressure using a SpeedVac.  
Digested peptides were bound and washed on Thermo Fisher Scientific HyperSep C-18 
SpinTips (San Jose, CA), resuspended in peptide buffer (95% H2O/5% acetonitrile/0.1% 
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formic acid) and filtered through Millipore Microcon 10 kDa centrifugal filters (Billerica, 
MA), with the digested peptides collected as flow-through. 
 
2.5 Peptide Derivatization 
N-terminal derivatization was utilized in this dissertation to produce simplified 
MS/MS patterns for aiding de novo sequencing. Prior to N-terminal derivatization, 
lysines were converted to homoarginine residues through a guanidination step (except 
where noted) to ensure modification with 4-sulfophenyl isothiocyanate (SPTIC) 
exclusively at the N-terminus and not at the ε-amine group of lysines. A stock of 0.05 g 
O-methylisourea in 50 μL water was prepared and 5 μL of this stock solution, 50 μL of 5 
N ammonium hydroxide, and approximately 10 nmol of the protein digest or model 
peptide was combined. This mixture was then incubated for 10 minutes at 65 °C, after 
which the sample was desalted via C18 spin columns.   
The SPITC and 4-(chlorosulfonyl)phenyl isocyanate (SPC) derivatization 
procedures used in this study were adapted from previous reports.4, 5 Briefly, a stock 
solution of SPITC was made by dissolving approximately 1 mg of SPITC in 100 μL of a 
20 mM NaHCO3 solution (pH ~9.5).  A 20 μL aliquot of this stock was combined with 10 
nmol of peptide or protein digest, which was then incubated for approximately 30 
minutes at 55 °C. For SPC-modified peptides, a stock solution was made by dissolving 
approximately 1 mg of SPC in 100 μL acetonitrile. A 20 μL aliquot of this stock was 
combined with 10 nmol of peptide in a 50:50 pyridine/water (v/v) solution, which was 
then incubated for approximately 30 minutes at ambient temperature. After incubation, 
all samples were cleaned up using C18 spin columns. For direct infusion experiments, 
working solutions of 10 μM peptides in 49.5:49.5:1.0 water/methanol/acetic acid (v/v/v) 
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solution were prepared before infusion at a flow rate of 3 μL/min into the mass 
spectrometer.  
 
2.6 Infrared Multiphoton Dissociation  
Infrared multiphoton dissociation (IRMPD) was performed on a modified Thermo 
Fisher (San Jose, CA) LTQ two-dimensional linear ion trap mass spectrometer equipped 
with a Synrad 50-W continuous wave CO2 laser (model 48-5; Mukilteo, WA). Laser 
radiation at a wavelength of 10.6 μm was introduced into the linear ion trap via a 
modified back plate containing a ZnSe window.3 IRMPD was also utilized on a modified 
ThermoFinnigan LCQ Deca XP three-dimensional quadrupole ion trap mass 
spectrometer equipped with the same Synrad 50-W continuous wave CO2 laser.
1 
Radiation at 10.6 μm was introduced into the quadrupole ion trap through a 5 mm hole 
drilled into the ring electrode. With the laser operated at full power, irradiation times of 
10 – 250 ms (LTQ) and 25 – 500 ms (LCQ) were used with an activation q value of 0.1. 
IRMPD in a modified Thermo Fisher (San Jose, CA) LTQ Velos was performed in both 
the high and low pressure cells using a Synrad 50 W continuous wave CO2 laser (model 
48-5; Mukilteo, WA) operated at full power (~50 W). The precursor m/z was placed at a 
q-value of 0.1 for all IRMPD experiments, and irradiation times ranged from 5.0 – 18.0 
ms. 
 
2.7 Electron Transfer Dissociation  
Electron transfer dissociation (ETD) was performed on a Thermo Fisher (San 
Jose, CA) LTQ XL two-dimensional linear ion trap mass spectrometer equipped with an 
ETD unit. Fluoranthene anions were introduced as the electron-transfer reagent for ETD 
experiments with reaction times of 100 ms. ETcaD was carried out using ET reaction 
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times of 100 ms followed by isolation of the charge-reduced radical, and a 30 ms CID 
period.  
 
2.8 Vacuum Ultraviolet Dissociation  
Vacuum Ultraviolet Dissociation (UVPD) was performed on a Thermo Fisher 
Scientific LTQ XL linear ion trap (LIT) mass spectrometer (San Jose, CA) outfitted with 
a Coherent ExciStar XS excimer laser (Santa Clara, CA) operated at 193 nm. The laser 
setup was similar to that previously described,1 except a CaF2 lens was used to transmit 
193 nm photons into the LIT.  For UVPD experiments, the laser was pulsed once per scan 
with an energy of 8 mJ/pulse and a pulse duration of 5 ns. Pulse variable experiments 
used a laser pulse frequency of 500 Hz. Data-dependent LC-MS/MS was performed in 
two different ways. For LC-MS/UVPD runs (i.e., only UVPD was used for activation), 
the first event was the full mass scan (m/z range of 400 – 2000) followed by ten 
consecutive UVPD events on the ten most abundant ions from the full mass scan with 
one UV pulse applied per MS/MS scan. A q-value of 0.1 was used for each UVPD event. 
For LC-MS/UVPD/CID runs (i.e., comparison between UVPD and CID), the first event 
was the full mass scan (m/z range of 400 – 2000) followed by ten alternating UVPD/CID 
events on the five most abundant peaks for a total of five UVPD and five CID events per 
cycle. A q-value of 0.1 and a default activation period of 30 μs were used for each UVPD 
event. Although the actual irradiation time was only 5 ns (the duration of a single laser 
pulse) for UVPD, the commercial LTQ software limited the activation period to a 
minimum of 30 μs. 
For activated photoelectron detachment dissociation (a-EPD) experiments, a q-
value of 0.1 and an activation of 9 pulses (18 ms), 1 mJ/pulse, 500 Hz were used to 
generate the charge reduced, radical anion species, which was subsequently activated 
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using a normalized collision energy of 35%, q-value of 0.25, and collision duration of 30 
ms. 
 
2.9 Automated Database Searching  
The automated searching of LC-MS/MS data is vital to the success of proteomic 
analysis. Typically, experimental MS/MS spectra are searched against theoretical spectra 
generated in silico from known protein sequence databases. Various scoring algorithms 
are then applied to the data to access its validity. False discovery rates (FDR) calculated 
from searching data sets against a reversed decoy database are also applied to further 
filter the true positives from the false positives. The database searching algorithms (both 
for intact and digested proteins) that were utilized in the chapters herein are described in 
the subsequent sections.   
 
2.9.1 ProsightPTM 2.0 
ProsightPTM 2.06-8 was used for database searching of Bos taurus proteins (e.g., 
ubiquitin and carbonic anhydrase). Peaks were picked by Origin 7.0, and charge states 
were manually assigned. Excel was used to generate zero-charge (deconvoluted) spectra 
by multiplying the m/z values (from Origin) by assigned charge states and subtracting 
appropriate protons. The spectra were input into ProsightPTM in its absolute mass mode 
using average masses, and a precursor mass window of 2000 Da and a fragment tolerance 
of 1.5 Da were used for all searching. Probability scores (p-score) are based on a Poisson 
distribution that reflects the probability of matching identified product ions to a given 
protein sequence; scores equal to or lower than 0.05 are statistically significant.9, 10 
Expectation values equal the probability score multiplied by the number of protein 
sequences in the Bos taurus database (i.e. expectation value = p-score x 2,869,593 protein 
 
28
forms).11 The PDE score, which is based on the McLuckey score,12 takes into account 
product ion intensities and places weighting factors that increase scores when product 
ions stem from cleavages N-terminal to proline (5x weighting factor), C-terminal to 
aspartic acid (5x weighting factor), C-terminal to lysine (4x weighting factor), C-terminal 
to glutamic acid (2x weighting factor), N-terminal to proline and C-terminal to aspartic 
acid (10x weighting factor), N-terminal to proline and C-terminal to lysine (9x weighting 
factor), and N-terminal to proline and C-terminal to glutamic acid (7x weighting factor). 
These cleavages are particularly prominent as compared to other backbone locations. 
Higher PDE scores reflect better confidences in protein identification. 
 
2.9.2 SEQUEST 
Prior to SEQUEST interpretation of the MS/MS data, UVPD mass spectra were 
subjected to a background subtraction procedure to reduce/eliminate photoionization 
products. Background spectra were collected when no sample was being infused and thus 
no ions were detected in the trap, and at isolation m/z values of 250, 500, 750, or 1000 
(isolation width of 4 m/z), using a protocol discussed in more detail later. Each centroid 
background spectra was the culmination of 20 averages of three microscans. The LC-
MS/UVPD RAW files were subtracted from the background RAW files using Thermo 
Fisher Xcalibur version 2.0.7 software.   
SEQUEST was used for in silico MS/MS interpretation through the Thermo 
Fisher Scientific Proteome Discoverer 1.0 software package. For SEQUEST, a 
signal:noise ratio of 3, a precursor mass tolerance of 1.5 Da, and a fragment mass 
tolerance of 0.8 Da were used. Product ion series for UVPD included a, b, c, x, y, and z 
ions, and for CID included b and y ions except where noted. UVPD and CID spectra were 
manually separated from LC-MS-UVPD/CID files for direct comparison. Non-redundant, 
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bovine (25,243 sequences) and human (33,819 sequences) protein databases from the 
NCBI were used for searching of BSA and HT-1080 samples, respectively. Oxidation of 
methionines and carbamidomethyl modification of cysteines were set as dynamic and 
static (respectively) side chain modifications. Peptide hits were filtered against decoy 
databases at a 1% false discovery rate (FDR) (based on Xcorr vs. charge), and were 
manually verified by the presence of matching immonium ions and predicted sequence 
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 Chapter 3  
Comparison of Infrared Multiphoton Dissociation and Collision 
Induced Dissociation of Supercharged Peptides in Ion Traps  
 
3.1 Overview 
The number and types of diagnostic ions obtained by infrared multiphoton 
dissociation (IRMPD) and collision-induced dissociation (CID) were evaluated for 
supercharged peptide ions created by electrospray ionization of solutions spiked with m-
nitrobenzyl alcohol.  IRMPD of supercharged peptide ions increased the sequence 
coverage compared to that obtained by CID for all charge states investigated. The number 
of diagnostic ions increased with the charge state for IRMPD; however, this trend was 
not consistent for CID as the supercharged ions did not always yield the greatest number 
of diagnostic ions. Significantly different fragmentation pathways were observed for the 
different charge states upon CID or IRMPD with the latter yielding far more immonium 
ions and often fewer uninformative ammonia, water, and phosphoric acid neutral losses. 
Pulsed-q dissociation (P-QD) resulted in an increase in the number of internal product 
ions, a decrease in sequence-informative ions, and reduced overall ion abundances. The 
enhanced sequence coverage afforded by IRMPD of supercharged ions was demonstrated 
for a variety of model peptides, as well as for a tryptic digest of cytochrome c. 
 
3.2 Introduction 
Collision-induced dissociation (CID) is the most common method used for 
sequencing peptides and identifying PTMs,1 but uninformative labile neutral losses for 
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both unmodified and modified peptides remain a consistent problem. Recently, electron 
capture dissociation (ECD)2 in FT-ICR instruments, a method that involves the reaction 
of multiply-charged cations with low energy electrons, and electron transfer dissociation 
(ETD)3 in ion trap instruments, a technique which exploits the reaction of multiply-
charged cations with radical anions, have been developed to combat this neutral loss 
problem by affording complementary c- and z-type backbone cleavages that leave labile 
modifications intact. These methods have been particularly promising for characterization 
of PTMs;4-8 however, both techniques suffer from low fragmentation efficiencies, 
especially for lower charge states,9, 10 as compared to CID.  
Infrared multiphoton dissociation (IRMPD) is another tandem MS method that 
has been successfully implemented in FT-ICR, time-of-flight, and quadrupole ion trap 
instruments systems.6, 11-24 Much of the appeal of IRMPD in quadrupole ion traps is 
related to the broader m/z trapping range possible than for conventional CID.  This stems 
from the ability to reduce the rf trapping voltage during ion activation, an option that is 
detrimental for CID due to the decrease in energy deposition associated with lower rf 
trapping voltages.25 This low-mass cutoff (LMCO) problem associated with CID 
prohibits the detection of many diagnostic b and y ions of lower m/z as well as immonium 
ions, the latter which are particularly useful in determining the amino acid composition of 
unknown peptides. Furthermore, these lower m/z diagnostic ions are important for de 
novo sequencing algorithms and can be useful for the rapid determination of modified 
amino acids (i.e. phosphorylated, acetylated, and methylated residues).26-28 Because all 
ions are continuously irradiated during the activation period, IRMPD can also promote 
secondary dissociation of primary product ions and thus lead to formation of a more 
diverse array of diagnostic ions compared to CID.25, 29 Several methods have been 
explored to combat the low IRMPD efficiencies of larger peptides. For example, the 
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Glish group developed thermally-assisted IRMPD (TA-IRMPD),25 which involved 
heating the bath gas in the ion trap to increase the internal energies of ions. Our group has 
pursued peptide derivatization strategies to increase the photoabsorptivity of ions and/or 
decrease their critical energies for dissociation.30-33 
Charge state has a significant impact on ion peptide dissociation due to changes in 
peptide conformation and proton mobility, with more highly charged states often yielding 
a greater array of structurally informative backbone cleavages.9, 34  More highly-charged 
peptides also have increased coulombic repulsion which may facilitate dissociation 
compared to lower-charged species. Iavarone and Williams have explored the use of 
additives such as m-nitrobenzyl alcohol (m-NBA) that increase the surface tension and 
reduce the vapor pressure of ESI droplets, thus generating higher protein and peptide 
charge states.35-39 This phenomenon has been termed supercharging. Tandem mass 
spectrometry has recently been employed for the analysis of these supercharged ions, 
revealing interesting fragmentation trends such as enhanced formation of diagnostic ions 
upon CID of the highest supercharged state of proteins38 and increased sequence 
coverage upon ETD of the highest supercharged state of tryptic peptides.9 Although 
targeting ions in higher charge states can potentially increase the number of redundant 
product ions (i.e., ones formed in multiple charges states), this has not proven to be a 
pervasive problem.  
In the present study, the IRMPD and CID spectra of supercharged peptides 
obtained in ion trap mass spectrometers are compared. The more highly charged ions 
have lower critical energies; however, increased sequence coverage is most notable for 
IRMPD, which is attributed in part to the ongoing IR absorption and secondary 
dissociation of primary sequence ions throughout the activation period. Moreover, 
IRMPD allows detection of a greater array of diagnostic low m/z ions. Activation of 
 
34
higher charge states is particularly advantageous for IRMPD since collisional cooling is 
competitive with energization due to the very low energy deposition per IR photon.40 A 




3.3.1 Peptides, Proteins, and Reagents 
All peptides, proteins, and reagents were purchased from Sigma-Aldrich (St. 
Louis, MO) except for the following: the peptides DRVYIHPFHLVIH and 
DAEFRHDSGYEVHHEK were purchased from BACHEM (King of Prussia, PA), the 
phosphorylated peptides KRpTIRR and NRVpYIHPF from AnaSpec (San Jose, Ca), and 
immobilized TPCK trypsin beads were purchased from Pierce Biotechnology, Inc. 
(Rockford, IL).   
 
3.3.2 ESI-MS/MS 
For conventional analysis, model peptides were diluted to approximately 10 μM 
with 49.5%/49.5%/1.0% (v/v) water/methanol/acetic acid solution prior to direct infusion 
at 3 μL/min into the mass spectrometer. Peptides were supercharged by the addition of 1 - 
2% (v/v) m-NBA into the above working solutions prior to MS analysis.  
Model peptides were analyzed using a modified Thermo Fisher (San Jose, CA) 
LTQ two-dimensional linear ion trap mass spectrometer equipped with a Synrad 50-W 
continuous wave CO2 laser (model 48-5; Mukilteo, WA). Laser radiation at a wavelength 
of 10.6 μm was introduced into the linear ion trap via a modified back plate containing a 
ZnSe window.33 Tryptic peptides were analyzed using a modified ThermoFinnigan LCQ 
Deca XP three-dimensional quadrupole ion trap mass spectrometer equipped with the 
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same Synrad 50-W continuous wave CO2 laser.
30 Radiation at 10.6 μm was introduced 
into the quadrupole ion trap through a 5 mm hole drilled into the ring electrode. With the 
laser operated at full power, irradiation times of 10 – 250 ms (LTQ) and 25 – 500 ms 
(LCQ) were used with an activation q value of 0.1 during IRMPD experiments. For 
certain tryptic peptides, the He bath gas pressure was reduced during laser irradiation to 
allow for greater fragmentation efficiencies. A higher q value of 0.25 was used for CID 
experiments to afford more efficient ion activation at the expense of a more limited m/z 
trapping range. For all charge states, the CID voltage or IR irradiation time was adjusted 
to cause dissociation of approximately 100% (if possible) of the precursor ions. P-QD 
experiments were performed on the LTQ mass spectrometer with a q value of 0.7 and an 
activation time of 0.1 ms. For the present study, a product ion is considered to be detected 
in a CID, P-QD, or IRMPD mass spectrum if the ion peak has a S/N equal to or greater 
than three. Dissociation efficiencies were calculated based on the percentage of precursor 
ion abundance (based on ion peak area) converted into product ions, where a value of 
100% signifies that the initial abundance of the isolated precursor ion is completely 
accounted for by the summed abundances of all product ions.  Sequencing efficiencies 
(SEFF) were calculated based on the percentage of precursor ion abundance (based on 
ion peak area) converted into diagnostic ions (e.g. b, y, and immonium). A value of 100% 
indicates that the entire abundance of the selected precursor ion is converted into 
sequence-informative product ions. Although neutral losses, such as loss of ammonia or 
water, can give some useful information pertaining to the sequence of a peptide, these 
ions are often redundant or complicate spectra and are thus not classified as informative 
sequence ions. SEFF is a more useful parameter for assessing the diagnostic value of an 
MS/MS experiment, since product ions produced from neutral losses, such as ammonia 
loss or via dehydration, and internal fragments are not included. Moreover, redundant 
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multiply charged product ions were not counted in total diagnostic ion counts nor 
included in SEFF calculations. For the objectives of the present study, the term 
“immonium ion” is used to encompass both immonium and  immonium-related ions.   
 
3.3.3 Tryptic Digest 
Cytochrome c (50 μM) was digested with 100 μL immobilized TPCK trypsin 
beads in 50 mM ammonium bicarbonate incubated for 18 hours at 37 °C. After digestion, 
the excess beads were discarded and the remaining tryptic peptides were diluted to 10 μM 
with 49.5%/49.5%/1.0% water/methanol/acetic acid solution prior to analysis.  The 
tryptic peptides were supercharged by the addition of 1 - 2% m-NBA. Working solutions 
were directly infused into the mass spectrometer at 3 μL/min. 
 
3.4 Results and Discussion 
In this chapter, IRMPD experiments were undertaken by using both a two-
dimensional linear ion trap mass spectrometer and a three-dimensional quadrupole ion 
trap mass spectrometer.  IRMPD yielded the same number of diagnostic ions for both 
instruments; however, the irradiation times were approximately four times lower for the 
linear ion trap. The improved dissociation efficiency for the linear ion trap is attributed to 
a longer laser path length and/or better overlap of the laser with the ion cloud. For a more 
systematic investigation, the linear ion trap was used for all CID and IRMPD 
comparisons of model peptides, and the quadrupole ion trap was used for all CID and 




3.4.1 Model Peptides 
 The addition of m-NBA to the peptide solutions typically increased the maximum 
observed charge state by one through the addition of one extra proton with little overall 
impact on total ion abundances. For example, by conventional ESI-MS analysis the 
peptide KFHEKHHSHRGY yielded a highest charge state of 4+ as seen in Figure 3.1A. 
However, with the addition of m-NBA the 5+ supercharged state emerged as the 
dominant ion (Figure 3.1B). All four observed charge states of the peptide were 
subjected to IRMPD as illustrated in Figure 3.1C – 3.1F.  The IRMPD spectrum of the 
2+ charge state is dominated by the intact precursor ion and only a few product ions of 
low abundance. The triply protonated peptide also exhibits relatively low IR 
photodissociation efficiency (i.e. only 52% of the original isolated precursor ion is 
converted into product ions), with much of the precursor ion surviving the irradiation 
period and only a modest number of diagnostic ions formed. Exposure of the 2+ and 3+ 
ions to long irradiation times (250 ms) did not yield a high degree of product ions, a 
factor attributed to the competition between IR energization and collisional cooling. 
However, the higher charge states (e.g. 4+ and 5+) required shorter irradiation times (100 
ms), displayed much higher IRMPD efficiencies (up to 75% conversion of parent ions 
into total product ions), and yielded greater numbers of diagnostic ions. The sequencing 
efficiency (SEFF) ranged from 8% for the doubly charged peptide up to 39% for the 
highest charge state (5+). Activation of the highest charge state by IRMPD resulted in the 
greatest proportional yield of sequence-informative ions (b, y, and immonium). The 5+ 
supercharged state of KFHEKHHSHRGY also produced the most extensive sequence 
coverage upon IRMPD with six b ions, ten y ions, and three immonium ions.  For CID of 
this same peptide (Figure 3.2), all charge states yielded a similar number of sequence 
ions (on average four b ions and seven y ions).  The 3+ charge state yielded the greatest  
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Figure 3.1 ESI mass spectra of KFHEKHHSHRGY (a) with 1% acetic acid and 
49.5%/49.5% MeOH/H2O (b) supercharged with 1% m-NBA, 1% acetic 
acid, and 49%/49% MeOH/H2O. IRMPD mass spectra of the protonated 
peptide KFHEKHHSHRGY (c) 2+ charge state, 50 watts, t = 250 ms (d) 
3+ charge state, 50 watts, t = 250 ms (e) 4+ charge state, 50 watts, t = 100 
ms (f) 5+ supercharged state, 50 watts, t = 100 ms. 
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number of diagnostic ions upon CID, yet produced only 13 total sequence ions (six b ions 
and seven y ions) and no immonium ions.  High CID dissociation efficiencies were 
achieved for all charge states, ranging from 68% to 87% conversion of the selected 
precursor ions into product ions. More importantly, SEFF values ranged from 16% for 
the 4+ charge state up to 36% for both the +3 and +5 charge states, all of which were 






































































































































Figure 3.2 CID mass spectra of the protonated peptide KFHEKHHSHRGY (a) 2+ 
charge state, 29 mV collision voltage (b) 3+ charge state, 24 mV collision 
voltage (c) 4+ charge state, 17 mV collision voltage (d) 5+ supercharged 
state, 16 mV collision voltage.  
 
The supercharged states also yielded greater sequence coverage for peptides that 
readily absorb IR radiation, such as phosphorylated peptides. As seen for the series of 
IRMPD spectra of the phosphorylated peptide KRpTIRR in Figure 3.3, the loss of 
phosphoric acid dominates the spectra for the lower charge states (1+ to 3+). In contrast, 
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the greatest array of diagnostic ions is seen for the 4+ peptide by IRMPD.  Figure 3.3 
illustrates that the total sequence coverage increases with each additional charge. 
Phosphoric acid loss is significant upon IRMPD of the lower charge states but has less of 
an impact for the higher charge states, and is still less substantial than that observed upon 
CID.  
























































































M + H - H3PO4
b5 + H2O 




Figure 3.3 IRMPD mass spectra of the protonated phosphorylated peptide KRpTIRR, 
(a) 1+ charge state, 50 watts, t = 14 ms (b) 2+ charge state, 50 watts, t = 14 
ms (c) 3+ charge state, 50 watts, t = 14 ms (d) 4+ supercharged state, 50 
watts, t = 10 ms. 
 
A series of eight peptides were analyzed by both IRMPD and CID to explore the 
impact of supercharging on the sequence coverage for peptides as a function of their size 
(6 to 16 amino acids) and phosphorylation status. The results are summarized in bar 
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graph form in Figure 3.4. For peptides subjected to IRMPD as seen in Figure 3.4A, the 
number of diagnostic ions increased with increasing charge state, with the supercharged 
state always producing the greatest number of informative ions. For CID (Figure 3.4B), 
however, this trend was not consistent and the supercharged ion did not always yield the 
greatest number of diagnostic ions.  Activation of the higher charged ions often required 
lower CID voltages than lower charge states.  Those peptides for which the higher charge 
states produced fewer diagnostic ions upon CID typically underwent dehydration which 
accounts for their less diagnostic fragmentation patterns.  For IRMPD, however, fewer of 
these uninformative neutral losses were seen for the supercharged states which may be in 
part due to rapid secondary dissociation of these primary product ions into more useful 
diagnostic ions.  This phenomenon could explain the general enhancement in the total 
number of informative product ions observed for IRMPD compared to CID.  
Figure 3.4C shows a side-by-side comparison of CID and IRMPD for the best 
performing charge states (i.e. the charge state which produced the greatest total number 
of diagnostic ions) for each model peptide included in the study.  This bar graph 
comparison confirms that IRMPD of the supercharged peptide uniformly affords the 
greatest sequence coverage. This increased sequence coverage for IRMPD is attributed to 
a combination of three factors:  1) reduction in the ion critical energies for higher charge 
states due to some combination of coulombic effects and enhanced proton mobility, 2) 
broader m/z trapping range due to alleviation of the low mass cutoff, and 3) ongoing IR 
absorption and secondary dissociation that leads to a greater array of ions and 
transformation of less informative ions (i.e. product ions from neutral loss of water, 




















































































































































































































































































































































































































































































































Figure 3.4 Number of diagnostic ions (y, b, and immonium) from different charge 
states of protonated peptides (a) using IRMPD (b) and CID.  The best 
performers (i.e. most diagnostic ions) for each method (e.g. IRMPD and 
CID) are compared in (c). The average IRMPD irradiation times were 98 
ms (1+), 116 ms (2+), 84 ms (3+), 51 ms (4+), and 48 ms (5+). Activation 
times for CID were 30 ms with average collisional voltages of 40 mV 





3.4.2 Tryptic Digest of Cytochrome C 
In a manner similar to that described above for the model peptides, IRMPD and 
CID were used to evaluate a series of tryptic peptides from cytochrome c.  The tryptic 
digest was mixed with 1% m-NBA, and then each charge state of each tryptic peptide was 
analyzed by CID and IRMPD.  The number of diagnostic product ions (b, y, and 
immonium ions) were tabulated, and the results are summarized in Figure 3.5A and 
3.5B, respectively.  An increasing number of diagnostic ions were formed for higher 
peptide charge states by IRMPD of the tryptic peptides, a trend not observed for CID. 
Also, IRMPD of the supercharged ions consistently yielded a greater number of 
diagnostic ions compared to CID.  As confirmed again in a side-by-side bar graph that 
highlights the best CID results compared to the best IRMPD results for the series of 
tryptic peptides, IRMPD of each supercharged peptide afforded the greatest number of 
diagnostic ions in every case (Figure 3.5C). m-NBA has been used previously to create 
supercharged ions of tryptic peptides analyzed by LC-MS, 9 and we expect that this 
strategy combined with IRMPD would further facilitate protein characterization. 
The dissociation efficiencies for conversion of precursor ions into product ions 
were also assessed for various tryptic peptides and charge states. For example, for the 1+ 
charge states of EDLIAYLK and GITWK, only 26% and 18% of the parent ions, 
respectively, were converted into product ions upon IR irradiation. Conversely, the 
IRMPD efficiencies increased to 43% and 48%, respectively, for the 2+ charge state.  In 
comparison, the CID efficiencies ranged from 32% to 53% and 36% to 51% for the two 
charge states of EDLIAYLK and GITWK, respectively. For the peptide 
IFVQKCAQCHTVEK, the IRMPD efficiencies ranged from 55% for the 1+ charge state 
to 61% for the doubly-charged state to 57% for the triply-charged state. In comparison, 
the CID efficiencies ranged from 47% - 61% for the same peptide.  Similar IRMPD 
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efficiencies and trends were seen for the 1+, 2+, and 3+ charge states of 




























































































































































































































































































































































































































































Figure 3.5 Number of diagnostic ions (y, b, and immonium) of various tryptic 
peptides from cytochrome c (a) using IRMPD (b) and CID.  The best 
performers (i.e. most diagnostic ions) for each method (e.g. IRMPD and 
CID) are compared in (c). The average IRMPD irradiation times were 209 
ms (1+), 123 ms (2+), and 50 ms (3+). Activation times for CID were 30 




SEFF values were also compared to the more traditional dissociation efficiencies 
for the tryptic peptides described above. CID of EDLIAYLK and GITWK yielded SEFF 
values ranging from 6% - 5% and 5% - 10% for the 1+ and 2+ charge states, respectively. 
Conversely, SEFF values obtained by IRMPD for the same two peptides in the singly-
charged and doubly-charged states ranged from 4% - 27% and 2% - 30%, respectively. 
For the peptide IFVQKCAQCHTVEK, the IRMPD SEFF values ranged from 8% for the 
1+ charge state to 19% for the 2+ charge state and up to 21% for the 3+ charge state. In 
comparison, the CID SEFF values ranged from 11% - 19% for the same peptide. Thus, 
although IRMPD often resulted in lower dissociation efficiencies (i.e. percentage of 
original isolated precursor converted into total product ions) as compared to CID, the 
SEFF values (original isolated precursor converted into diagnostic product ions) for the 
supercharged states were often higher for IRMPD. This increase in the SEFF values for 
IRMPD of the highest charge states reflects both the diminishment in uninformative 
neutral losses (e.g., H2O, NH3) and reduction in the formation of internal ions compared 
to CID. 
Figure 3.6 shows the trends in the distributions of b, y, and immonium ions for 
one representative tryptic peptide, HKTGPNLHGLFGRK, in a quadrupole ion trap 
obtained by CID as the CID voltage is varied or by IRMPD as the irradiation time is 
varied. Figures 3.6A and 3.6B show the distributions for the 3+ charge state, and the 
results for the 2+ charge state are shown in 6c and 6d.  At longer irradiation times, 
IRMPD yielded significantly different distributions of product ions, including immonium 
ions and more b and y ions, compared to CID.  For IRMPD, higher irradiation times were 
needed to dissociate the doubly-charged peptide, and the sequence coverage was lower. 
For CID, the total number of sequence ions observed was the same for both charge states.  
On average, a total of twelve b and y ions were seen for both charge states using CID, 
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with one additional b ion and one fewer y ion detected for the 2+ charge state as 
compared to the triply-charged species. For the +2 charge state, an average of seven b, 
two y, and three immonium ions were seen when using IRMPD. Conversely, the average 
total b and y ion count increased to sixteen (seven b and nine y ions), and an average of 
five immonium ions were seen with IRMPD of the +3 charge state. 
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Figure 3.6 The distribution of diagnostic ions as a function of CID voltage or IRMPD 
irradiation time for protonated HKTGPNLHGLFGRK: (a) CID (3+), (b) 
IRMPD (3+), (c) CID (2+) and (d) IRMPD (2+). 
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3.4.3 Secondary Dissocation of Product Ion using MS3 
To further explore the occurrence of secondary dissociation during IRMPD, a 
product ion stemming from the neutral loss of water and another that incorporates the 
addition of water were selectively isolated and subjected to a second stage of ion 
activation in MS3 experiments (Figure 3.7). The 3+ charge state of the peptide 
DRVYIHPFHL was collisionally activated to promote dehydration, resulting in the [M-
H2O]
3+ ion of high abundance. This product ion was then isolated and activated by 
IRMPD, thus resulting in the formation of two abundant b sequence ions and one 
immonium ion but very few secondary ions attributed to uninformative losses of water or 
ammonia. The triply-charged DRVYIHPFHL also produced a primary product ion, [b9 + 
H2O]
2+, of high abundance upon CID. This product ion was isolated and subjected to 
IRMPD, yielding three abundant b sequence ions and one immonium ion as well as a few 
internal product ions of low abundance. These MS3 results suggest that the less 
informative neutral loss and neutral addition products ions that are commonly formed 
upon CID (or IRMPD) can be converted to more diagnostic product ions upon further 
activation. Since CID is a resonant process that causes energization of solely the selected 
precursor ion, it is only the non-resonant IRMPD method that can successfully convert 























































Figure 3.7 MS3 spectra of (a) the isolated [M+3H-H2O]
3+ ion and (b) the isolated 
[b9+H2O]
2+ ion produced upon CID and then dissociated by IRMPD at 50 
watts and 75 ms from the peptide DRVYIHPFHL. The selected precursor 
ion is denoted by *. 
 
3.4.4 P-QD Comparison 
As a final comparison, the tryptic peptide HKTGPNLHGLFGRK in the 3+ charge 
state was subjected to P-QD41 to assess the total number of diagnostic ions since this 
dissociation method, like IRMPD, alleviates the LMCO problem associated with CID. P-
QD entails activating the precursor ion at a high q value and high CID energy for a short 
time, and then quickly lowering the trapping rf voltage to detect product ions of low m/z. 
At a P-QD voltage of  46 mV, only four diagnostic ions were observed with much of the 
ion signal attributed to undesirable internal fragments at m/z values that clutter the range 
where b and y ions would be found (Figure 3.8). As the P-QD voltage was increased to 
53 mV, the total ion abundance was reduced by 85%, the level of noise increased, and a 
total of only two sequence ions were detected (spectrum not shown).  Increasing the P-
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QD voltage beyond 66 mV decreased the total ion abundance by over 97%, and the noise 
level obscured any fragment ion peaks. For comparison, when this triply-protonated 
peptide was subjected to IRMPD, twenty-two diagnostic ions were produced with a low 
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Figure 3.8 P-QD mass spectrum of triply protonated HKTGPNLHGLFGRK at 46 






IRMPD of the supercharged states of peptide ions resulted in the most informative 
array of sequence ions when compared to dissociation of lower charge states by IRMPD 
or upon dissociation of any charge state by CID. In addition, the number of immonium 
ions was dramatically increased with IRMPD of supercharged ions, which could aid in 
identification of PTMs. In general, the total number of diagnostic ions increased with 
increasing charge state for IRMPD. This trend was not observed for CID, and often lower 
charge states led to the greatest number of diagnostic ions. IRMPD of supercharged ions 
is anticipated to be particularly beneficial for larger peptides or proteins to maximize 
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Simplifying Fragmentation Patterns of Multiply Charged Peptides by 




N-terminal peptide derivatization strategies used in conjunction with tandem mass 
spectrometry to yield simplified fragmentation patterns have shown limited success for 
the de novo sequencing of multiply charged peptides, including those predominantly 
formed in LC-ESI-MS experiments.  Significant proton mobilization occurs for multiply 
charged peptides upon collisional activation, resulting in the formation of both N-
terminal and C-terminal product ions rather than an exclusive series of C-terminal ions 
preferred for de novo sequencing algorithms.  To circumvent this problem, multiply 
charged, N-terminally derivatized peptides were subjected to electron transfer reactions 
with fluoranthene anions to produce singly charged, radical species. Upon subsequent 
“soft” collision induced dissociation (CID), highly abundant z-type ions were formed 
nearly exclusively, which yielded simplified fragmentation patterns amenable to de novo 
sequencing methods.  Furthermore, the simplified series of z ions were shown to retain 
labile phosphoric acid moieties and were also observed for peptides not possessing basic 
C-terminal residues – a type of peptide that poses more challenges to traditional collision 
induced dissociation. This improved LC-MSn strategy was demonstrated for a variety of 





Mass spectrometry (MS) has increasingly become the analytical method of choice 
in the field of proteomics in recent years due to significant advances in instrumentation, 
sampling techniques, and data interpretation algorithms. Although there have been 
tremendous inroads, there also remain some unresolved limitations in practical 
applications.  For example in a recent study conducted this year, 24 proteomics labs were 
given a sample of Escherichia coli spiked with 20 proteins and of these participating labs, 
only six correctly identified the 20 proteins.1  While discouraging, these results were a 
significant improvement compared to a similar study conducted the previous year.  One 
key problem resulting in protein misidentification is a high false positive rate in 
computer-guided interpretation of tandem mass spectra. In a typical “bottom-up” 
approach, proteins are first enzymatically digested, and then tandem MS is performed on 
the resulting peptides. De novo algorithms or cross-correlation scoring methods can then 
be used to decipher the tandem mass spectra, assign peptide sequences, and integrate the 
data sets to identify proteins.2-8 However, often the tandem mass spectra are extremely 
complex with many redundant product ions that cause errors in spectral interpretation,9-11 
leading to incorrect identification of proteins or unidentified proteins. To enhance the 
success of de novo sequencing methods, measures have been taken to reduce the 
complexity of product ion spectra. Keough et al. first reported the derivatization of the N-
terminus of peptides with sulfonic acid groups, which upon dissociation yield mass 
spectra with an extensive array of C-terminal ions (e.g. y ions) void of neutralized N-
terminal ions (e.g. b ions).12 This technique greatly improved the accuracy of de novo 
peptide sequencing methods. A number of other studies have described the potential 
merits of other derivatization procedures for proteomic applications.10, 11, 13-34 For 
example, the N-terminal sulfonation reagent 4-sulfophenyl isothiocyanate (SPITC) in 
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conjunction with ESI-MS/MS and MALDI-MS/MS has proved to be useful identifying 
sites of ubiquitination.18, 19 Our group has used N-terminal sulfonation with infrared 
multiphoton dissociation (IRMPD) to improve de novo sequencing of peptides by 
eliminating the low mass cutoff inherent to ion traps.11 Recently, we have synthesized a 
new N-terminal reagent with a highly IR-absorbing phosphonite group that increased the 
dissociation efficiencies and sequence information obtained upon IRMPD.35  
One major drawback to the use of N-terminal derivatization strategies is that the 
simplification of the fragmentation patterns of peptides is substantially impaired when 
multiply charged precursor ions are analyzed.14, 15, 18, 20 For example, when doubly 
charged SPITC-modified peptides are dissociated, the N-terminal b ions are no longer 
neutralized due to the presence of the extra mobile proton, and the utility of the 
derivatization procedure is greatly reduced.14 This is particularly problematic for LC-ESI-
MS applications in which tryptic peptides are typically multiply protonated (i.e. charge 
states of 2+ and greater).36 Lee et al. described a method to simplify the fragmentation 
patterns of these multiply charged ions by using isotopically-labelled SPITC, but extra 
derivatization steps and more elaborate spectral interpretation were needed.15 Our group 
has attached UV chromophores to the N-terminus of peptides, and the modified peptides 
almost exclusively produced y ions upon ultra-violet photodissociation (UVPD), a 
striking selectivity attributed to the secondary dissociation and rapid annihilation of the 
UV chromophore-containing b ions.34 However, due to the slow repetition rate of the 
laser (10 Hz) and the requirement for multiple laser pulses used in this application, 
analysis on a chromatographic timescale could not be achieved. 
In recent years, other ion activation methods have been developed as alternatives 
to collision induced dissociation.  Electron-based dissociation techniques such as electron 
capture dissociation (ECD)37 in FT-ICR instruments and electron transfer dissociation 
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(ETD)38 in ion traps have shown to be particularly promising for characterization of post-
translational modifications (PTMs)38-45 and for increasing peptide sequence coverage.36, 46 
Both methods involve the reaction of multiply charged cations with either low energy 
electrons (ECD) or radical anions (ETD), producing complementary c- and z-type 
backbone cleavages that retain labile PTMs such as phosphorylation. For peptides of 
lower charge, however, these electron-based methods yield charge-reduced radicals from 
the precursor as the most abundant products with low yields of c and z products.36, 47 
Recently, both the Coon and McLuckey groups have implemented supplemental 
collisional activation (i.e. low-energy CID) of charge-reduced peptide radicals after the 
electron transfer reaction (ETcaD), thus affording significantly improved peptide 
sequence coverage.47-49  Both ETD and ECD are promising new alternatives to CID for 
sequencing peptides, but the resulting spectra remain rather complex with both N-
terminus and C-terminus product ions that can complicate de novo interpretation.  
In this study, doubly protonated peptides derivatized at the N-terminus via 
reactions with 4-sulfophenyl isothiocyanate (SPITC) or 4-(chlorosulfonyl)phenyl 
isocyanate (SPC) (Figure 4.1) were converted to charged-reduced radical species after 
gas-phase electron transfer (ET) reactions with fluoranthene radicals. The resulting 
singly-charged radical species were then subjected to subsequent collisional activation 
(ETcaD), which produced an enhanced series of z ions void of N-terminal ions. This 
spectral simplification strategy was performed using a linear ion trap on a liquid 
chromatographic timescale, and improved de novo sequencing was realized for a variety 







Myoglobin and cytochrome c from equine heart, and all reagents were purchased 
from Sigma-Aldrich (St. Louis, MO). The peptides KRPPGFSPFR and ASHLGLAR 
were obtained from BACHEM (King of Prussia, PA), the phosphorylated peptides 
KRpTIRR and TRDIYETDYpYRK from AnaSpec (San Jose, Ca), and immobilized 
TPCK-treated trypsin beads from Pierce Biotechnology, Inc.  (Rockford, IL).  All 
solvents were purchased from Fisher Scientific (Fairlawn, NJ).   
 
4.3.2 Derivatization and Sample Preparation 
Before N-terminal derivatization, lysines were converted to homoarginine 
residues through a guanidination step (except where noted) to ensure modification with 4-
sulfophenyl isothiocyanate (SPTIC) exclusively at the N-terminus and not at the ε-amine 
group of lysines. A stock of 0.05 g O-methylisourea in 50 μL water was prepared and 5 
μL of this stock solution, 50 μL of 5 N ammonium hydroxide, and approximately 10 
nmol of the protein digest or model peptide was combined. This mixture was then 
incubated for 10 minutes at 65 °C, after which the sample was desalted via C18 spin 
columns.   
The SPITC and 4-(chlorosulfonyl)phenyl isocyanate (SPC) derivatization 
procedures used in this study were adapted from previous reports.16, 50 Briefly, a stock 
solution of SPITC was made by dissolving approximately 1 mg of SPTIC in 100 μL of a 
20 mM NaHCO3 solution (pH ~9.5).  A 20 μL aliquot of this stock was combined with 10 
nmol of peptide or protein digest, which was then incubated for approximately 30 
minutes at 55 °C. For SPC-modified peptides, a stock solution was made by dissolving 
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approximately 1 mg of SPC in 100 μL acetonitrile. A 20 μL aliquot of this stock was 
combined with 10 nmol of peptide in a 50:50 pyridine/water (v/v) solution, which was 
then incubated for approximately 30 minutes at ambient temperature. After incubation, 
all samples were cleaned up using C18 spin columns. For direct infusion experiments, 
working solutions of 10 μM peptides in 49.5:49.5:1.0 water/methanol/acetic acid (v/v/v) 
solution were prepared before infusion at a flow rate of 3 μL/min into the mass 
spectrometer. 
For protein samples, 100 μL of immobilized TPCK-treated trypsin beads and 10 
micromoles of ammonium bicarbonate were used to digest 10 nmol of protein prior to the 
derivatization procedures.  Digestion occurred for 18 hours at 37 °C, and the beads were 
discarded after digestion.   
 
4.3.3 Mass Spectrometry and Liquid Chromatography 
Mass spectrometric analysis was performed on a Thermo Fisher (San Jose, CA) 
LTQ XL two-dimensional linear ion trap mass spectrometer equipped with an ETD unit. 
Fluoranthene anions were introduced as the electron-transfer reagent for ETD 
experiments with reaction times of 100 ms.  Standard parameters (q-value equal to 0.25 
and activation times of 30 ms) were used for all CID experiments. ETcaD was carried out 
using ET reaction times of 100 ms followed by isolation of the charge-reduced radical, 
and a 30 ms CID period. For all MSn experiments, a product ion was considered to be 
detected in an ETD, CID, or ETcaD mass spectrum if the ion peak had a signal: noise 
ratio equal to or greater than three.  
A Hitachi L-7000 (Hitachi Ltd.) analytical HPLC system was used for liquid 
chromatographic separations. Samples containing 10 μM digested protein were injected 
(10 μL) onto a Symmetry300 reversed-phase C18 column (Waters, Milford, MA) (2.1  
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50 mm, 3.5 m packing) with a matched guard column (2.1  10 mm, 3.5 m packing). 
Eluents consisted of 0.2% formic acid in water (A), and 0.2% formic acid in acetonitrile 
(B). Gradient elution was performed as follows: 95% (A) for 2 minutes followed by a 
linear gradient to 40% (A) over 60 minutes at a flow rate of 0.300 mL/min. Data-
dependent aquisition was used for all LC-MSn analysis with the first scan event being a 
full mass spectrum at a m/z range of 400 – 2000, and subsequent events consisting of 
ETD, CID, and ETcaD of the one or two most abundant peaks. A normalized collision 
energy of 35% (61 – 142 mV) was used for all LC-CID-MS analysis. 
 
4.4 Results and Discussion 
 
4.4.1 N-terminally Derivatized Multiply Charged Peptides 
 Two commonly used commercial reagents (e.g. SPITC and SPC) were used for 
N-terminal derivatization reactions of the peptides, resulting in a mass addition of 215 Da 
for SPITC and 199 Da for SPC. The structures of both reagents - SPITC and SPC - are 
shown in Figure 4.1. As noted previously, the chlorine atom in SPC is hydrolyzed and 
replaced with a hydroxyl group in aqueous solution.16 The sulfonic acid group present in 
both reagents introduces a negative charge at the N-terminus, thus reducing the overall 
charge of the peptides and simplifying the tandem mass spectra by effectively 
neutralizing N-terminal product ions (e.g. b, a, and c ions).   This simplification of the 
product ion spectra of singly charged sulfonate-derivatized peptides has been documented 
previously and has proven to be especially beneficial for de novo sequencing strategies.10-
12, 26 Upon CID, an enhanced set of C-terminal ions (y ions) are produced, and redundant 
N-terminal products (b, a ions) are formed as neutral species and are not detected. 
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However, when more than one positive charge resides on the derivatized peptide, the N-
terminal products formed upon CID may retain a charge, thus nulling the benefit of the 
derivatization process for spectral simplification. This increased spectral convolution is 
illustrated in Figure 4.2 for the doubly charged derivatized peptide ASHLGLAR in 
which N- and C-terminal product ions of multiple charge states are detected. Upon ESI, 
the N-terminal derivatized peptide ASHLGLAR was predominantly observed in the 2+ 
charge state (data not shown). CID of the doubly charged ions yielded complex spectra 
containing both y and redundant a and b ions (with these N-terminal ions retaining the 
original SPITC- or SPC-modification) (see Figures 4.2A and 4.2B). Moreover, product 
ions in multiple charge states are observed, as is the case for the y7 ion, which further 
complicates spectral interpretation. This loss in spectral simplification for multiply 
charged peptides is the primary reason that N-terminal sulfonation reactions have mainly 













Figure 4.1 Structures of the N-terminal derivatization reagents 4-sulfophenyl 
isothiocyanate (SPITC) and 4-(chlorosulfonyl)phenyl isocyanate (SPC). 
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Figure 4.2 CID mass spectra of the doubly charged peptide ASHLGLAR (a) 
derivatized with SPITC, 12 mV collision voltage, q = 0.25;  (b) 
derivatized with SPC, 14 mV collision voltage, q = 0.25. The unmodified 
peptide is denoted by M and the precursor ion by an asterisk (*).  The 
partial decomposition of the SPITC or SPC moiety resulting in a bonded 
carbon and sulfur atom attached N-terminally to the peptide is denoted by 
CS. 
 
An alternative approach, as described in the present study, relies on using ETD 
(via ETcaD) rather than CID for characterization of the N-terminal derivatized peptides.  
In this case, doubly charged SPITC- or SPC-modified peptides were subjected to electron 
transfer reactions, producing low amounts of sequence ions and predominantly charge-
reduced peptide radical cations (singly charged) as illustrated in Figure 4.3. 
Subsequently, the resulting charged-reduced ions were subjected to collisional activation, 
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a net process termed ETcaD, which yielded a simple set of C-terminal (z ions) without 
any redundant N-terminal ions (c, b, or a ions) (see Figure 4.4).  The ETcaD spectrum of 
doubly charged SPITC-modified ASHLGLAR is illustrated in Figure 4.4A, displaying a 
complete series of z-type ions and no N-terminal ions. Some z product ions were 
observed as radicals and others as even electron ions, a result which is discussed in more 
detail later.  Also, a product ion attributed to the loss of both the SPITC moiety and 
ammonia (net loss of 232 Da) was observed in all ETcaD spectra; this characteristic loss 
can be used as a marker for every SPITC-modified peptide.  It is a spectral feature that is 
especially convenient when the derivatization of peptide mixtures might be incomplete, 
and one needs a facile means to screen the species of interest. As also seen in Figure 
4.4A, product ions attributed to partial cleavage of the SPITC moiety are observed in the 
m/z range of 850 to 1040.  These product ions are thought to stem from the low energy, 
radical-driven dissociation processes of ETcaD since many of these ions were not 
observed upon CID of the singly-charged, even-electron peptides. Regardless, these ions 
do not cause substantial spectral congestion as they do not overlap with the z ion series 






















[M + 2H + SPITC]+




Figure 4.3 Electron transfer dissociation (no supplemental collisional activation) of 
doubly-charged SPITC-modified lysine-bradykinin.  The precursor ion is 
denoted by *. 
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Figure 4.4 ETcaD mass spectra of the doubly charged peptide ASHLGLAR (a) 
derivatized with SPITC, 24 mV subsequent collision voltage, q = 0.12; (b) 
derivatized with SPITC, 42 mV subsequent collision voltage, q = 0.16; (c) 
derivatized with SPC,  42 mV subsequent collision voltage, q = 0.16 . 
Product ions due to partial decomposition of the SPITC or SPC moiety are 
denoted by #.  The unmodified peptide is denoted by M, and the charge-
reduced radical precursor ion is denoted by *. 
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ETD of SPITC- or SPC-derivatized peptides with more than two charges resulted 
in significant abundances of both c- and z-ions and increased sequence coverage than 
obtained upon ETD of the doubly charged SPITC- or SPC-derivatized peptides, which is 
analogous to the ETD behavior of unmodified peptides (i.e. more efficient formation of 
both c- and z- ions).  However, significant abundances of non-dissociated charge-reduced 
peptides were also observed.  Because the ETD spectra for the SPITC- and SPC-modified 
peptides in the higher charge states display both the N-terminal and C-terminal sequence 
ions, the resulting spectra contain redundant ions that are less amenable to de novo 
sequencing. 
 
4.4.2 Formation of zn-1 versus yn-1 Product Ions 
It has previously been shown that yn-1 is the most abundant product formed upon 
CID of SPITC-modified peptides, both singly and doubly charged.14, 15 This phenomenon 
is illustrated in Figure 4.2A in which both the singly and doubly charged y7 ion dominate 
the CID mass spectrum obtained for doubly protonated SPITC-ASHLGLAR.  This 
process is promoted by nucleophilic attack of the sulfur atom of the SPITC moiety on the 
carbonyl oxygen atom of the adjacent amino acid, resulting in an Edman-type 
degradation.14, 32 Derivatization of peptides with SPC, which is identical to SPITC except 
for substitution of a oxygen atom for the sulfur, alleviates the domination of the yn-1 ion 
due to the reduced nucleophilicity of the oxygen.16 This leads to a more even distribution 
of y ions that is preferable for de novo sequencing (Figure 4.2B); however, both y and b 
series were produced upon CID of the doubly protonated, SPC-derivatized peptide which 
led to numerous redundant ions and a cluttered spectrum.  These CID patterns are 
characteristic of other doubly charged, SPITC- and SPC-derivatized peptides: dominant 
formation of the yn-1 ion for the former and more importantly cluttered spectra for both; 
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thus neither was ideal for sequencing peptides in mixtures using an LC-ESI-MSn 
approach. 
In contrast, ETcaD of the SPITC-modified peptides using low supplemental 
collision voltages yielded a broad series of z ions and did not result in enhanced 
formation of the yn-1 (or corresponding zn-1) product ions, a result that was surprising 
given the lability of the peptide bond that normally is cleaved to form the yn-1 ion upon 
CID (see Figure 4.4A with comparison to Figure 4.2A). However, ETcaD using a higher 
collision voltage produced a more abundant yn-1 ion, in addition to the series of z ions 
(Figure 4.4B). The yn-1 ion is easily identifiable because it is 16 Da greater in mass than 
the zn-1 ion, but its presence can largely be eliminated by using lower energy ETcaD 
conditions as demonstrated in Figure 4.4A. To optimize the formation of the preferred z-
type ions over the low energy yn-1 product, the collision voltage and q-value were varied 
systematically during the CID activation period.  Figure 4.5 illustrates the resulting trend 
for formation of the zn-1 versus yn-1 ions for doubly protonated SPITC-modified 
ASHLGLAR. As seen in Figure 4.5, the zn-1 dominates at lower energy ETcaD 
conditions and the yn-1 ion dominates at higher energy ETcaD conditions (i.e. higher q-
value and/or greater CID voltage). These experiments parallel Coon’s initial ETcaD work 
where more b and y ions (instead of c and z) were seen at higher q-values and greater 
collision energies.47 The absence of any y product ions using lower energy ETcaD 
conditions suggests that the radically-driven dissociation pathway that leads to z-type 
ions could be a lower energy process compared to the process that leads to the formation 
of the yn-1 ion. 
Another way to suppress the formation of the yn-1 ion is to use SPC as the 
derivatization reagent. Figure 4.4C shows the ETcaD mass spectrum of doubly charged 
SPC-modified ASHLGLAR, and no yn-1 ion was formed using any ETcaD conditions; 
 
70
however some low abundance y ions (e.g. y4 and y5) were detected at high q-values and 
CID energies. Because the SPC derivatization procedure involves the use of a less 
desirable 50% pyridine solution and reaction yields were often low, SPITC was used as 
the N-terminal derivatizing reagent for the remainder of the study. The SPITC reaction 
procedure consistently produced the highest yields of modified peptides. For example, 
guanidination and SPITC derivatization of the tryptic digest of myoglobin (described in 
more detail in subsequent sections) resulted in 100% conversion of unmodified peptides 




Figure 4.5 Percent abundance of zn-1 versus yn-1 (i.e. zn-1/(zn-1 +yn-1) × 100)  in ETcaD 





4.4.3 LC-MSn Analysis of SPITC-Derivatized Tryptic Peptides 
To evaluate the analytical utility of the ETcaD method for protein 
characterization, myoglobin was selected as a model protein for tryptic digestion and 
SPITC derivatization.  Under LC-MS conditions, most of the resulting SPITC-modified 
tryptic peptides were observed in the 2+ charge state upon ESI. Thus, for data-dependent 
LC-MS experiments, the doubly charged peptides were typically the ones subjected to 
ion activation. ETcaD, CID, and ETD spectra were collected in a data-dependent manner 
for the tryptic peptides in several charge states for separate LC runs of SPITC-derivatized 
and non-derivatized peptides.  The peak areas of the product ions for all C-terminal ions 
and all N-terminal ions were summed separately and converted to percentages.  The 
results are displayed in Figure 4.6 to allow ready comparison of the preference for 
formation of C-terminal (z ions) versus N-terminal product ions and other redundant ions 
such as ones in multiple charge states and redundant C-terminal species.  The extreme C-
terminal product ion selectivity for the ETcaD spectra obtained for the doubly charged 
SPITC-peptides is readily apparent, as demonstrated by the percentages of C-terminal 
ions ranging from 95.3% to 100.0% with an average of 97.1% in Figure 4.6.  In 
comparison, CID of the doubly charged SPITC-modified peptides produced more 
complicated spectra containing both N-terminal and C-terminal ions. Three of the 
peptides (LFTGHPETLEK, FDKFK, and HLKTEAEMK) appeared to show high C-
terminal ion selectivity upon CID, but this was due to production of very dominant yn-1 
ions and not due to production of a comprehensive series of y ions as would be needed 
for effective de novo sequencing. Due to the limited m/z range of the ion trap (up to 2000 
m/z), larger tryptic peptides such as YLEFISDAIIHVLHSK were unable to be analyzed 
by the ETcaD method after N-terminal derivatization.   Although ETD alone and ETD 
with supplemental CID of unmodified peptides has been shown to increase the level of 
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sequence coverage and also to promote retention of labile modifications in the product 
ions,36, 38, 47 these electron transfer based methods yield spectra that are often much more 
complicated than traditional CID spectra because highly abundant c-, z-, and a-type ions 
are present as well as low abundance y ions. Thus, the SPITC derivatization procedure in 
conjunction with ETcaD, not ETD alone, is a key factor that leads to the preferential 
formation of C-terminal ions. Both ETcaD and CID can be set up as successive scan 
events during a single data-dependent LC-MS run; therefore, these methods can be used 
in a complementary rather than competitive mode to increase the overall sequence 
coverage. In the present study, the average sequence coverage obtained was 86% for all 
N-terminally derivatized peptides analyzed by ETcaD (shown in Figure 4.6) with two 
major factors that limited the sequence coverage: (1) the low mass cutoff (LMCO) of the 
ion trap instrument prohibited detection of the lowest m/z product ions, and (2) 
miscleavages from proline residues inherent to ETD. The high sequence coverage 
obtained was comparable to previous reports of 89% coverage of unmodified peptides by 
ETcaD.47  Also, the increased spectral simplification afforded by ETcaD of the SPITC-
modified peptides could better unveil miscleavages stemming from the presence of 
proline residues based on characteristics gaps in the observed series of z ions.  In 
summary, the combination of ETcaD with SPITC-derivatization affords the best outcome 
















































Figure 4.6 Comparison of ETcaD, CID and ETD results for multiply charged tryptic 
peptides from myoglobin obtained by LC-MSn. SPITC-derivitized 
peptides are denoted by (SPITC), and unmodified peptides by (unmod.). 
The peak areas of the product ions for all C-terminal ions and all N-
terminal ions were summed separately and converted to percentages. All 
lysines are guanidinated for SPITC-modified peptides. Ф denotes peptides 
with high apparent C-terminal ion selectivity upon CID, but which was 
actually due to production of very dominant yn-1 ions and not due to 
production of a comprehensive series of y ions as would be needed for 
effective de novo sequencing. 
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4.4.4 Phosphorylated Peptides 
One of the biggest advantages of using electron-based dissociation techniques 
such as ETD is that labile modifications of amino acids generally remain intact, a factor 
that greatly aids in identifying PTMs.38-45  However, loss of phosphoric acid is still a 
substantial dissociation pathway for phosphopeptides examined by ETcaD in a linear ion 
trap.47 To circumvent this shortcoming, we evaluated the use of ETcaD for analysis of the 
N-terminal sulfonated phosphorylated peptide KRpTIRR. The ETcaD spectra for the 
SPITC-derivatized peptides (i.e. ET of the 2+ and 3+ charge states, then collisional 
activation of the resulting singly charged radicals; see Figures 4.7A and 4.7B, 
respectively) displayed an enhanced series of z ions with minimal loss of phosphoric acid. 
Conversely, ETcaD of doubly charged unmodified KRpTIRR (Figure 4.7C), CID of 
singly charged SPITC-modified KRpTIRR (Figure 4.7D), and CID of doubly charged 
SPITC-modified KRpTIRR (Figure 4.7E) all showed abundant losses of phosphoric acid 
and lower sequence coverage.51 A possible explanation for the minimized loss of 
phosphoric acid for SPITC-derivatized peptides in comparison to unmodified peptides 
upon ETcaD is that the loss of SPITC or SPITC + ammonia moieties are even lower 
energy pathways in comparison to the loss of phosphoric acid, rendering the latter 
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Figure 4.7 ETcaD of the phosphorylated peptide KRpTIRR (a) derivatized with 
SPITC (doubly charged), 25 mV subsequent collision voltage, q = 0.20; 
(b) derivatized with SPITC (triply charged)’ 30 mV subsequent collision 
voltage, q = 0.20; (c) unmodified (doubly charged), 21 mV subsequent 
collision voltage, q = 0.20; and CID of KRpTIRR (d) derivatized with 
SPITC (singly-charged),  45 mV collision voltage, q = 0.25; (e) 
derivatized with SPITC (doubly charged),  14 mV collision voltage, q = 
0.25.  Product ions due to cleavage of a portion of the SPITC moiety are 
denoted by #, and precursor ions for CID spectra are denoted by *. The 
unmodified peptide is denoted by M. 
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The peptide TRDIYETDYpYRK was also N-terminally derivatized with SPITC 
and subjected to ETcaD analysis. Like the peptide KRpTIRR, SPITC-
TRDIYETDYpYRK showed very high sequence coverage upon ETcaD with little neutral 
loss of phosphoric acid, which is illustrated for the triply charged species in Figure 4.8. 
These results illustrate that the combination of N-terminal derivatization and ETcaD can 
simultaneously simplify spectra and aid identification of PTMs. 
 



























Figure 4.8 ETcaD of the phosphorylated peptide TRDIYETDYpYRK derivatized 
with SPITC (triply charged), 67 mV subsequent collision voltage, q = 
0.14. Product ions due to cleavage of a portion of the SPTIC moiety are 
denoted by #, the unmodified peptide by M, and the precursor ion for 
subsequent CID by *. 
 
4.4.5 Benefits of Enhanced z- Ions over Enhanced y- Ions 
Although, ETcaD of multiply charged N-terminally sulfonated peptides and CID 
of singly-charged N-terminally sulfonated peptides are complementary methods for data-
dependent LC-MS analyses, there are significant advantages of the former method. One 
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obvious advantage is that the more highly charged, larger peptides provide greater protein 
sequence coverage, and their fragmentation patterns can only be successfully simplified 
by the ETcaD technique. Also as previously described, the z ions produced during the 
ETcaD technique retain labile PTMs. In contrast, CID of the even-electron, singly-
charged SPITC-derivatized peptides produced y ions which did not retain PTMs and 
offered lower sequence coverage for phosphopeptides. Furthermore, a highly basic 
residue (e.g. arginine or homoarginine) is needed at the C-terminus to enhance the y ions 
for CID analysis of SPITC-modified peptides.14 Without these highly basic residues, the 
proton is not sequestered on the C-terminus (i.e. it is more mobile), resulting in a more 
diverse array of both C-terminus and N-terminus ions and lower sequence coverage.  
However, a highly basic arginine or homoarginine is not needed at the C-terminus when 
using ETcaD due to the different radical dissociation mechanism inherent to electron-
based methods, yet the resulting spectra still offer high sequence coverage and yield a 
single dominant series of product ions. This advantage has already been seen for the 
peptide GHHEAELKPL in Figure 4.6. Therefore, the combination of ETcaD and N-
terminal derivatization could potentially be used for spectral simplification of a variety of 
peptide mixtures created from proteins using enzymes that do not necessarily cleave after 
lysines and arginines. 
 
4.4.6 Formation of Even Electron versus Radical z Ions 
Since both even electron and radical z product ions are formed by ETcaD, it was 
relevant to assess the formation preference of these two types of z ions.  These two types 
can generally be distinguished from each other as both the even electron and radical ion 
peaks are usually present at each z ion position and differ by one mass unit. However, the 
ability to predict the preference for formation of the radical or even electron z ions would 
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enhance the success of de novo sequencing algorithms since some amino acids differ in 
mass by only one amu.  To gain insight into the z ion distributions, area counts of all even 
electron and radical z ions were tabulated for each z ion (z1, z2, z3…z14) from 15 different 
peptide precursor ions corresponding to a total of 23 different spectra, which included 
different charge states and two different CID q-values and collision voltages. Both 
SPITC-modified model peptides and SPITC-modified peptides from tryptic digests of 
myoglobin and cytochrome c were included in this facet of the study.  The percentages of 
even electron z ions relative to the total amount of even electron and radical z ions are 
summarized in Figure 4.9 for each zn product.  As illustrated in Figure 4.9, there is a 
notable increase in the formation of even electron z ions as the length of the z ion 
decreases. The identity of specific amino acids adjacent to the cleaved amide bond had 
little or no impact on the extent of even electron z ion formation. However, further 
investigation with large data sets may be warranted. There was also no trend in the 
formation of one type of z ion when using lower or higher energy ETcaD conditions.  
The proposed mechanism for the formation of even electron z species from z 
radical species has been described previously, and it involves the formation of a hydrogen 
bond between the z radical and a c even electron species (either in an intramolecular or 
intermolecular process).52 The z radical strips a hydrogen atom from the c ion, forming an 
even electron z ion and a radical c product.52 This pathway is consistent with the trend 
seen in Figure 4.9: the longer z ions may have greater opportunity to fold and form 
stabilizing intramolecular hydrogen bonds, thus suppressing hydrogen bond formation 
with c ions. For the case of SPITC-derivatized peptides, the c products expected upon 
separation of the z and c species are neutralized instead of remaining positively charged. 
 
79























































Percentage of even electron z ions
 
 
Figure 4.9 Percentage of even electron versus radical z ions as a function of z ion 
length for 15 different peptide precursor ions and a total of 23 different 
spectra. n = the total number of peptides that had observable z ions at each 
specified sequence position. 
 
4.5 Conclusions 
ETcaD of multiply charged, N-terminally sulfonated peptides results in significant 
spectral simplification via almost exclusive formation of z-type ions. This method offers 
advantages not only compared to CID of multiply charged N-terminally derivatized 
species, but also to electron transfer based methods (i.e. ETD, ETcaD) of unmodified 
peptides. The enhanced series of z ions was shown to retain labile phosphoric acid 
moieties and also allow efficient sequencing of a broad range of peptides, including 
proline-rich ones and non-tryptic species. High sequence coverage was attained for all 
peptides with the largest limiting factor being the low mass cutoff (LMCO) inherent to 
the ion trap, which sometimes limited the detection of the lowest m/z ions. By using a 
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photodissociation method, such as IRMPD instead of CID during the subsequent 
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Top-Down Protein Fragmentation by Infrared Multiphoton 
Dissociation in a Dual Pressure Linear Ion Trap  
 
5.1 Overview 
Infrared multiphoton dissociation (IRMPD) was implemented in a novel dual 
pressure linear ion trap for rapid top-down proteomics. The high pressure cell provided 
improved trapping and isolation efficiencies while the isotopic profiles of 10+ charged 
ions could be resolved by mass analysis in the low pressure cell that enabled effective top 
down protein identification. Striking differences between IRMPD in the low pressure cell 
and CID in the high pressure cell were observed for proteins ranging from 8.6 kDa to 29 
kDa. Due to secondary dissociation, IRMPD yielded product ions in significantly lower 
charge states as compared to CID, thus facilitating more accurate mass identification and 
streamlining product ion assignment. This outcome was especially useful for database 
searching of larger proteins (~29 kDa) as IRMPD substantially improved protein 
identification and scoring confidence. Also, IRMPD showed an increased selectivity 
towards backbone cleavages N-terminal to proline and C-terminal to acidic residues 
(especially for the lowest charge states), which could be useful for a priori spectral 
predictions and enhanced database searching for protein identification. 
 
5.2 Introduction 
The most common proteomics technique for protein analysis uses a bottom-up 
mass spectrometry strategy.1, 2 Here, proteins are extracted from cells, enzymatically 
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digested, separated, ionized, and analyzed by MS and MS/MS. Database search 
algorithms are then employed to correlate MS/MS spectra with sequence and ultimately 
the parent protein. The top-down strategy, an alternative to the bottom-up approach, 
relies on fragmentation of intact protein cations in the gas phase (i.e., no enzymatic 
digestion). Although more challenging,  top-down methods offer certain benefits over the 
bottom-up approaches including the elimination of enzymatic digestion procedures, 
access to contextual post translational modification (PTM) information, and direct 
knowledge about the molecular weights of the intact proteins.3-5 To date, top-down 
proteomic applications have mainly been undertaken on FT-ICR instruments,3 which can 
resolve highly charged product ions created  upon collision induced dissociation (CID),6-8 
electron capture dissociation (ECD),9-11 infrared multiphoton dissociation (IRMPD),12 or 
ultraviolet photodissociation (UVPD)13 of the intact proteins. Top-down applications 
utilizing various hybrid instrument platforms such as the linear ion trap (LIT)/FT-ICR,4 
LIT/time-of-flight,5, 14 and LIT/orbitrap15 that allow physical separation of the ion 
activation and mass analysis steps have gained momentum. 
Recently, some inroads in top-down proteomics have been achieved using 
cheaper, faster, and more robust quadrupole ion trap instruments.12-18 For instance, 
McLuckey and coworkers have shown successful protein  identification by dissociation 
of whole proteins by CID followed by gas-phase ion/ion reactions undertaken to convert 
multiply charged product ions into singly charged ions for easier product ion 
assignment.16-19 Other groups have reported top-down protein analysis in quadrupole ion 
traps by combining electron transfer dissociation (ETD) with other ion/ion reactions20 or 
by using extended ETD periods.21  Although these ion trap techniques have shown 
substantial promise in the identification of proteins, they generally require relatively long 
activation/reaction times (up to 300 ms)21 or require greater abundances of precursor ions 
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than conventional CID.18  Some of the resulting singly charged product ions that are 
useful for protein identification may have m/z values beyond the  range of a typical 
quadrupole ion trap (i.e., greater than m/z 2000) due to the subsequent proton transfer 
reactions.18   
IRMPD is another useful tandem MS method that allows trapping and detection 
of a wide m/z range because the trapping conditions are decoupled from the activation 
process,22  IRMPD promotes secondary dissociation,12, 23, 24 and IRMPD can be used for 
confident identification of some types of post-translational modifications (PTMs).23, 25-28 
Due to the substantial competition between IR energization and collisional cooling that 
occurs at typical operating pressures of quadrupole ion traps (~1 mtorr), IRMPD has had 
limited implementation in quadrupole ion trap instruments. Our group and others have 
investigated methods to improve fragmentation efficiencies in these instruments by 
attaching IR absorbing chromophores,29-32 focusing the laser source,33 supercharging the 
ions of interest prior to activation,24 thermal assistance,34 and more recently utilizing a 
dual pressure linear ion trap.35 However, efficient top-down proteomics using IRMPD in 
quadrupole ion traps until now has remained largely unexplored. Due to the inherent 
lower pressures of FT-ICR and linear ion trap/time-of-flight mass analyzers, both 
McLafferty and Siu have used these instruments in conjunction with IRMPD for 
successful top-down analysis.12, 36   In both of these prior studies, the dominant IRMPD 
pathways involved cleavages of the protein backbone on the C-terminal side of glutamic 
and aspartic acid residues as well as on the N-terminal side of proline residues.12, 36  
Another formidable challenge of top-down proteomics stems from the lack of 
knowledge about the gas-phase fragmentation behavior of whole protein cations.37 
Improvements to a priori spectral predictions and incorporation into searching algorithms 
could result in more confident protein identification. Therefore, strategies have been 
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developed by Julian and coworkers to direct backbone fragmentation of intact proteins at 
specific residues,38 but this approach necessitates chemical derivatization. Others have 
reported an increased selectivity of backbone cleavages N-terminal to proline and C-
terminal to acidic residues (glutamic acid and aspartic acid) after CID of whole 
proteins,39-43 but this preferential cleavage has been difficult to predict a priori and 
depends heavily on precursor charge state. For example, it has been shown that at low 
precursor charge states, cleavages C-terminal to aspartic acid, and to a lesser extend C-
terminal to glutamic acid, are prevalent.40 Nonspecific cleavages have shown to dominate 
at intermediate charge states, and cleavages N-terminal to proline are abundant at higher 
charge states.40 
In the present study, IRMPD is implemented in a dual pressure linear ion trap for 
top-down protein analysis. Fragmentation patterns (i.e., charge state distributions and 
backbone cleavage selectivity) of proteins after IRMPD in the low pressure cell are 
compared to CID results in the high pressure cell. Further comparisons between the two 





Myoglobin and cytochrome c from equine (Equus caballus) heart, bovine (Bos 
Taurus) carbonic anhydrase, ubiquitin, and -SI-casein, and all other reagents were 
purchased from Sigma-Aldrich (St. Louis, MO). Proteins were analyzed without further 
purification. Working solutions of 10 μM proteins in 49.5:49.5:1.0 water/methanol/acetic 
acid (v/v/v) were prepared and directly infused at a flow rate of 3 μL/min into the mass 
spectrometer; ions were formed through electrospray ionization.   
 
88
5.3.2 Mass Spectrometry and Infrared Multiphoton Dissociation 
Proteins were analyzed using a modified LTQ Velos, which is a differentially 
pumped dual pressure linear ion trap (Thermo Fisher, San Jose, CA).44 The high pressure 
cell was operated at nominally 4.7 mTorr, and the low pressure cell at nominally 0.3 
mTorr. Protein ions are accumulated in the high pressure cell for more efficient trapping 
and isolation, and were then transferred to the low pressure cell where m/z analysis was 
performed in zoom scan mode. The automatic gain control (AGC) was set to 500, and the 
ESI voltage to 4.5 kV. Sheath and auxiliary nitrogen gas flow rates were 0.12 L/min and 
0.3 L/min, respectively. The heated capillary temperature was maintained at 200ºC. 
IRMPD experiments were performed in both the high and low pressure cells using a 
Synrad 50 W continuous wave CO2 laser (model 48-5; Mukilteo, WA) operated at full 
power (~50 W). Laser radiation at a wavelength of 10.6 μm was introduced into the linear 
ion trap via a modified back plate containing a ZnSe window.32 The precursor m/z was 
placed at a q-value of 0.1 for all IRMPD experiments, and irradiation times ranged from 
5.0 – 18.0 ms. CID experiments were performed in the high pressure cell to maximize 
dissociation efficiencies. Standard parameters (q-value of 0.25 and activation times of 30 
ms) were used for all CID experiments. Further IRMPD and MS3 experiments were 
performed on a modified, LTQ XL linear ion trap mass spectrometer (Thermo Fisher 
Scientific, San Jose, CA). All spectra were generated from 20 – 34 averages of three 
microscans.   
 
5.3.3 Data Analysis 
The charge states of product ions were identified by inspection of the isotopic 
envelope. Sequence ions were identified when two criteria were met:  when appropriate 
isotopic envelopes could be distinguished and the ion peaks had signal:noise ratios equal 
 
89
to or greater than three. Origin 7.0 was used to compute peak areas and intensities for 
further MS/MS data interpretation. Dissociation efficiencies were calculated based on the 
percentage of the original precursor ions (based on peak areas) which were converted into 
product ions. A value of 100% signified that the initial area of the isolated precursor ion 
peak was completely accounted for by the summation of all the areas of the product ion 
peaks. ProsightPTM 2.045-47 was used for database searching of Bos taurus proteins (e.g., 
ubiquitin and carbonic anhydrase). Peaks were picked by Origin 7.0, and charge states 
were manually assigned. Excel was used to generate zero-charge (deconvoluted) spectra 
by multiplying the m/z values (from Origin) by assigned charge states and subtracting 
appropriate protons. The spectra were input into ProsightPTM in its absolute mass mode 
using average masses, and a precursor mass window of 2000 Da and a fragment tolerance 
of 1.5 Da were used for all searching. Probability scores (p-score) are based on a Poisson 
distribution that reflects the probability of matching identified product ions to a given 
protein sequence; scores equal to or lower than 0.05 are statistically significant.14, 48 
Expectation values equal the probability score multiplied by the number of protein 
sequences in the Bos taurus database (i.e. expectation value = p-score x 2,869,593 protein 
forms).49 The PDE score, which is based on the McLuckey score,50 takes into account 
product ion intensities and places weighting factors that increase scores when product 
ions stem from cleavages N-terminal to proline (5x weighting factor), C-terminal to 
aspartic acid (5x weighting factor), C-terminal to lysine (4x weighting factor), C-terminal 
to glutamic acid (2x weighting factor), N-terminal to proline and C-terminal to aspartic 
acid (10x weighting factor), N-terminal to proline and C-terminal to lysine (9x weighting 
factor), and N-terminal to proline and C-terminal to glutamic acid (7x weighting factor). 
Higher PDE scores reflect better confidences in protein identification. 
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5.4 Results and Discussion 
In this chapter, proteins ranging from 8.6 kDa to 29 kDa (e.g., ubiquitin, 
myoglobin, cytochrome C, and carbonic anhydrase) were ionized by ESI and injected 
into a dual pressure linear ion trap for mass analysis. Ions were accumulated in the high 
pressure cell for more efficient trapping and isolation, and were then transferred to the 
low pressure cell for high resolution mass analysis. For MS/MS experiments, proteins 
could be dissociated in either cell. All product ion spectra were acquired using the zoom 
scan rate in which ions up to the 10+ charge state could be isotopically resolved with 
peak widths of ~0.1 u (FWHM) at m/z 1000 (Figure 5.1).  By performing mass analysis 
in the low pressure cell, resolution is considerably improved over that obtained in 
traditional high pressure linear ion traps, thus enabling the resolution and ready 
identification of significantly higher charged product ions. 
 
 



































Figure 5.1 Expansion of isotopic profiles of 10+ product ions. 
 
91
5.4.1 IRMPD Protein Dissociation Efficiency 
 The dissociation efficiencies for various charge states of ubiquitin (7+ through 
12+) produced by IRMPD in the low pressure cell and by CID in the high pressure cell 
were compared. In general, both activation methods yielded high dissociation efficiencies 
(i.e., near 80% on average of all charge states analyzed), although the dissociation 
efficiency was slightly lower for IRMPD compared to CID (78 + 6% for IRMPD versus 
86 + 4% for CID).  The higher CID efficiency was attributed to the more efficient 
energization of ions in the high pressure cell.44 The improved fragmentation observed for 
IRMPD using the low pressure cell of the linear trap, particularly for the intact proteins 
targeted in this study, was a vast improvement over that observed in traditional, single 
pressure, linear ion traps. 
 
5.4.2 Protein Fragmentation 
The efficient dissociation of proteins by IRMPD in the low pressure cell is 
illustrated in Figure 5.2A for the 7+ charge state of ubiquitin (irradiation time of 18 ms). 
The dominant product ions were those from selective backbone cleavages N-terminal to 
proline (“P”) or C-terminal to acidic residues (“D” for aspartic acid and “E” for glutamic 
acid). Product ions evolving from backbone cleavage between an adjacent acidic residue 
(C-terminal) and proline (N-terminal) were denoted by either “E/P” or “D/P.” Product 
ions resulting from all other nonselective cleavages (i.e., ones producing other a, b, and y 
ions) were denoted by . The corresponding CID mass spectrum of the 7+ charge state of 
ubiquitin is shown in Figure 5.2B.  Comparison of the spectra in Figures 5.2, a (IRMPD) 
and b (CID), reveal several differences. For instance, the majority of the product ions 
formed upon IRMPD were observed in significantly lower charge states than those 
produced by CID, thus enabling easier interpretation of isotopic profiles and higher mass 
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accuracy assignments. This phenomenon was observed previously for IRMPD of 
peptides in a dual pressure linear trap35 and was attributed to secondary dissociation of 
the more highly charged product ions. Also, due to secondary dissociation the 
distributions of product ions observed in the IRMPD and CID mass spectra were 
considerably different. For example, the most abundant sequence ions (e.g., b and y ions) 
in the IRMPD mass spectrum included those stemming from backbone cleavages C-
terminal to aspartic acid residues (D), whereas for CID the most abundant products arose 
from backbone cleavages between adjacent glutamic acid (C-terminal) and proline (N-
terminal) residues as well as those from nonselective backbone cleavages (other a, b, and 
y ions). The broader m/z trapping range possible during IRMPD also enabled the 
identification of low mass product ions, ones which could not be detected upon CID due 
to the low mass cutoff established by the rf voltage used during ion activation (e.g., b2 
and b3). Some internal ions of low abundance resulting from backbone cleavages N-
terminal to proline and C-terminal to acidic residues were also observed upon IRMPD. 
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Figure 5.2 Ubiquitin, MW 8,565 Da [M + 7H]7+ (m/z 1224.5) dissociated by (a) 
IRMPD in the low pressure cell, t = 18.0 ms and (b) CID in the high 
pressure cell, 21% NCE. Product ions resulting from selective cleavages 
N-terminal to proline and C-terminal to acidic residues are denoted by P 
and D, E (respectively). Internal ions resulting from these selective 
cleavages are denoted by #. Product ions resulting from unselective 
cleavages are denoted by , and precursor ions by *. 
 
Another example is shown in Figure 5.3 for the analysis of myoglobin in the 14+ 
charge state by IRMPD (Figure 5.3A) and CID (Figure 5.3B).  Again, lower product ion 
charge states and higher abundances of ions attributed to selective backbone cleavages N-
terminal to proline and C-terminal to acidic residues are observed upon IRMPD (15 ms). 
In general, the IRMPD spectrum was much less complex and thus easier to interpret. 
Conversely, CID resulted a notably more cluttered spectrum with several unidentifiable 
ions in charge states too high to resolve the isotopic distribution (denoted by “?”) under 
the mass analysis resolution conditions achieved using the experimental conditions 
described in the methods section above. Moreover, the most abundant products and in 
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fact more than half of the total product ions from CID resulted from nonselective 
backbone cleavages. CID did, however, generate a greater array of product ions, albeit at 
the expense of low mass sequence ions, such as the b2 ion, and low mass internal ions, 
that serve as useful fingerprint ions when identifying intact proteins. 
   









































































































Figure 5.3 Myoglobin, MW 16,951 Da [M + 14H]14+ (m/z 1211.7) dissociated by (a) 
IRMPD in the low pressure cell, t = 15.0 ms and (b) CID in the high 
pressure cell, 22% NCE. Product ions resulting from selective cleavages 
N-terminal to proline and C-terminal to acidic residues are denoted by P 
and D, E (respectively). Small internal ions of two amino acids are 
denoted by . Product ions resulting from unselective cleavages are 
denoted by , and precursor ions by *. 
 
Even for higher molecular weight proteins in high precursor charge states, 
IRMPD yields product ions in low charge states with a high selectivity for backbone 
cleavages occurring N-terminal to proline and C-terminal to acidic residues.  This general 
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trend is illustrated in Figure 5.4A, which shows the IRMPD spectrum of the 20+ charge 
state of carbonic anhydrase (29 kDa) at a short irradiation time of only 9 ms. Several low 
mass sequence ions (e.g., y2, b2, b3, and b4) were again observed for IRMPD that were not 
detected upon CID (Figure 5.4B). Both dissociation methods generated the same number 
of identified sequence ions; however, CID had many more highly charged ions that were 
neither resolved nor identified. Also, as seen previously, a greater portion of the product 
ions were attributed to ones resulting from nonselective backbone cleavages for CID as 
















































































































Figure 5.4 Carbonic anhydrase, MW 29,025 Da [M + 20H]20+ (m/z 1452.4) 
dissociated by (a) IRMPD in the low pressure cell, t = 9.0 ms and (b) CID 
in the high pressure cell, 10% NCE. Product ions resulting from selective 
cleavages N-terminal to proline and C-terminal to acidic residues are 
denoted by P and D, E (respectively). Internal ions resulting from these 
selective cleavages are denoted by #, and small internal ions of two amino 
acids are denoted by . Product ions resulting from unselective cleavages 
are denoted by , and precursor ions by *. 
 
Dissociation of the 10+ charge state of cytochrome C by IRMPD (Figure 5.5A) 
and CID (Figure 5.5B) resulted in large product ion signals from the detachment of heme 
from the protein backbone; however, major spectral differences were still observed. 
Again, lower charged product ions were seen for IRMPD as compared to CID.  In fact, 
for IRMPD at an irradiation time of 11.0 ms (Figure 5.5A), 68% of the total abundance 
of product ions (based on integrated peak areas) resulted from singly charged ions. This 
 
97
surprisingly low charge state distribution was rather unexpected, but could be attributed 
to increased IR absorptivity from the covalently attached heme group that promotes even 
more extensive secondary dissociation relative to unmodified (non-heme) proteins. Also 
due to secondary dissociation, the anticipated [M – Heme]9+ ion was not detected upon 
IRMPD. This [M – Heme]9+  ion was highly abundant in the CID spectrum and proved to 
be a dead-end (noninformative) product that provided no diagnostic sequence 
information. CID did generate, however, a greater array of sequence ions as compared to 
IRMPD, albeit few low mass sequence ions due to the intrinsic narrow m/z range 
characteristic of the trapping conditions typically employed for CID. Both dissociation 
methods yielded product ions mainly from nonselective backbone cleavages. This 
behavior was quite different compared to that noted for the prior three proteins 
(especially for IRMPD), which generally resulted in highly selective fragmentation 
patterns (i.e., high propensity for backbone cleavages N-terminal to proline and C-
terminal to acidic residues). The apparent lower cleavage selectivity for cytochrome C 
upon IRMPD is attributed to the generation of mostly smaller, singly charged product 
ions, as discussed previously, in lieu of those arising from proline- and acidic residue-
directed cleavages. The smaller ions resulting from secondary dissociation would only 
show elevated backbone cleavage selectivity if high abundances of proline and acidic 
residues were located near the N-terminus and C-terminus for a given protein, which for 
cytochrome C is not the case.  We speculate that the enhanced secondary dissociation of 
cytochrome c is directly related to the presence of the heme group. To support this 
hypothesis about the special role of  IR-absorbing modifications and the impact on 
secondary dissociation, a single pressure linear quadrupole ion trap (LTQ XL) was 
employed for the dissociation of the phosphorylated protein -SI-casein, which has eight, 
highly IR-absorbing phosphorylation sites. Over 52% of the product ion current 
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generated upon IRMPD of the 15+ charge state of this protein was attributed to singly 
and doubly charged product ions (data not shown), a distribution that mirrors the IRMPD 
results obtained for the heme-containing cytochrome C in which most of the product ions 
were detected in the lowest charge states. Interestingly, for the case of -casein, the 
small, lower charged product ions originated preferentially from selective backbone 
cleavages N-terminal to proline and C-terminal to acidic residues. The sequence of -SI-
casein protein chain, unlike cytochrome C, has a high frequency of proline and acidic 
amino acids near the N-terminus and C-terminus. 
For all proteins analyzed, IRMPD and CID yielded poor overall sequence 
coverage - instead fragmentation was directed in both methods to selective backbone 
cleavages (i.e., N-terminal to proline and C-terminal to acidic residues). Therefore, there 
were often multiple product ions that resulted from the same backbone cleavage site (i.e., 
the same products occurring in multiple charge states and/or sequence ions (e.g., a, b, and 
y) observed for the same backbone cleavage). Regardless, CID in general produced more 
unique backbone cleavages as compared to IRMPD. Upon CID, ubiquitin (9+), 
myoglobin (14+), carbonic anhydrase (30+), and cytochrome C (10+) generated product 
ions originating from 24%, 14%, 12%, and 33% (respectively) of the total possible 
cleavage sites for each protein. In contrast, IRMPD of ubiquitin (9+, 10+, 12+), 
myoglobin (16+), carbonic anhydrase (22+), and cytochrome C (16+) produced ions 
arising from  19%, 9%, 10%, and 29% (respectively) of the total possible cleavage sites 
for each protein.   These particular charge states were chosen for each activation method 
because they produced the most unique cleavages out of all charge states analyzed for 
each protein and dissociation method. In general, protein ions in charge states exhibiting 
the greatest selectivity for cleavages N-terminal to proline and C-terminal to acidic 
residues ultimately yielded low sequence coverages, as expected. 
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Figure 5.5 Cytochrome C, MW 12,360 Da [M + 10H]10+ (m/z 1237.0) dissociated by 
(a) IRMPD in the low pressure cell, t = 11.0 ms and (b) CID in the high 
pressure cell, 26% NCE. Product ions resulting from selective cleavages 
N-terminal to proline and C-terminal to acidic residues are denoted by P 
and D, E (respectively). Internal ions resulting from these selective 
cleavages are denoted by #, and small internal ions of two amino acids are 
denoted by . Product ions resulting from unselective cleavages are 
denoted by , and precursor ions by *. Due to space constraints in (b), low 
abundant product ions are listed below the CID spectrum. 
 
5.4.3 IRMPD and CID Product Ion Charge State Comparison  
To display the charge state distribution of ions resulting from IRMPD versus 
those from CID, the peak areas for each observed sequence ion in the various charge 
states were summed and plotted for all precursor ion charge states of all proteins 
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precursors (Figure 5.6). Percentages are based on the summed peak areas for a particular 
product ion charge state divided by the total peak areas for all charge states in a given 
spectrum, and percentage ranges (i.e. 0-20%, 20-40%, etc.) are represented by different 
colors. To create a more detailed graduated color scale, darker shades of the same color 
represent higher elevations and thus percentages on the higher end of the range.  The 
distributions shown in Figure 5.6 illustrate that IRMPD generated product ions in lower 
charge states relative to CID. In fact, the production of sequence ions in low charges 
states by IRMPD facilitated their confident assignment, as reflected in Figure 5.6 by the 
lack of any product ions in ambiguous charge states in contrast to the companion CID 
results. The mass spectrometer allows charge states up to 10+ to be isotopically resolved; 
moreover, most product ions with charge states between 11+ and 16+ could be identified 
based on their m/z values and by limiting the charge states to a few reasonable values 
based on some resolution of the isotope peaks.  In contrast to the IRMPD results, every 
protein except for the smallest one, ubiquitin, generated significant portions of product 
ions in high charge states upon CID that could neither be resolved nor identified. This 
occurrence was especially problematic for the highest precursor charge states. CID also 
more often generated multiple isobaric product ions that could not be identified due to 
unresolved, overlapping isotopic patterns of two or more ions, as illustrated in Figure 5.7 
for a product ion (y48
4+, m/z 1393) of carbonic anhydrase (20+) observed upon IRMPD 
and CID.  Only in the IRMPD mass spectrum could the product ion be isotopically 
resolved and thus identified as y48
4+, whereas the peak in the CID mass spectrum may be 
the overlap of multiple product ions.  Both Figure 5.6 and Figure 5.7 illustrate how the 
production of lower charged sequence ions by IRMPD is particularly beneficial for top-
down applications using mass spectrometers which have intrinsically lower resolving 
powers and mass accuracies, such as quadrupole ion traps. Note that the higher resolution 
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scan rate (Ultrazoom mode) was not utilized in this study, but could possibly help to 
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Figure 5.6 Comparison of the charge state distributions of product ions generated by 
IRMPD versus CID for (a) ubiquitin, (b) carbonic anhydrase, (c) 
myoglobin, and (d) cytochrome c as a function of precursor charge state. 
The colored contour plots display the percentages of product ions in 
specific charge states for each selected precursor charge state. Darker 
shades of the same color represent higher elevations and correspond to 
percentages on the higher end of the range.  Product ions with ambiguous 












































Figure 5.7 (a) Resolved 4+ product ion (m/z 1393) after IRMPD of carbonic 
anhydrase (20+) (b) Unresolved product ion (m/z 1393) ion after CID of 
carbonic anhydrase (20+). 
 
5.4.4 IRMPD and CID Cleavage Selectivity Comparison 
The ability to better predict top-down spectra a priori could enhance the design 
and implementation of algorithms for protein identification. Figure 5.8 shows a graphical 
comparison of the distributions of the products created from the most selective backbone 
cleavages (N-terminal to proline and C-terminal to acidic residues) and those stemming 
from nonselective backbone cleavages (i.e., all other backbone cleavages that lead to 
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other a, b and y ions) for all charge states of all proteins by IRMPD and CID. Selective 
cleavages are represented collectively by different shades of blue, and nonselective 
backbone cleavages by red. The black boxes that surround individual pie graphs are used 
to highlight those charge states that yield the greatest portion of selective backbone 
cleavages (i.e., largest blue segments), both for IRMPD and CID. As seen in Figure 5.8, 
the precursor charge state exerts a significant influence on the backbone cleavage trends 
for both activation methods, an observation which has been reported previously for CID 
data.18, 39 Aside from the results for cytochrome C, the lowest precursor charge states 
consistently yielded the most selective backbone cleavages for IRMPD, thus indicating 
that IRMPD of ions in lower charge states offers the best option for producing the most 
predictable cleavage sites a priori. The decreased cleavage selectivity for the lowest 
charge state (10+) of cytochrome C upon IRMPD is attributed to the generation of mostly 
singly charged product ions near the termini of the protein, which for cytochrome C was 
low in proline and acidic residues, as discussed previously. For CID, there was no 
predictable pattern with respect to the charge states that showed the greatest backbone 
cleavage selectivity, and the overall backbone cleavage selectivity of CID never rivaled 
that obtained by IRMPD (i.e., less substantial blue segments for the CID data in Figure 
5.8). The enhanced cleavage site selectivity for IRMPD is hypothesized to evolve from 
the efficient secondary dissociation of large, highly charged product ions initially 
produced from nonselective backbone cleavage sites (i.e., ones not involving proline or 
acidic residues). To investigate this phenomenon further, MS3 experiments using CID 
were performed in a single pressure linear quadrupole ion trap (LTQ XL) to mimic the 
type of secondary dissociation that is presumed to occur upon IRMPD in the dual 
pressure linear ion trap (Figure 5.9).  Ubiquitin (7+) was dissociated by CID, and the two 





5+) were then individually isolated and subjected to another stage of CID.  
Interestingly, both of these nonselective products dissociate nearly exclusively into ions 
resulting from selective backbone cleavages (i.e., ones labeled with P, D, or E in Figure 
5.9), all of which are similarly observed in the IRMPD spectrum of ubiquitin (7+) 
obtained in the dual pressure linear ion trap (i.e., compare Figure 5.2A with Figure 5.9). 
Therefore, it is evident that secondary dissociation by IRMPD not only reduces the 
overall charge states of product ions but also ultimately induces greater backbone 
cleavage selectivity.  
Lastly, when using the dual pressure linear ion trap mass spectrometer, the most 
abundant product ions in the IRMPD spectra obtained for the lowest precursor charge 
states were attributed invariably to selective backbone cleavages and were also always y 
ions, which is consistent with previous studies showing y-type ions are more stable than b 
ions upon IR irradiation.51 Using this information and the intact molecular weight, it may 
be possible to more rapidly identify proteins with high confidence by only a few pieces of 
data – if the protein sequence is available in the database employed. 
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Figure 5.8 Backbone cleavage site comparison of IRMPD versus CID for (a) 
ubiquitin, (b) myoglobin, (c) cytochrome c, and (d) carbonic anhydrase. 
The blue-shaded areas represent the portion of product ions that stem from 
backbone cleavages that occur C-terminal to acidic residues and/or N-
terminal to proline residues. Those product ions that arise from cleavages 
between DP or EP residues may be classified as both N-terminal to proline 
and C-terminal to acidic residues and thus are collectively categorized as 
"acidic residue/proline" ions (lightest blue color). The red areas represent 
the portion of products arising from other nonselective backbone 
cleavages. The black boxes highlight those charge states that dissociated 
(by IRMPD or CID with the highest overall selectivity towards backbone 

















































































Figure 5.9 MS3 of ions produced from unselective backbone cleavages of ubiquitin. 
(a) CID of [M + 7H]7+ of m/z 1224.5(15% NCE) followed by CID of the 
y59
5+ product ion of m/z 1332.5 (19% NCE). (b) CID of [M + 7H]7+ of m/z 
1224.5 (15% NCE) followed by CID of the y61
5+ product ion of m/z 1378.5 
(19% NCE). Product ions resulting from selective cleavages N-terminal to 
proline and C-terminal to acidic residues are denoted by P and D, E 
(respectively). Product ions resulting from unselective cleavages are 
denoted by , and precursor ions by *. 
 
5.4.5 Current Top-down Algorithm Searching 
Prosight PTM 2.0 was employed to investigate the use of one of the current top-
down searching algorithms for protein identification based on the raw data from the dual 
pressure linear ion trap IRMPD and CID methods. For each Bos taurus protein (e.g., 
ubiquitin and carbonic anhydrase), the charge states that yielded the most selective 
backbone cleavages and the charge states with the greatest sequence coverage (i.e., the 
greatest number of unique backbone cleavages) for both IRMPD and CID were selected 
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for ProsightPTM searching against the Bos taurus protein database (Table 5.1). For 
ubiquitin, the top ranked protein identified from the database search had the correct 
sequence for both dissociation methods and each charge state (i.e., most selective and 
greatest sequence coverage) when considering only the probability and expectation 
scores. IRMPD yielded similar and satisfactory scores for each charge state (i.e. lower p-
scores and lower expectation values signify more confident matches). However, the CID 
scores were quite varied; the charge state (11+) that exhibited the most selective cleavage 
behavior yielded the worst score of any ubiquitin charge state (e.g., p-score = 2.25 x 10-
6), and the charge state giving the greatest sequence coverage (9+) had the best score of 
all charge states (e.g., p-score = 2.16 x 10-18) among both the CID and IRMPD data.  
Conversely, for the much larger and N-terminally modified (acetylation) carbonic 
anhydrase protein, IRMPD outperformed CID most likely due to the more accurate mass 
assignments of the inherently lower charged product ions. Again, the protein was 
successfully identified via the IRMPD data, and both charge states (20+, 22+) yielded 
similar and satisfactory scores. The CID data on the other hand was less successful for 
identification of the protein (i.e., the correct sequence was ranked third) and yielded poor 
p-scores for both charge states (p-score of 2.60 x 10-5 for the 24+ charge state and p-score 
1.42 x 10-7 for the 30+ charge state). Since smaller proteins such as ubiquitin have lower 
precursor charge states compared to larger proteins, product ions are generated in 
relatively low charge states which allow more accurate mass assignments of the fragment 
ions produced by either method (CID or IRMPD) in the dual pressure quadrupole linear 
ion trap. As a result, CID may be the best option for small protein identification using 
current top-down searching algorithms (based on probability and expectation scoring) 
since higher sequence coverage is generally achieved. IRMPD, however, offers clear 
advantages for larger proteins as earlier discussed. The charge state also played an 
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important role in the success of CID; however, a large difference was not found in the 
scores generated from IRMPD mass spectra of proteins in the charge states that yielded 
the most selective cleavages versus those that yielded the greatest number of sequence 
ions. Interestingly, even though IRMPD consistently produced fewer sequence ions and 
resulted in lower sequence coverage as compared to CID, protein identification was more 
successful by IRMPD because product ions were assigned with greater confidence due to 
their lower charge states.   
Since IRMPD yields abundant product ions arising from cleavage sites adjacent to 
N-terminal prolines and C-terminal acidic residues (glutamic acid and aspartic acid), PDE 
scores, which take into account these selective cleavages, were also used to gauge protein 
identification confidence (Table 5.1). PDE scoring utilizes weighting factors that are 
multiplied by the abundances of product ions that result from selective backbone 
cleavages as described in the Experimental Section of this study. The PDE weighting 
factors include 7x for ions arising from cleavages N-terminal to proline and C-terminal to 
glutamic acid (EP), 5x for ions related to cleavages N-terminal to proline (P), 5x for ions 
stemming from cleavages C-terminal to aspartic acid (D), and 2x for ions arising from C-
terminal to glutamic acid (E) cleavages. As expected, the charge states that promoted the 
most selective fragmentation (for both activation methods) resulted in the highest and 
best scores even with inherently lower total numbers of product ions and lower sequence 
coverage. For ubiquitin, the highest PDE score (560) was obtained from the CID mass 
spectrum of the 11+ charge state due to a very high percentage of product ion signal 
attributed to cleavages between glutamic acid and proline (EP) residues. However, the 
charge state (7+) that exhibited the highest backbone cleavage selectivity upon IRMPD 
also had a high PDE score (384), but unlike CID, was in a predictable low charge state. 
For the larger carbonic anhydrase protein, the charge state that yielded the greatest 
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cleavage selectivity upon IRMPD (20+) gave the highest PDE score as compared to the 
charge state that yielded the greatest sequence coverage by IRMPD (22+) or each charge 
state by CID (i.e., the ones which produced the most selective and the greatest sequence 
coverage).  
In summary, IRMPD in the dual pressure linear ion trap allowed confident protein 
identification using various scoring options in top-down searching algorithms. Due to the 
distinctive and elevated backbone cleavage selectivity observed upon IRMPD over CID, 
protein identification confidence potentially could be increased further by placing an 
even higher emphasis on backbone cleavages N-terminal to proline and C-terminal to 
acidic residues, especially when undertaking IRMPD on the lowest precursor charge 
states. 
 
_____________________________________________________                            _                          
                 dissociation      dissociation  
Protein (charge state)    method*           behavior          ranking      p-score    expectation    PDE             
 
Ubiquitin (7+)           IRMPD           most selective 1        6.08 x 10-10       1.74 x 10-3       384 
Ubiquitin (9+)           IRMPD           most coverage 1        3.29 x 10-9         9.43 x 10-3       189 
Ubiquitin (11+)                 CID            most selective 1        2.25 x 10-6         6.45                560 
Ubiquitin (9+)                 CID                 most coverage 1        2.16 x 10-18       6.19 x 10-12     105  
    
Carbonic Anhydrase (20+)  IRMPD           most selective 1        3.65 x 10-11        1.05 x 10-4       270   
Carbonic Anhydrase (22+)  IRMPD           most coverage 1        2.72 x 10-10       7.81 x 10-4        228 
Carbonic Anhydrase (24+)  CID            most selective 3        2.60 x 10-5         74.7                 157 
Carbonic Anhydrase (30+)  CID            most coverage 3        1.42 x 10-7         4.07 x 10-1        143 
 _____________________________________________________                            _                                       
*IRMPD was performed in the low pressure cell; CID was performed in the high pressure 
cell. 
 




IRMPD afforded efficient dissociation of intact protein cations in a dual pressure 
linear ion trap.  Product ions from IRMPD were formed in significantly lower charge 
states compared to the ones generated by CID. Furthermore, IRMPD of the lowest charge 
states of the protein precursor ions produced the highest degree of selective backbone 
cleavages (i.e., N-terminal to proline and C-terminal to acidic residues) as compared to 
higher charge states of the same method or any charge state by CID. These attributes of 
IRMPD are particularly beneficial for a priori spectral predictions and improved 
algorithm searching for protein identification by top-down methods using trapping 
instruments. Furthermore, with the use of ion parking via ion-ion reactions prior to ion 
activation,50, 52 the ion signal could be concentrated in a low precursor charge state 
followed by IRMPD to yield the highest backbone cleavage selectivity with maximum 
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Ultrafast Ultraviolet Photodissociation at 193 nm and its Applicability 
to Proteomic Workflow  
 
6.1 Overview 
Ultraviolet photodissociation (UVPD) at 193 nm was implemented on a linear ion 
trap mass spectrometer for high-throughput proteomic workflows. Upon irradiation by a 
single 5 ns laser pulse, efficient photodissociation of tryptic peptides was achieved with 
production of a, b, c, x, y, and z sequence ions, in addition to immonium ions and v and w 
side-chain loss ions. The factors that influence the UVPD mass spectra and subsequent in 
silico database searching via SEQUEST were evaluated. Peptide sequence aromaticity 
and the precursor charge state were found to influence photodissociation efficiency more 
so than the number of amide chromophores, and the ion trap q-value and number of laser 
pulses significantly affected the number and abundances of diagnostic product ions (e.g., 
sequence and immonium ions). Also, photoionization background subtraction was shown 
to dramatically improve SEQUEST results, especially when peptide signals were low. A 
liquid chromatography – mass spectrometry (LC-MS) – UVPD strategy was implemented 
and yielded comparable or better results relative to LC-MS – collision induced 
dissociation (CID) for analysis of proteolyzed bovine serum albumin and lysed human 





Large scale, “bottom-up” characterization of cellular proteomes has been 
enormously successful1 and continues to improve due to ongoing innovation in the areas 
of mass spectrometric instrumentation, tandem mass spectrometry (MSn) techniques, 
sampling, separations, and bioinformatics. Typical high-throughput, bottom-up 
workflows consist of the separation of complex mixtures of digested proteins followed by 
online mass spectrometry (MS) and MSn analysis. Proteins are then qualitatively and/or 
quantitatively identified by in silico database searching algorithms that interpret the MS 
data. Four of the most popular algorithms, SEQUEST,2 MASCOT,3 OMSSA,4 and X! 
Tandem,5 were recently compared,6 and each algorithm yielded acceptable and similar 
results for a complex human protein sample. In terms of MS instrumentation, the 
introduction of the Orbitrap7, 8 and hybrid linear ion trap (LIT)-Orbitraps9, 10 have 
afforded significantly better mass accuracy and resolution (i.e., a resolving power of 
~80,000 – 100,000 at  m/z of around 1000)7, which has greatly increased selectivity in 
database searching for bottom-up experiments. Also, the analysis times of mass 
spectrometers continue to decrease. The newly released dual-pressure linear ion trap 
(Velos),11 for example, has decreased cycle times two-fold by technological advances 
that eliminate prescans and allow faster scan rates in a low pressure trap.  This 
improvement significantly increased the experimental duty cycle over more traditional 
trapping instruments, resulting in more protein identifications and a deeper depth of 
analysis into the proteome.11 Moreover, the benefits and growing popularity of ultrafast 
separation techniques (e.g., ultra high performance liquid chromatography (UHPLC), 
microfluidics, capillary electrophoresis (CE), etc.), will certainly spur the development of 
even faster MS instrumentation as well as strategies that can efficiently sample extremely 
narrow peaks.  
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For successful protein identification, bottom-up approaches rely on the collection 
of informative tandem mass spectra that critically depend on the activation technique 
used. In recent years there have been many advances in activation technology, but there 
still remains no universal method that can successfully and efficiently analyze all proteins 
and their peptide constituents. The two most popular tandem mass spectrometric 
techniques used in large scale analysis of cellular proteins are the traditional collision 
induced dissociation (CID) and the more recently introduced electron transfer 
dissociation (ETD).12 The latter has shown the most success for identifying and 
sequencing phosphorylated peptides and was recently shown to significantly outperform 
CID in characterizing the phosphoproteome of various human cells.13, 14 CID on the other 
hand, is an established, sensitive, and robust method that has successfully identified the 
most proteins based on analysis of complex tryptic peptide mixtures in shotgun bottom-
up experiments.15, 16 Higher-energy C-trap dissociation (HCD), a form of CID that allows 
smaller m/z product ions to be detected, has recently been implemented on the newest 
hybrid Orbitraps and has yielded comparable results to that of CID for complex 
biological samples.10, 17 All of the techniques just described (CID, ETD, and HCD) 
require between 10 – 100 ms of activation time (depending on the specific instrument and 
analytes) for efficient precursor dissociation, posing a significant drawback with respect 
to implementation of high throughput strategies. 
The use of single or multiple photons for activation and dissociation of peptides 
has also shown promise. 18-21 Ultraviolet photodissociation at 193 nm of peptides was 
first performed in the 1980’s,22-25 but experiments were limited to a few selected peptides 
on Fourier transform ion cyclotron resonance (FTICR) mass spectrometers. A recent 
renaissance in the use of short wavelength (157 and 193 nm)26-31 ultraviolet 
photodissociation (UVPD) coupled mainly to time-of-flight (TOF) instruments has 
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occurred due to the ultrafast (nanosecond) activation timescales and the rich tandem mass 
spectrometric information obtained (i.e., more types of backbone ions are observed 
compared to traditional activation methods). There have been noteworthy inroads in the 
implementation of MALDI-TOF-MS with UVPD for high-throughput proteomic 
workflows,32 although inefficient ion activation has hindered the analysis of the lowest 
abundance proteins/peptides,27 coupled with the typical need for ~2000 spectral averages 
(~40 s) for each spectrum.26, 32 Another recently introduced and promising 
photodissociation method, femtosecond laser induced ionization/dissociation (fs-LID), 
produced rich fragmentation patterns for peptides (i.e., a, b, c, x, y, and z ions were all 
observed) using extremely fast femtosecond laser pulses, yet required rather long total 
activation periods (up to 200 ms).33 
If a single short UV pulse (5 ns) was employed for photodissociation for high-
throughput liquid chromatography – tandem mass spectrometry (LC-MS/MS) instead of 
using conventional CID (30 msec activation time), an additional 1800 peaks could 
conceivably be analyzed per hour of analysis using traditional quadrupole ion traps.20 
This increase in duty cycle would be even more dramatic when using newer generation 
linear ion traps,11 or when directly compared to strategies that use the slower activation 
methods such as ETD (typically 100 msec activation time). However, if the spectral 
information produced by UVPD pales in comparison to that afforded by gold standard 
methods such as CID, then the benefits of ultrafast photoactivation will be negated. 
Therefore, a thorough comparison of UVPD and CID as applied to LC-MS/MS analysis 
and in silico data interpretation is warranted. 
In the present study, UVPD at 193 nm is implemented on a linear ion trap mass 
spectrometer for high-throughput proteomic workflows. Efficient photodissociation of 
tryptic peptides is achieved using a single 5 ns laser pulse with minimal need for spectral 
 
119
averaging. The factors that affect the optimization of universal photodissociation 
parameters for LC-MS/UVPD experiments and successful in silico database searching via 
SEQUEST are investigated. This ultrafast photodissociation method yields comparable or 
better results compared to CID for complex samples of proteolyzed bovine serum 
albumin (BSA) (1 µg) and lysed human HT-1080 cytosolic fibrosarcoma cells (10 µg 
lysate) and represents a high-throughput LCMS/MS strategy based on photodissociation 





All acids and buffer components, BSA, proteomics grade trypsin, and all model 
peptides were purchased from Sigma-Aldrich (St. Louis, MO), except the peptides 
KRPPGFSPFR, YRPPGFSPFR, DRVYIHPFHLVIH, DAEFRHDSGYQVHHQK, 
HCKFWW, GNHWAVGHLM, and ASHLGLAR, which were purchased from 
BACHEM (King of Prussia, PA). KAKAA and RAAAA were synthesized by Bio Basic 
(Ontario, Canada). Solvents for direct infusion and HPLC were obtained from Fisher 
Scientific (Fairlawn, NJ).   
 
6.3.2 Sample Preparation 
BSA was reduced by adding a 10-fold molar excess of dithiothreitol (DTT) (100 
µL of 1.0 mM DTT) to 10 nmoles of BSA (10 µL of 1.0 mM protein), which was 
buffered to a pH of ~8.4 with ~4 µmoles ammonium bicarbonate. This solution was then 
incubated for one hour at 40 ˚C after which alkylation was performed by adding 4.0 µL 
of 1.0 M iodoacetamide (buffered to a pH of ~8.0 with ~20 µmoles ammonium 
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bicarbonate). This solution was incubated at ambient temperature for 45 minutes in the 
dark followed by subsequent quenching by the addition of excess DTT. For enzymatic 
digestion, 5.0 µL of 1.0 mg/mL trypsin in 1.0 mM HCl was added to the 
reduced/alkylated solution followed by incubation at 37˚C for 16 hours. 
HT1080 cells were suspended in low-salt buffer (10 mM Tris-HCl, 10 mM KCl, 
1.5 mM MgCl2, pH 8.0) to swell, and were then lysed by dounce homogenization. The 
whole cell lysate was centrifuged at 1000 × g to clarify the soluble lysate and to remove 
the insoluble pellet. Soluble lysate (2 mg/mL protein) was denatured by addition of 2,2,2-
trifluoroethanol (TFE) to 50% (vol/vol) and reduced with 15 mM DTT at 55˚C for 45 
min. Following reduction, the proteins were alkylated with 55 mM iodoacetamide at 
room temperature for 30 min. The sample was diluted in digestion buffer (50 mM Tris-
HCl, 2 mM CaCl2, pH 8.0) to a final TFE concentration of 5% (vol/vol). Trypsin was 
added to a 1:50 (enzyme:protein) concentration (w/w), and the sample was incubated at 
37˚C for 5 hrs.  The digestion was quenched with 1% formic acid and sample volume 
was reduced to 20 μl by centrifugation under reduced pressure using a SpeedVac.  
Digested peptides were bound and washed on Thermo Fisher Scientific HyperSep C-18 
SpinTips (San Jose, CA), resuspended in peptide buffer (95% H2O/5% acetonitrile/0.1% 
formic acid) and filtered through Millipore Microcon 10 kDa centrifugal filters (Billerica, 
MA), with the digested peptides collected as flow-through.   
 
6.3.3 Mass Spectrometry, Ultraviolet Photodissociation, and Liquid 
Chromatography 
Analysis by mass spectrometry was performed on a Thermo Fisher Scientific 
LTQ XL linear ion trap (LIT) mass spectrometer (San Jose, CA) outfitted with a 
Coherent ExciStar XS excimer laser (Santa Clara, CA) operated at 193 nm. The laser 
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setup was similar to that previously described,34 except a CaF2 lens was used to transmit 
193 nm photons into the LIT.  For UVPD experiments, the laser was pulsed once per scan 
with an energy of 8 mJ/pulse and a pulse duration of 5 ns. Pulse variable experiments 
used a laser pulse frequency of 500 Hz. For CID, a 30 ms activation time and a q-value of 
0.25 were used. For direct infusion, peptides were diluted to 10 M in 50/50 MeOH/H2O 
and 1% acetic acid prior to ESI-MS/MS analysis. The automated gain control (AGC) was 
set to 3×104 for MS and 1×104 for MSn scans.  An ESI voltage of 4 kV and a heated 
capillary temperature of 180°C were used for all mass spectrometry experiments.   
Liquid chromatography was performed using a Dionex UltiMate 3000 system 
(Sunnyvale, CA) using a capillary flow splitter. An Agilent ZORBAX 300SB-C18 column 
(Santa Clara, CA) (150 × 0.3 mm, 5 µm particle size) was used for all separations. The 
column temperature was kept constant at 40°C.  Eluent A consisted of 0.1% formic acid 
in water and eluent B 0.1% formic acid in acetonitrile. A linear gradient from 5% eluent 
B to 40% eluent B over 65 min at 5 µL/min was used. Injections of approximately 1 µg 
(20 picomoles) were used for the digested BSA sample and 10 µg for the HT-1080 lysate 
sample. Data-dependent LC-MS/MS was performed in two different ways. For LC-
MS/UVPD runs (i.e., only UVPD was used for activation), the first event was the full 
mass scan (m/z range of 400 – 2000) followed by ten consecutive UVPD events on the 
ten most abundant ions from the full mass scan with one UV pulse applied per MS/MS 
scan. A q-value of 0.1 was used for each UVPD event. For LC-MS/UVPD/CID runs (i.e., 
comparison between UVPD and CID), the first event was the full mass scan (m/z range of 
400 – 2000) followed by ten alternating UVPD/CID events on the five most abundant 
peaks for a total of five UVPD and five CID events per cycle. A q-value of 0.25, an 
activation time of 30 ms, and a normalized collision energy (NCE) of 35% were used for 
each CID scan event; NCE = (voltage × 30) / (0.000062 × m/z × 0.006325) in which 
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0.000062 is the TickAmpSlope and 0.006325 is the TickAmpInt. A q-value of 0.1 and a 
default activation period of 30 μs were used for each UVPD event. Although the actual 
irradiation time was only 5 ns (the duration of a single laser pulse) for UVPD, the 
commercial LTQ software limited the activation period to a minimum of 30 μs. The 
maximum injection time for all mass scan and MS/MS events was set to 100 ms. The 
dynamic exclusion duration was set to 50 s, the exclusion list size allowed for 500 
specified m/z values, and a single repeat count for LC-MS/UVPD and two repeat counts 
for LC-MS/UVPD/CID experiments. Each centroid mass spectrum and tandem mass 
spectrum was the average of three microscans. UVPD precursor dissociation efficiencies 
as well as pulse-variable and q-variable plots were calculated from ion peak areas using 
Origin 7.0.  Photodissociation efficiency (expressed as a percentage) is defined as 
follows: 100 – [(surviving precursor abundance/initial isolated precursor abundance) x 
100)], in which the precursor abundances are measured as ion peak areas. 
 
6.3.4 Background Subtraction and Data Analysis  
Prior to SEQUEST interpretation of the MS/MS data, UVPD mass spectra were 
subjected to a background subtraction procedure to reduce/eliminate photoionization 
products as described in detail in the results and discussion section. Background spectra 
were collected when no sample was being infused and thus no ions were detected in the 
trap, and at isolation m/z values of 250, 500, 750, or 1000 (isolation width of 4 m/z), 
using a protocol discussed in more detail later. Each centroid background spectra was the 
culmination of 20 averages of three microscans. The LC-MS/UVPD RAW files were 
subtracted from the background RAW files using Thermo Fisher Xcalibur version 2.0.7 
software.   
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SEQUEST was used for in silico MS/MS interpretation through the Thermo 
Fisher Scientific Proteome Discoverer 1.0 software package. For SEQUEST, a 
signal:noise ratio of 3, a precursor mass tolerance of 1.5 Da, and a fragment mass 
tolerance of 0.8 Da were used. Product ion series for UVPD included a, b, c, x, y, and z 
ions, and for CID included b and y ions except where noted. UVPD and CID spectra were 
manually separated from LC-MS-UVPD/CID files for direct comparison. Non-redundant, 
bovine (25,243 sequences) and human (33,819 sequences) protein databases from the 
NCBI were used for searching of BSA and HT-1080 samples, respectively. Oxidation of 
methionines and carbamidomethyl modification of cysteines were set as dynamic and 
static (respectively) side chain modifications. Peptide hits were filtered against decoy 
databases at a 1% false discovery rate (FDR) (based on Xcorr vs. charge), and were 
manually verified by the presence of matching immonium ions and predicted sequence 
ions (from selective cleavages). Peptides with less than six amino acids were also filtered 
out.  
 
6.4 Results and Discussion 
Activation of multiply-charged peptide cations upon absorption of 193 nm 
photons produces a mixture of a, b, c, x, y, and z ions and a few w and v side-chain loss 
ions. Foremost the b/y series followed by the a/x series are generally observed as the most 
abundant products, often yielding almost full sequence coverage from each of these four 
ion types. These spectra will be discussed in more detail later in the context of the study.  
As previously observed for photodissociation of peptides at 157 nm,30 singly-charged 
precursors result in more abundant products arising from side-chain losses as compared 
to those from multiply-charged precursors, which predominate in LC-MS/MS analysis.  
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Therefore, the generation of an extensive array of abundant a, b, c, x, y, and z sequence 
ions in addition to immonium ions indicates that  the UVPD spectra at 193 nm are well 
suited to in silico database searching, as shown in this study. 
 
6.4.1 Impact of Aromatic Side-chains and Charge State on UVPD 
 Having a set of robust and universal activation parameters that will yield both 
high dissociation efficiencies and informative product ions is important for analyzing a 
variety of peptides of different sizes, amino acid sequences, and charge states in a single 
LC-MS/MS run. In the present study, the UV photodissociation efficiencies were 
evaluated for a series of peptides of varying lengths, charge states, and sequences, 
including ones containing residues with aromatic side-chains. The results are summarized 
in bar graph form in Figure 6.1A, in which the abundance of the surviving precursor is 
monitored relative to the abundance of the original precursor ion, thus allowing 
estimation of photodissociation efficiencies using a single (5 ns, 8 mJ) pulse.  Figure 
6.1A shows the photodissociation efficiencies relative to the number of aromatic side-
chains, ranging from zero to three.  The photodissociation efficiency increases with the 
number of amino acids containing aromatic side-chains (tryptophan, tyrosine, 
phenylalanine), with efficiencies ranging from 50% for ASHLGLAR (2+) to 98% for 
HCKFWW (2+). This trend was also observed for peptides with nearly identical 
sequences (e.g., KRPPGFSPFR, RPPGFSPFR, and YRPPGFSPFR, all 2+), but differing 
by one aromatic group. KRPPGFSPFR and RPPGFSPFR each contained two aromatic 
groups and yielded similar photodissociation efficiencies of 80 + 2% and 78 + 3%, 
respectively. YRPPGFSPFR, on the other hand, contains an additional tyrosine and 






























































































































































































































































































































Figure 6.1 (a) Photodissociation efficiencies of peptides (2+ charge state) with 
varying numbers of aromatic side-chain residues (phenylalanine, tyrosine, 
and tryptophan); the number of aromatic side-chains increases from left to 
right. (b) Photodissociation efficiencies of peptides with constant aromatic 
side-chain residues (one phenylalanine and one tyrosine) with varying 
peptide length and charge state. Each peptide was dissociated with one 5 
ns, 8mJ pulse and a q value of 0.1. Photodissociation efficiency is defined 
as follows: 100 – [(surviving precursor abundance/isolated precursor 
abundance) × 100). Aromatic residues are underlined. 
 
The total abundances of the immonium product ions (based on peak areas) were 
plotted as a function of the number of laser pulses for the doubly-charged YRPPGFSPFR 
(Figure 6.2). The abundances of the arginine (R), serine (S), and proline (P) immonium 
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ions increase on going from one to two UV pulses and plateau after two laser pulses. 
However, for the phenylalanine (F) and tyrosine (Y) immonium ions, the abundances of 
the Y immonium ions steadily decrease after the first pulse and likewise the abundances 
of the F ions diminish after the third pulse (see inset), a result consistent with their 
enhanced secondary dissociation due to higher photoabsorptivity. Similarly, the decrease 
in the abundance of the tyrosine immonium ions substantially exceeded the decrease in 
abundance of the phenylalanine immonium ions, suggesting a significant difference in 
photoabsorptivities or stabilities of these two species. The general consensus for vacuum 
UVPD (157 and 193 nm) is that photodissociation efficiency is generally mediated by the 
photoabsorptivities of the backbone amide chromophores.19, 24, 31 While this is true for 
peptides with no F, Y, and W residues, the presence of amino acids bearing these 
aromatic side-chains seems to strongly influence the dissociation behavior in the present 
study, as noted in Figure 6.1A and Figure 6.2, and as also noted previously for UVPD at 
266 nm.35  
In Figure 6.1B, the photodissociation efficiency is shown for a series of peptides 
containing the same number and types of aromatic amino acids (one phenylalanine and 
one tyrosine), while the lengths and charge states of the peptides are varied.  Each peptide 
from the shortest (DRVYIHPF, 8 residues) to the longest (DAEFRHDSGYQVHHQK, 16 
residues) yielded nearly identical photodissociation efficiencies, ranging from 69 to 85% 
even when the total number of amino acids doubled.   Also, as the charge state increased, 
the photodissociation efficiencies increased, presumably due to some combination of 
greater proton mobility and greater coulombic repulsion, an effect also observed 
previously for IR photodissociation.36 The results in Figure 6.1 reinforce that the number 
of aromatic side-chains and the precursor charge state influence photodissociation 
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Figure 6.2 Immonium ion product area versus the number of laser pulses (5 ns, 8 mJ 
per pulse) for YRPPGFSPFR (2+) at a q-value of 0.045. The areas of 
arginine (R) and proline (P) immonium ions are summed together since 
their nominal m/z values are isobaric. The inset is zoomed in on the 
product ion areas of serine (S), phenylalanine (F), and tyrosine (Y). G 
immonium ions are not typically observed and thus are not monitored. The 
R and P immonium ions have the same m/z values and thus are monitored 
collectively. 
 
6.4.2 Impact of Number of Laser Pulses and RF Trapping Voltage on UVPD 
The influence of the number of laser pulses and the rf trapping voltage (as 
reflected by the q-value) on peptide dissociation was examined for the doubly- and triply-
charged state of YRPPGFSPFR (Figure 6.3). The percentages of sequence, immonium, 
and precursor ions (based on ion peak areas) were tracked as a function of the varied 
parameter (i.e., number of pulses or q-value). Upon increasing the number of laser pulses 
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while maintaining a constant q-value of 0.05, the abundances of sequence ions increased 
up until two laser pulses for the doubly-charged species (Figure 6.3A) and up until 
between one and two laser pulses for the triply-charged species (Figure 6.3B), after 
which the abundances of these ions decreased. As the abundances of the precursor and 
sequence ions decreased with increasing laser pulses, immonium ions dominated the 
spectra especially after the fourth pulse for the doubly-charged species and the third pulse 
for the triply-charged species; this trend is attributed to their formation and survival upon 
UVPD of the precursor ions as well as ongoing secondary dissociation of primary 
sequence ions into immonium ions.  
Upon increasing the q-value while keeping the number of laser pulses constant 
(using a single 8 mJ, 5 ns pulse), higher q-values (especially increasing from 0.05 to 0.1) 
resulted in a greater extent of precursor dissociation and more sequence information 
without significant loss of low mass diagnostic ions upon activation of both the doubly- 
and triply-charged precursors (Figure 6.3C and Figure 6.3D). However, at q-values 
above approximately 0.15, many low mass sequence and immonium ions were lost due to 
limitations associated with the low mass cutoff (LMCO) inherent to ion traps. Even for 
low m/z precursors (e.g., peptides in high charge states) where there is no significant 
LMCO, using higher q-values (0.1 versus 0.05) resulted in increased sequence 
information as seen for triply-charged ASHLGLAR in Figure 6.4. This increase in 
sequence information at higher q-values likely arises from the reduction in the size of the 
ion cloud and thus its better overlap with the laser beam in the ion trap, which has been 




















































Figure 6.3 Percent abundances (as measured by peak area) of diagnostic and 
precursor ions versus number of laser pulses for (a) [YRPPGFSPFR + 
2H]2+ (b) [YRPPGFSPFR + 3H]3+. Percent abundances (as measured by 
peak area) of diagnostic and precursor ions versus q-value for (c) 
[YRPPGFSPFR+ 2H]2+ (d) [YRPPGFSPFR+ 3H]3+. The q-value was held 
at 0.045 for pulse variable experiments. For variable q-value experiments, 


































































Figure 6.4 UVPD spectra of the model peptide ASHLGLAR (3+) using an activation 
of a single 5 ns, 8 mJ pulse at 193 nm and a q-value of (a) 0.1 and (b) 
0.05. Circled sequence ions are unique to the spectrum collected at a q-
value of 0.1. All other peaks (product ions) were observed in both spectra 
(q-value = 0.1 and q-value = 0.05). The precursor is denoted by *. 
 
To afford the most informative tandem mass spectral information (with respect to 
sequence and immonium ions) in the most high-throughput manner, a single 5 ns (8 mJ) 
laser pulse and a q-value of 0.1 was used as the universal set of dissociation parameters 
for the remainder of the LC-MS/UVPD study. Using these activation parameters, full 
sequence coverage from both N-terminal and C-terminal ions was achieved from a rich 
array of diagnostic ions for two tryptic-like peptides, YRPPGFSPFR (3+) and 
ASHLGLAR (2+), each which have significantly different dissociation efficiencies as 
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previously described (see Figure 6.5 for spectra). Furthermore, the presence of the side-
chain loss sequence ions, w3 and w5, from ASHLGLAR (Figure 6.5B) allows the 
differentiation of the isobaric leucine and isoleucine residues; however, this ion type has 
yet to be incorporated into current in silico algorithms. 
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Figure 6.5 UVPD spectra of the model peptides (a) YRPPGFSPFR, 3+ and (b) 
ASHLGLAR, 2+. A q-value of 0.1 and an activation of one 5 ns, 8 mJ 





6.4.3 LC-MS/UVPD with Background Subtraction for In Silico Interpretation 
Upon introducing 193 nm photons into the linear ion trap, significant ion 
abundances are seen from photoionization products. Similar products have been observed 
previously using 157 nm UVPD and are thought to originate from photoionization of 
background organic species in the vacuum system.30 This photoionization phenomenon is 
illustrated in Figure 6.6. With no sample solution being infused or analyte ions injected 
into the ion trap, the region of the mass spectrum from m/z 496 to 504 was isolated to 
empty the trap of any residual ions (Figure 6.6A). Upon subsequent irradiation of the 
trapping volume using one 5 ns (8 mJ) laser pulse, significant background 
photoionization products are observed around ~m/z 200 (Figure 6.6B). These products 
are problematic because they overlap with potential low m/z diagnostic ions, impeding in 
silico spectral interpretations and reducing sensitivity. Therefore, a procedure for 
photoionization background subtraction was implemented and applied to subsequent LC-
MS/UVPD runs in conjunction with standard in silico database searching (via 
SEQUEST). The background spectrum must be representative of the types and 
abundances of background ions formed during UVPD spectra, thus requiring acquisition 
using a similar scan program (i.e., similar trapping conditions and time segments).  To 
achieve this goal, background spectra were collected using various m/z isolation windows 
(e.g., 250 + 4, 500 + 4, 750 + 4, and 1000 + 4) in an effort to find a universal background 
spectrum that could be applied to entire LC-MS/MS runs and also avoid loss of ions due 
to the LMCO. Photoionization abundances differed between the various m/z isolation 
windows used as seen in Figure 6.7 due to variations in trapping efficiencies. 
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Figure 6.6 (a) Isolation of m/z 500 + 4 with no sample solution infusion and the laser 
off and (b) isolation of m/z 500 + 4 with no solution infusion and the laser 





































Figure 6.7 Background photoionization spectra using an isolation of (a) m/z 250 + 4, 
(b) m/z 500 + 4, (c) m/z 750 + 4, and (d) m/z 1000 + 4. Each spectrum was 
collected with no sample solution infusion, and UVPD activation of one 5 
ns (8 mJ) pulse and the q-value was set to 0.1. 
 
The effectiveness of the background subtraction on the UVPD spectra can be seen 
in Figure 6.8 for the BSA tryptic peptide LGEYGFQNALIVR (2+) using an isolation 
window of m/z 500 + 4.  Table 6.1 shows the SEQUEST results obtained for the tryptic 
digest of BSA analyzed by LC-MS/UVPD both without background subtraction and with 
background subtraction using background spectra acquired using the four different m/z 
isolation windows as described above (statistics were based on three runs). For each 
SEQUEST score (Xcorr and probability), a higher confidence is associated with a higher 
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score (this scoring system will be described in more detail later in this study). The use of 
background subtraction applied to entire LC-MS/UVPD runs significantly enhanced 
SEQUEST identifications and scores (XCorr and probability) for all four background 
subtraction options as compared to using no background subtraction procedure. 
Background subtraction of the photoionization spectrum acquired by isolating m/z 500, 
750, and 1000 all outperformed the m/z 250 isolation window. The background spectra 
acquired using the m/z 250 window yielded lower photoionization product abundances 
compared to the other three isolation windows, thus resulting in a less effective 
subtraction of the background ions from the UVPD spectra.  From these results, 
background subtraction using photoionization spectra at isolation windows of m/z 500 + 
4, 750 + 4, or 1000 + 4 were applied individually to all LC-MS/UVPD spectra for the 
remainder of the study to improve algorithm confidence and peptide identification. The 
best in silico searching results were then used for CID comparisons in subsequent 
sections. 






























































Figure 6.8 LC-MS/UVPD spectrum of the BSA peptide LGEYGFQNALIVR (2+) 
with (a) no background subtraction and (b) with background subtraction. 
A q-value of 0.1 and a photoactivation of one 5 ns, 8 mJ pulse were used 
for each spectrum. Background subtraction was achieved by subtracting 
the photoionization background spectrum (photoactivation after isolation 
of m/z 500 + 4) from the entire LC-MS/UVPD run. The precursor is 
denoted by *, and each spectrum is the average of three microscans. 




Subtraction m/z 250   m/z 500  m/z 750  m/z 1000  
 
Sequence Coverage 66 + 4%  70 + 3%  74 + 3%  75 + 4%  76 + 5% 
 
Max Sequence Coverage 69%  74%  77%  78%  81% 
 
Protein Score  409 + 19 555 + 33 683 + 20 709 + 20 677 + 25 
 
Max Protein Score 425.26  583.26  699.08  729.49  705.51 
 
Number of Peptides 111 + 7  141 + 9  171 + 8  195 + 21 198 + 17 
 
Unique Peptides  41 + 3  43 + 1  47 + 4  48 + 3  49 + 5 
 
Max Peptide Xcorr Score 7.48  7.73  7.44  7.21  7.42 
 
∑ Peptide Xcorr Score 371 + 20 471 + 22 561 + 22 623 + 55 632 + 38 
 
Max Peptide Prob. Score 128.26  140.85  300.00  300.00  130.40 
 
∑ Peptide Prob. Score 3055 + 85 3977 + 196 4807 + 136 5248 + 248          5150 + 263 
 
 
Table 6.1 SEQUEST analysis of LC-MS/UVPD of a BSA tryptic digest without 
background subtraction, and with background subtraction using 
background spectra from various isolation m/z. Each isolation (m/z 250, 
m/z 500, m/z 750, and m/z 1000) has a width of + 4 u. For each LC-
MS/UVPD run, an activation of one 5 ns (8 mJ) pulse and q-value of 0.1 
was used. Background spectra were collected with no ESI infusion at the 
beginning of the first of three LC-MS/UVPD runs. For each type of 
SEQUEST score, a higher confidence is associated with a higher score. 
 
6.4.4 LC-MS/MS: Comparing UVPD and CID 
A data-dependent LC-MS/MS method was developed that enabled alternating 
UVPD and CID scans of each peptide ion and allowing the most direct comparison of the 
attributes of the resulting tandem mass spectra upon application of the search algorithms. 
SEQUEST comparisons of the resulting LC-MS/MS data acquired for a tryptic digest of 
BSA are summarized in Table 6.2. A major reason SEQUEST was selected as the search 
algorithm over other algorithms such as MASCOT and OMSSA is that all major product 
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ion types (e.g., a, b, c, x, y, z) can be searched simultaneously in each spectrum. This 
capability directly benefits peptide identification and scoring for UVPD since Xcorr 
scores (the major peptide scoring system of SEQUEST) are a measure of how well a 
theoretical spectrum matches an experimental spectrum, and UVPD yields richer spectra 
with more a, b, c, x, y, and z ions compared to the array of ions obtained upon CID 
(typically b and y). In general, the UVPD spectra lead to significantly higher peptide 
Xcorr scores relative to those arising from the analogous CID spectra, often resulting in a 
higher number of peptide identifications (comparing the first column with the third 
column of Table 6.2). Examples of spectra illustrating this outcome are shown in Figure 
6.9 for the BSA peptide RPCFSALTPDETYVPK (3+) identified via LC-MS/MS. UVPD 
generated significantly more sequence ions and greater coverage than did CID, the latter 
which suffered both from the loss of diagnostic ions from the ion trap due to the low 
mass cutoff and missed backbone cleavages. The resulting Xcorr scores for 
RPCFSALTPDETYVPK (3+) from UVPD and CID were 4.90 and 3.58, respectively.  
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UVPD  UVPD   CID  CID 
(a,b,c,x,y,z)  (b,y)  (b,y)              (a,b,c,x,y,z) 
 
                                                                                                                                                                       
Number of Peptides   100 + 3  73 + 8  80 + 5  83 + 3 
 
Number of Peptides    80 + 4  68 + 7  77 + 3  79 + 1 
(1.1 probability filter) 
 
Unique Peptides    37 + 1  30 + 1  35 + 2  33 + 3 
 
Unique Peptides     33 + 1  29 + 1  34 + 2  32 + 3 
(1.1 probability filter) 
 
Max Peptide Xcorr Score   7.19  5.16  5.17  5.61 
 
∑ Peptide Xcorr Score   309 + 16 193 + 18 231 + 2  231 + 11 
 
Max Peptide Prob. Score   300.00  126.79  129.22  126.79 
 
∑ Peptide Prob. Score   2844 + 187 2472 + 174 2851 + 59            3067 + 117 
 
 
Table 6.2 SEQUEST results of LC-MS/UVPD/CID of a BSA tryptic digest based on 
triplicate runs. UVPD and CID were both searched using a,b,c,x,y,z and 
b,y product ions as indicated in the table. An activation of one 5 ns (8 mJ) 
pulse, and q-value of 0.1 was used for UVPD. For each SEQUEST score, 
a higher confidence is associated with a higher score. 
 
To investigate whether this increase in scoring was a direct result of increased 
spectral information upon UVPD or rather an artifact of searching using a greater array of 
sequence ions (i.e., searching with a, b, c, x, y, z for UVPD versus b, y for CID), both the 
UVPD and CID spectra were searched first using a, b, c, x, y, z and then again using only 
b, y product ions as seen in Table 6.2. For the UVPD data, searching with more ions 
dramatically increased peptide identifications and scoring as compared to searching with 
only b and y ions (comparing the first and second columns of Table 6.2). There was no 
significant difference within error (statistics based on three runs), however, when 
searching with a, b, c, x, y, z versus just b, y for the CID data (comparing the third and 
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fourth columns of Table 6.2). Therefore, the increase in scoring and number of peptide 
identifications obtained from the UVPD data is likely the result of more informative 




























































































































Figure 6.9 (a) UVPD spectrum (193 nm) of the BSA peptide 
RPCFSALTPDETYVPK (3+), q-value of 0.1 and an activation of one 5 
ns, 8 mJ pulse. (b) CID spectrum of BSA peptide 
RPCFSALTPDETYVPK (3+), q-value of 0.25, 30 ms activation, 35% 
NCE. Each spectrum is the average of three microscans. The precursor is 
denoted by *. The UVPD and CID spectra were collected from back-to-
back LC-MS/UVPD/CID data-dependent events. The cysteine in the 
peptide has a carbamidomethyl modification. 
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One drawback with database searching using many sequence ions is the potential 
for an increase in false positives even after filtering at a 1% false discovery rate (FDR). 
The majority of these false positives that passed the 1% FDR yielded low probability 
scores of 1.00, indicating a high probability that the peptide was identified by chance, and 
thus could be eliminated by additional filtering based on a probability score threshold. 
While this procedure is effective, it also eliminates many of the true positives identified 
by UVPD. Many of these true positives with low probability scores were a result of 
singly charged peptides producing many abundant side-chain loss sequence ions (e.g., v, 
d, w, m). For example, UVPD of the singly-charged, BSA peptide YLYEIAR (Figure 
6.10) yielded a good Xcorr score of 3.04, but a poor probability score of 1.00. Manual 
interpretation of this spectrum showed that seven of the eleven most abundant sequence 
ions were v, w, and m side-chain loss ions with many even lower abundance side-chain 
loss ions also present in the spectrum. While side-chain loss ions are very useful for 
sequencing peptides and differentiating between leucine and isoleucine residues, they 
impede current in silico database searching algorithms, such as SEQUEST, which lack 
the ability to identify these ions. As observed herein and previously using UVPD at 157 
nm,30 the formation of side-chain loss ions was most notable for singly-charged peptides 
which are less often observed in LC-ESI-MS due to the use of acidic and aqueous eluents 
that usually produce peptides in charge states greater than or equal to 2+. Regardless, 
even after further filtering of true positive peptide hits based from low probability scores, 





















































Figure 6.10 UVPD spectrum of the BSA peptide YLYEIAR (1+), q-value of 0.1 and 
an activation of one 5 ns, 8 mJ pulse. The precursor is denoted by *, and 
the neutral loss of ammonia is denoted by #. The ion labeled as “m1,3” 
represents the side-chain loss of tyrosine radicals from the precursor, and 
“m1,3 - 43” represents sequential loss of CH3CO radicals from  “m1,3”. 
 
To investigate the performance of the high-throughput-UVPD method for 
complex, biologically relevant samples, data-dependent LC-MS/UVPD/CID analysis was 
applied to a lysed human HT-1080 cytosolic fibrosarcoma cell sample. Examples of the 
UVPD and CID mass spectra obtained for one peptide from this facet of the study are 
shown in Figure 6.11.  Figure 6.12 illustrates the SEQUEST results for the top twenty-
five protein hits; the protein names and further SEQUEST scoring information are 
summarized in Table 6.3. All UVPD and CID spectra for which peptides were 
successfully identified through SEQUEST searching were manually separated and 
verified for each protein. As seen in Figure 6.12A, both UVPD and CID yielded 
comparable results with respect to peptide identifications with UVPD often affording 
several additional peptide identifications. The sums of the peptide Xcorr scores for each 
protein were significantly better for UVPD as compared to CID (Figure 6.12B). This 
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increase in scoring likely arises from the more informative spectra produced by UVPD 
versus CID as noted previously in this report for the BSA tryptic digest. For example, the 
UVPD mass spectrum of the doubly charged, HT-1080 peptide 
DLYANTVLSGGTTMYPGIADR (Figure 6.11A) shows many a, b, c, x, y, z product 
ions and yields full sequence coverage from both series of N-terminal and C-terminal 
ions. CID of the same peptide, however, yielded significantly less spectral information 
and incomplete peptide sequence coverage (Figure 6.11B). Thus, the Xcorr scores were 
6.78 and 4.44 for UVPD and CID, respectively. No significant trend with respect to 
probability scores was observed for UVPD versus CID (Figure 6.12C); however, CID 
did outperform UVPD with respect to the summation of these scores for several proteins 
(e.g, Protein # 4, 5, 6, and 14) due to the presence of a few peptides with very high, max 
probability scores as seen in Table 6.3. The total protein identifications were comparable 
between the two methods for the back-to-back LC-MS/UVPD/CID analysis. After 
peptide filtering at a 1% FDR followed by further filtering of peptides with probability 
scores less than 1.00, CID spectra identified 191 proteins and UVPD spectra identified 
202 proteins. Overall, the faster UVPD method (using a single 5 ns, 8 mJ pulse) 
performed comparably or often better than the slower CID approach even for complex 

















































































































































Figure 6.11 (a) UVPD spectrum (193 nm) of the beta actin peptide 
DLYANTVLSGGTTMYPGIADR (2+) from a human HT-1080 cytosolic 
lysed cell sample, q-value of 0.1 and an activation of one 5 ns, 8 mJ pulse. 
Low abundant w4, w6, and w14 side-chain loss ions were observed, but 
were not labeled on the spectrum. (b) CID spectrum of the beta actin 
peptide DLYANTVLSGGTTMYPGIADR (2+) from a human HT-1080 
cytosolic cell sample, q-value of 0.25, 30 ms activation, 35% NCE. Each 
spectrum is the average of three microscans. The precursor is denoted by 
*. The UVPD and CID spectra were collected from back-to-back LC-








































































Figure 6.12 SEQUEST analysis of LC-MS/UVPD/CID of human HT-1080 cytosolic 
lysed cells: (a) number of peptides identified for UVPD versus CID for 
each protein (b) sum of peptide Xcorr scores for each protein for UVPD 
and CID (c) sum of peptide probability scores for each protein for UVPD 
and CID. The top twenty-five protein hits were used for manual separation 
and comparison of UVPD and CID data. The protein names and further 




# Unique  Max peptide       ∑ Peptide  Max Peptide      ∑ Peptide 
# Peptides  Peptides  Xcorr Score Xcorr Score Prob. Score Prob. Score 
Protein # 1 = vimentin – gi62414289:   
UVPD 36 (30)  27 (25)  6.27  122  137.32  1037  
CID 31 (30)  26 (25)  5.40  88  110.94  1174 
Protein # 2 = enolase 1 – gi4503571: 
UVPD 20 (18)  18 (16)  6.64  86  128.85  981 
CID 22 (20)  17 (15)  6.87  82  117.52  1139 
Protein # 3 = beta actin – gi4501885: 
UVPD 28 (25)  18 (15)  6.78  103  125.04  1094 
CID 26 (23)  15 (14)  5.72  77  112.65  1138 
Protein # 4 = tubulin, beta polypeptide – gi29788785:  
UVPD 17 (15)  14 (12)  9.89  84  124.43  863 
CID 19 (19)  15 (15)  8.15  76  300.00  1371 
Protein # 5 = tubulin, beta 2 – gi5174735: 
UVPD 17 (14)  14 (11)  9.89  81  124.43  801 
CID 18 (18)  14 (14)  8.15  72  300.00  1325 
Protein # 6 = glyceraldehydes-3-phosphate dehydrogenase – gi7669492: 
UVPD 17 (16)  11 (10)  7.35  62  126.07  730 
CID 14 (14)  10 (10)  5.97  55  300.00  1212 
Protein # 7 = heat shock protein 90kDa  alpha (cytosilic), class A member 1 isoform 2 – gi40254816: 
UVPD 14 (14  13 (13)  7.46  58  119.47  668 
CID 14 (14)  12 (12)  4.19  43  91.48  674  
Protein # 8 = heat shock protein 90kDa  alpha (cytosilic), class A member 1 isoform 1 – gi63029937: 
UVPD 15 (14)  14 (13)  7.46  61  119.47  696 
CID 14 (14)  13 (13)  4.19  42  91.48  654 
Protein # 9 = annexin A2 isoform 2 – gi50845386: 
UVPD 15 (14)  14 (13)  6.84  59  103.47  510 
CID 12 (12)  10 (10)  4.26  39  93.63  519 
Protein # 10 = pyruvate kinase 3 isoform 1 – gi33286418: 
UVPD 16 (15)  13 (12)  7.07  69  128.64  742 
CID 13 (12)  12 (11)  5.42  45  111.12  692 
Protein # 11 = heat shock protein 90kDa  protein 1, beta – gi20149594: 
UVPD 15 (14)  13 (13)  6.76  56  110.15  650 
CID 14 (14)  13 (13)  4.32  41  101.63  626 
Protein # 12 = eukaryotic translation elongation factor 2 – gi4503483: 
UVPD 14 (10)  14 (10)  7.08  55  127.83  639 
CID 12 (11)  12 (11)  4.97  40  119.12  658 
Protein # 13 = tubulin, beta, 4 – gi50592996: 
UVPD 11 (9)  11 (9)  5.36  41  98.45  483 
CID 11 (11)  10 (10)  4.28  37  93.97  637 
Protein # 14 = lactate dehydrogenase A – gi5031857: 
UVPD 9 (6)  9 (6)  7.36  40  140.25  518 
CID 12 (12)  12 (12)  6.32  39  300.00  751 
Protein # 15 = tubulin alpha 6 – gi14389309: 
UVPD 10 (10)  10 (10)  6.55  43  115.67  603 
CID 11 (11)  11 (11)  5.65  38  102.71  560 
Protein # 16 = eukaryotic translation factor elongation factor 1 alpha 1 – gi4503471: 
UVPD 11 (10)  9 (8)  7.13  46  97.79  300 
CID 8 (8)  6 (6)  5.75  28  119.59  429 
Protein # 17 = phosphoglycerate kinase 1 – gi4505763: 
UVPD 9 (7)  8 (7)  5.85  32  87.78  397 
CID 7 (7)  7 (7)  5.62  29  110.55  474 
Protein # 18 = myosin, heavy polypeptide 9, non-muscle – gi12667788: 
UVPD 8 (7)  8 (7)  5.75  32  121.89  543 
CID 7 (7)  7 (7)  5.89  27  116.48  442 
Protein # 19 = heat shock protein 70kDa  8 isoform 1/2 – gi5729877 / gi24234686: 
UVPD 7 (6)  7 (6)  6.57  29  132.10  357 
CID 9 (9)  8 (8)  5.78  28  103.39  353 
Protein # 20 = actinin, alpha 4 – gi12025678: 
UVPD 9 (7)  9 (7)  5.02  34  92.21  435 
CID 6 (6)  6 (6)  4.08  19  85.42  383 
Protein # 21 = aldolase A – gi34577112: 
UVPD 7 (7)  7 (7)  5.84  24  98.73  298 
CID 7 (7)  7 (7)  5.53  27  122.45  453 
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Protein # 22 = cofilin 1 (non-muscle) – gi5031635: 
UVPD 7 (5)  6 (4)  9.07  32  300.00  483  
CID 5 (5)  4 (4)  6.65  18  115.02  330 
Protein # 23 = actinin alpha 1 – gi4501891: 
UVPD 6 (6)  6 (6)  4.87  25  105.62  411 
CID 5 (5)  5 (5)  4.14  18  95.53  367 
Protein # 24 = triosephosphate isomerase 1 – gi4507645: 
UVPD 7 (6)  7 (6)  7.12  27  88.44  307 
CID 5 (5)  5 (5)  4.81  18  129.37  375 
Protein # 25 = talin 1 – gi16753233: 
UVPD 6 (2)  6 (2)  5.24  19  81.96  89 
CID 6 (6)  6 (6)  5.53  23  105.58  269 
 
 
Table 6.3 UVPD and CID comparison of the number of peptides identified, sum and 
max peptide Xcorr score, and sum and mass peptide probability score 
from SEQUEST for the top twenty-five protein hits of a human HT-1080 
cytosolic cell lysate sample. The UVPD and CID spectra were collected 
from back-to-back LC-MS/UVPD/CID data-dependant events. Numbers 
in parenthesis represent the number of peptide identifications after 
filtering out peptides with a probability score less than 1.1. For each 
SEQUEST score, a higher confidence is associated with a higher score. 






The results in the present study illustrate the utility of using ultrafast UVPD for 
high-throughput proteomic workflows. UVPD at 193 nm results in ample production of a, 
b, c, x, y, and z sequence ions, in addition to immonium ions and v and w side-chain loss 
ions.  Photodissociation efficiencies range from 50-98% for doubly-charged peptides 
using a single laser pulse.  Peptides containing one or more amino acids with aromatic 
side-chains exhibit higher dissociation efficiencies than peptides without aromatic 
groups, and the length of the peptide has relatively little impact on UVPD efficiency.  A 
background subtraction procedure to account for the formation of rather high abundances 
of ions due to photoionization of background organic species during the UVPD period 
was implemented and significantly improved subsequent SEQUEST scoring and peptide 
identifications for complex mixtures analyzed by LC-UVPD-MS. Comparable and often 
improved in silico searching results were achieved for biologically relevant samples, 
including a human HT-1080 cytosolic fibrosarcoma cell sample, using ultrafast UVPD in 
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193 nm Photodissociation for Acidic Proteome Characterization  
 
7.1 Overview 
193 nm ultraviolet photodissociation (UVPD) was implemented to sequence 
singly and multiply charged peptide anions. Upon dissociation by this method, a-/x-type, 
followed by d and w side-chain loss ions, were the most prolific and abundant sequence 
ions, often yielding 100% sequence coverage. The dissociation behavior of singly and 
multiply charged anions was significantly different with higher charged precursors 
yielding more sequence ions; however, all charge states investigated (1- through 3-) 
produced rich diagnostic information. UVPD at 193 nm was also shown to successfully 
differentiate and pinpoint labile phosphorylation modifications. The sequence ions were 
produced with high abundances, requiring limited averaging for satisfactory spectral 
quality. The intact, charge-reduced radical products generated by UV photoexcitation 
were also subjected to collision induced dissociation (termed, activated – electron 
photodetachment dissociation (a-EPD)), but UVPD alone yielded more predictable and 
higher abundance sequence ions.  With the use of a basic (pH ~11.5), piperidine-modified 
mobile phase, LC-MS/UVPD was implemented and resulted in the successful analysis of 






The advent of new high performance tandem mass spectrometers equipped with 
the most versatile collision- and electron-based activation methods as well as ever-more 
powerful database search algorithms have catalyzed tremendous progress in the field of 
proteomics.1-4 Despite these advances in instrumentation and methodologies, there are 
few methods that fully exploit the information available from the acidic proteome. 
Typical high-throughput, bottom-up workflows consist of chromatographic separation of 
complex mixtures of digested proteins followed by online mass spectrometry (MS) and 
MSn analysis. This bottom-up approach remains the most popular strategy for protein 
identification, biomarker discovery, quantitative proteomics, and elucidation of post-
translational modifications. To date, proteome characterization by mass spectrometry has 
overwhelmingly focused on analysis of peptide cations,5 resulting in an inherent bias 
towards basic peptides that easily ionize under acidic mobile phase conditions and 
positive polarity MS settings. Given that approximately 50% of peptides/proteins are 
naturally acidic, coupled with the fact that many of the most important PTMs (e.g., 
phosphorylation, acetlylation, sulfonation, etc.) significanlty decrease the isoelectric 
points of peptides,6, 7 there is a compelling need for better analytical methodologies for 
characterization of the acidic proteome.  
A principal reason for the shortage in methods for peptide anion characterization 
is the lack of MS/MS techniques befitting for efficient and predictable dissociation of 
peptide anions. Despite the growing array of new ion activation methods for dissociation 
of peptides, most are best suited for analysis of positively-charged peptides. CID of 
peptide anions, for example, yields unpredictable fragmentation behavior with spectra 
subjugated by neutral losses from both precursor and product ions;8 insufficient peptide 
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sequence information is also the result. The two most promising new electron-based 
methods, electron-capture dissociation (ECD) and electron-transfer dissociation (ETD), 
are only applicable to positively-charged ions, not anions.9-12 Due to the known 
inadequacy of CID and the lack of feasibility of ECD and ETD for peptide anion 
sequencing, several alternative MSn methods have been developed recently. Electron 
detachment dissociation (EDD) using high energy electrons to induce backbone 
cleavages was developed for peptide anions.13, 14 Another new technique, negative 
electron transfer dissociation (NETD), entails reactions of radical cation reagents with 
peptide anions to promote electron transfer from the peptide to the reagent that causes 
radical-directed dissociation.15, 16 Activated-electron photodetachment dissociation (a-
EPD), an MS3 technique, uses UV irradiation to produce intact peptide radical anions, 
which are then collisionally activated.17, 18 Despite these inroads in the characterization of 
peptide anions, these methods also suffer from several significant shortcomings. EDD 
and a-EPD are both low efficiency methods that require long averaging cycles and 
activation times that range from half a second up to multiple seconds, impeding the 
integration of these methods with chromatographic timescales.13-18 In addition, the 
fragmentation patterns frequently yield many high abundance neutral losses from product 
ions which clutter the spectra,13-16 and often low peptide sequence information.13, 17, 18  
In this chapter, we report the use of 193 nm photons (UVPD) for peptide anion 
activation, which yields rich and predictable fragmentation patterns with high sequence 
coverage on a fast liquid chromatographic timeline. This method shows promise for a 







Human aquaporin-2 (254-267), RQpSVELHSPQSLPR, was purchased from 
AnaSpec (Freemont, CA), and pp60c-src (521-533), TSTEPQpYQPGENL, and 
DRVYIHPFHLVIH were purchased from BACHEM (King of Prussia, PA). Piperidine 
and buffer components, α-casein, and proteomics grade trypsin were obtained from 
Sigma-Aldrich (St. Louis, MO). Native Pfu DNA polymerase was purchased from 
Strategene (La Jolla, CA). Oligonucleotides were synthesized by Integrated DNA 
Technologies Inc. (Coralville, IA).  Qiagen Inc. (Valencia, CA) supplied Ni-NTA 
agarose, Quiaprep Spin miniprep, PCR QIAquick Purification Kit, and QIAEX II Gel 
Extraction Kit.  Tryptone and yeast extract were obtained from USB corporation 
(Clevelend, OH).  The pET28a(+) vector was purchased from Novagen and pGEX 4T1 
vector was purchased from GE Healthcare. The remaining molecular biology reagents, 
including DNA ladders and protein molecular mass standards, were obtained from 
Invitrogen Corp. (Carlsbad, CA).  Ultrapure grade Tris and HEPES were purchased from 
Sigma (St. Louis, MO), Perkin Elmer supplied [γ-32P]-ATP.  P81 Ion Exchange cellulose 
chromatography paper was purchased from Whatman.  IPTG, and DTT were obtained 
from US Biologicals (Swampscott, MA).  Restriction enzymes, PCR00 reagents, and T4 
DNA ligase were from New England Biolabs (Beverly, MA).  The Mono Q HR 10/10 
anion exchange column and HiPrep 26/10 desalting column were purchased from 
Amersham Biosciences (Piscataway, NJ). 15 mL Amicon Ultra centrifugal filters and 
ultrafiltration membranes were from Millipore. The Escherichia coli strain DH5α, used 
for cloning and mutagenesis, and the strains BL21 (DE3) used for recombinant protein 
expression, were obtained from Invitrogen.  All other buffer components and chemicals 




7.3.2 General Methods 
Protocols for all the standard molecular biology manipulations including PCR, 
restriction enzyme digestion, ligation and transformation, were based on methods 
described by the manufacturer.  Plasmids were transformed into cells using a BTX 
Transporter Plus device.  UV-visible absorbance readings were taken on a Varian Cary 
Model 50 spectrophotometer.  A Pharmacia ÄKTATM FPLC system was used for the 
chromatographic purification steps.  Protein purity was analyzed by Tris-glycine sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under denaturing 
conditions on 12 % gels using the Bio-Rad Mini-protean III vertical gel electrophoresis 
apparatus. A Techne Genius Thermal Cycler was used for the polymerase chain reaction 
PCR (Techne Inc., Princeton, NJ). Radioactivity measurements were performed on a 
Packard 1500 scintillation counter. DNA constructs were verified by sequencing at the 
UT core facilities using an Applied Biosystem automatic DNA sequencer. 
 
7.3.3 Preparation of Proteins 
MKK7 phosphorylated by MEKK1c 
 Construction of pGEX4T1-MKK7-His6 – A construct encoding full-length 
Mus musculus mitogen-activated protein kinase kinase 7 (GenBank accession number 
NM_011944) with an N-terminal cleavable GST–tag and a C-terminal cleavable His6-tag 
(with the sequence, LVPRGSHHHHHH, containing a cleavage site for Thrombin 
protease), was created as follows.  First, PCR amplification of an MKK7 template was 
achieved by using the following oligonucleotides: forward (5’- CCG GAA TTC ATG 
GCG GCG TCC TCC CTG GAG CAG AAG - 3’) (EcoRI site in bold) and reverse (5’- 
ATG CGG CCG CTC TCA GTG ATG ATG ATG ATG ATG GGA TCC ACG CGG 
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AAC CAG CCT GAA GAA GGG CAG ATG GTG CTG - 3’) (NotI site in bold).  The 
PCR product was digested with EcoRI and NotI, and the resulting digested product 
ligated into an EcoRI–NotI digested pGEX-4T1 vector.  The ligation mixture was then 
transformed into DH5α E. coli cells with the appropriate antibiotic and the correct 
construct recovered using standard molecular biology procedures.   
Expression and purification of GST-MKK7-His6 – The pGEX 4T1 vector 
containing DNA encoding full length MKK7 was transformed into BL21 (DE3) electro-
competent cells.  From a single colony of freshly transformed cells, a 30 mL culture of 
Lauria Broth (LB) containing 50 µg/mL ampicillin was inoculated and incubated with 
shaking overnight at 37 ºC. The culture was diluted 100-fold into TB (Terrific Broth) 
media containing 50 µg/mL ampicillin, and incubated at 37 ºC with shaking.  Once the 
OD600 of the culture had reached 0.6, the expression was induced by 25 µM IPTG, and 
shaking continued at 25 ºC for 20 hours.  The cells were pelleted (8000 × g, 12 min) and 
the bacterial pellet immediately frozen in liquid nitrogen and stored at -80 ºC.  The frozen 
wet cells were resuspended in 150 mL of Buffer A (20 mM Tris, pH 8.0, 0.03% Brij-30, 
0.1% (v/v) β-mercaptoethanol, 5 mM imidazole, 1 mM benzamidine, 0.1 mM PMSF, and 
0.1 mM TPCK) containing 0.5 M NaCl, 0.2 mg/mL lysozyme, 1 mM MgCl2, and 20% 
glycerol.  The mixture was incubated at 4 ºC for 30 minutes, then Triton-100 was added 
to a final concentration of 1% (v/v) and the incubation at 4 ºC extended for another 30 
minutes.  The cell lysate was sonicated (at 5 s pulses with 5 s intervals) at 4 ºC for 5 
minutes and then cleared by centrifugation at 18,000 × g for 30 min.  The supernatant 
was agitated with Ni-NTA beads for 1 h at 4 °C.  After washing the beads with 150 mL 
of buffer A containing 10 mM imidazole and 20% glycerol, the GST-MKK7-His6 tagged 
protein was eluted using 25 mL buffer A (pH 8.0) containing 200 mM imidazole and 
20% glycerol.  The eluted protein was collected and dialyzed into buffer S (25 mM 
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HEPES pH 7.5, 50 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM DTT) containing 
20% glycerol.  The concentration was established using the Bradford reagent. The 
estimated yield is around 20 mg pure GST-MKK7-His6 per liter cells. 
Activation of GST-MKK7-His6 – 4 μM GST-MKK7-His6, 2 µM GST-MEKK1c 
(C-terminal 320 amino acids corresponding to the catalytic domain) were incubated for 
60 min at 30 °C in the presence of 4 mM ATP in 10 mL of activation buffer B (25 mM 
Hepes pH 7.5, 2 mM dithiothrietol, 20 mM MgCl2, 0.1 mM EDTA, 0.1 mM EGTA) and 
re-purified using a Ni-affinity column that purifies the active GST-MKK7-His6 away 
from GST-MEKK1c. The activated GST-MKK7-His6 was stored in buffer S containing 
20% glycerol at -80 ºC until further use. At least 60% of GST-MKK7-His6 has been 
recovered as pure active GST-MKK7-His6. 
JNK2α2 phosphorylated by MKK4 and MKK7 
Construction of pET28a(+)-JNK2α2 – 424 amino acids correspond to full-length 
protein from cDNA of wild type Homo sapiens mitogen-activated protein kinase 9; 
(GenBank accession number NM_002752) with N-terminal cleavable His6-tag was 
created using oligonucleotides: forward (5’- CTA GCT AGC ATG GGC GAC AGT 
AAA TGT GAC AGT-3’) (NheI site in bold) and reverse (5’- TA ATA  AGC TTG CTA 
CCT GAA GAA GGG CAG ATG GTG  -3’) (HindIII site in bold).  The PCR product 
was digested with NheI and HindIII, ligated into the NheI HindIII digested 
pET28a(+)vector, and then transformed into DH5α E. coli cells. The construct was 
verified by sequencing the DNA at the UT core facilities using an Applied Biosystem 
automatic DNA sequencer. 
Expression and purification of tagless JNK2α2–pET28a(+)-JNK2 was 
electroporated into the E.coli strain BL21(DE3).  Cells from a single colony were used to 
inoculate 30 mL Luria-Broth media containing 30 µg/mL kanamycin and grown 
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overnight at 37 °C.  The culture was diluted 100-fold into Luria broth containing 30 
µg/mL kanamycin and were grown at 37 °C to an O.D600 of 0.6, the cells then were 
induced by 500 µM IPTG and cultured for 3-5 hours at 30 °C. The cells were pelleted 
(8000 × g, 12 min) then lysed in 150 mL of buffer A containing 0.5 M NaCl and 1% 
Triton X-100, and sonicated for 20 min at 4 °C (at 5 s pulses with 5 s intervals).  The 
lysate was centrifuged for 30 minutes at 18000 × g and the supernatant agitated with Ni-
NTA beads for 1 h at 4 °C.  After washing the beads with 150 mL of buffer A containing 
10 mM imidazole, the His6-tagged proteins were eluted with 25 mL buffer A (pH 8.0) 
containing 200 mM imidazole.  The eluted proteins were applied to a Mono Q HR 10/10 
anion exchange column equilibrated in buffer C (20 mM Tris pH 8.0, (v/v) 0.03% Brij-
30, (v/v) 0.1% β-mercaptoethanol, 0.1 mM EDTA and 0.1 mM EGTA).  The column was 
developed over 15-17 column volumes with a linear gradient of 0-0.5 M NaCl.  Eluted 
fractions of His6-JNK2α2 were dialyzed overnight with thrombin cleavage buffer D (20 
mM Tris-HCl pH 8.4, 150 mM NaCl, and 0.1 % (v/v) β-mercapto ethanol).  The dialyzed 
protein was incubated with thrombin (1 unit thrombin/mg protein) and 2.5 mM CaCl2
 for 
3-5 hours at room temperature with mild agitation.  Cleavage was estimated by 10 % 
SDS/PAGE.  After cleavage, the reaction mixture (10 mL) was diluted fivefold with 
Buffer C and the protein was filtered and loaded on a Mono Q HR 10/10 anion exchange 
column equilibrated in buffer C.  The column was developed over 15-17 column volumes 
with a linear gradient of 0-0.5 M NaCl.  Eluted Fractions of tagless JNK2α2 were 
collected and dialyzed into buffer S containing 10% glycerol, the concentration was 
established using Bradford reagent and the purity assessed by 12% SDS/PAGE. The 
estimated yield is around 35 mg pure tagless JNK2α2 per liter cells. 
Activation of tagless JNK2α2 by active MKK4 and active MKK7 – 2 μM tagless 
JNK2α2, 100 nM active GST-MKK4  and 400 nM active GST-MKK7-His6 were incubated 
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for 60 min at 30 °C in presence of 4 mM ATP in 10 mL activation buffer B and re-
purified using Gel filtration column (120 ml HiLoad 16/60 Superdex 200 prep grade 
column) equilibrated in 25 mM HEPES buffer (pH 7.5) containing 100 mM KCl, 0.1 mM 
EDTA, 0.1 mM EGTA and 2 mM TCEP. The activated, tagless JNK2α2 was stored in 
buffer S containing 10% glycerol at -80 ºC until further use. At least 50% of tagless 
JNK2α2 has been recovered as active tagless JNK2α2. 
ERK2 phosphorylated by MKK1 
Expression, purification and activation of ERK2 – Activated His6-tagged ERK2 
(Rattus norvegicus mitogen activated protein kinase 1 with GenBank accession number 
NM_053842) was generated as essentially as described previously by Waas et al.1 with 
minor modifications.  Cleavage of the His6 tag before activation was achieved by 
subjecting 10 mg of purified (His6-tagged) inactive ERK2 to thrombin cleavage as 
described above for His6-JNK2α2.  The tagless ERK2 was recovered using a MonoQ 
column, the protein fractions were pooled and dialyzed overnight at 4 °C into buffer S 
containing 10% glycerol, then used for activation following the same previous protocol. 
p38 MAPKα phosphorylated by MKK6 
Expression and purification of tagless p38 MAPKα – A pET14B vector 
containing DNA sequences encoding Mus musculus mitogen-activated protein kinase 14 
- p38 MAPKα (GenBank accession number NM_011951) was used to express p38 
MAPKα as an N-terminal, His6-tagged protein in E. coli BL21 (DE3) pLysS. The enzyme 
was expressed and purified according to the method of Szafranska et al.19, 20 The His6-tag 
was removed by Thrombin (Novagen) and the enzyme preparation dialyzed overnight at 
4 °C into storage buffer S containing 5% glycerol and stored at -80 ºC until further use.  
Expression and purification of GST-MKK6b (S207E T211E) – MKK6b (S207E 
T211E) was expressed as a GST fusion protein in E. coli BL21 (DE3) pLysS.  The 
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protein was purified by Glutathione Sepharose™ High Performance (Amersham 
Biosciences) following exactly the same method of Szafranska et al.19, 20 Pooled protein 
fractions were dialyzed at 4 °C into buffer S, concentrated and stored at -80 ºC. 
Activation of p38 MAPKα by GST-MKK6b (S207E T211E) – p38 MAPKα (10.7 
mL, 14 mg) and GST-MKK6b (0.26 mL, 1.6 mg) were incubated for 5 min at 27 °C prior 
to the addition of ATP (4 mM) in 50 mL of activation buffer B and re-purified, 
essentially according to the method of Szafranska et al.19, 20 The activated, tagless p38 
MAPKα was stored in buffer S at -80 ºC until further use.   
 
7.3.4 Mass Spectrometry, Photodissociation, and High pH Liquid 
Chromatography 
Mass spectrometric measurements were carried out on a Thermo Fisher Scientific 
LTQ XL (San Jose, CA) using a laser setup similar to that previously described.21, 22 
Photodissociation was performed using a Coherent ExciStar XS excimer laser (Santa 
Clara, CA) at 193 nm. Direct infusion experiments utilized an online nanoESI setup using 
a conductive mini microfilter assembly from IDEX Health and Science (Oak Harbor, 
WA) coupled to a New Objectives uncoated PicoTip® nanoESI emmiter (Woburn, MA), 
which was operated at an ESI voltage of 2 kV. Peptides diluted to 10 µM in 50/50 
acetonitrile/10 mM ammonium acetate (pH 8) were directly infused by syringe pumping 
at 300 nL/min.  
Liquid chromatography using high pH eluents was carried out using a Dionex 
UltiMate 3000 system (Sunnyvale, CA) with an Agilent ZORBAX 300Extend-C18 
column (Santa Clara, CA) (150 × 0.3 mm, 3.5 µm particle size).  Eluent A was composed 
of 10 mM piperidine (~pH 11.5) in water and eluent B 10 mM piperidine (~pH 11.5) in 
acetonitrile. A 65 min linear gradient from 5% eluent B to 40% eluent B was used at a 
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flow rate of 4 µL/min. The mitogen-activated kinase mixture was injected at 
approximately five picomoles of tryptic digest per protein. Data-dependent LC-
MS/UVPD was performed as follows: the first event was the full mass scan (m/z range of 
400 – 2000) followed by ten UVPD events on the ten most abundant ions from the first 
event. One UV pulse was used per MS/MS scan with a q-value set to 0.1. Although the 
actual irradiation time was only 5 ns (the duration of a single laser pulse) for UVPD, the 
commercial LTQ software limited the activation period to a minimum of 30 μs. The 
maximum ion injection time was 100 ms for both full scan and MS/MS events, and the 
ESI voltage was -4 kV. A dynamic exclusion duration of 50 s was used with a list size of 
500 allowed m/z values, and a single repeat count. For LC-MS/UVPD, each full mass 
scan and tandem mass spectrum was the average of three and ten microscans, 
respectively. Peaks were picked using a signal-to-noise threshold of three and an 
observable isotopic distribution to assign charge states. For a-EPD experiments, a q-value 
of 0.1 and an activation of 9 pulses (18 ms), 1 mJ/pulse, 500 Hz were used to generate the 
charge reduced, radical species, which was subsequently activated using a normalized 




7.4 Results and Discussion 
 
7.4.1 193 nm UVPD of Singly and Multiply Charged Anions 
 CID of peptide anions generates spectra that are dominated by neutral losses 
from both precursor and product ions,8 yielding unforeseen fragmentation behavior and 
insufficient peptide sequence information. These downfalls are illustrated in Figure 7.1 
for CID of the doubly deprotonated aquaporin peptide, RQpSVELHSPQSLPR. Coupling 
an ArF excimer laser to a linear ion trap mass spectrometer allows implementation of 
ultraviolet photodissociation (UVPD) at 193 nm as an alternative to CID (details on the 
experimental setup can be viewed in the supporting information), yielding rich and 
informative spectra with high sequence coverage from predictable fragmentation patterns 
(see Figure 7.2A). As seen in this UVPD spectrum of the doubly charged aquaporin 
peptide, the main sequence ions observed are from the complementary a/x series, which 
are present in high abundance and large numbers. Occasionally, hydrogen migration 
occurs in conjunction with the formation of these a/x products, leading to hydrogen-rich 
or hydrogen-deficient ions denoted as an/xn + 1 in the spectral figures. The conventional 
a/x ions are more consistently observed. A few c ions and side-chain loss ions (e.g., d, v, 
ions) are also seen in the spectrum as well as Y-type ions, which originate from backbone 
cleavages N-terminal to proline; Y ions are produced from radical x-ions and have been 
observed previously upon vacuum UVPD of peptide cations.23 The combination of these 
sequence ions originating from both N- and C-termini resulted in 100% sequence 
coverage, and also allowed confident assignment of the site of phosphorylation. An 
interesting characteristic of the spectrum shown in Figure 7.2A is the highly abundant 
charge- reduced, radical species (labeled as [M – H]-•), which results from photo-induced 
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electron detachment from the selected peptide precursor. The observation of these types 
of charged-reduced products was reported previously upon UVPD at 262 nm; subsequent 
application of CID to these charge-reduced products (termed a-EPD) was used to gain 
additional peptide sequence information.17 An example a-EPD spectrum (using 193 nm 
photoexcitation) is shown in Figure 7.3. 
 
 





































Figure 7.1 CID spectra of human aquaporin-2 peptide, RQpSVELHSPQSLPR (2-). A 
collision energy of 69 mV, q-value of 0.25, and collision duration of 30 
ms was used for activation. Neutral losses of phosphoric acid, H2O, NH3, 
and H2CO are denoted by 







































































































Figure 7.2 UVPD (193 nm) spectra of human aquaporin-2 peptide (a) 
RQpSVELHSPQSLPR, 2-  and (b) RQpSVELHSPQSLPR, 1-. A q-value 
of 0.1 and an activation of 9 pulses (in a 18 ms activation period), 1 
mJ/pulse, at 500 Hz were used for each spectrum. Neutral losses of 
phosphoric acid, H2O, and NH3 are denoted by 

















































Figure 7.3 Activated – electron photodetachment dissociation (a-EPD) spectra of 
human aquaporin-2 peptide, RQpSVELHSPQSLPR, 2-. A q-value of 0.1 
and an activation of 9 pulses (in a 18 ms activation period), 1 mJ/pulse, 
500 Hz were used to generate the charge reduced, radical species, which 
was subsequently activated using a collision energy of 131 mV, q-value of 
0.25, and collision duration of 30 ms. Neutral losses of phosphoric acid, 
H2O, and NH3 are denoted by 
#, ˚, and *, respectively. 
 
Because ion activation/dissociation is often charge-state dependent, comparisons 
of the UVPD spectra were undertaken for peptide anions in different charge states. 
Figure 7.2B shows the UVPD spectrum of singly charged RQpSVELHSPQSLPR 
compared to the UVPD spectra of the doubly charged ion in Figure 7.2A. The sequence 
coverage is slightly lower (85%, corresponding to 11/13 possible backbone cleavages) for 
the 1- charge state than that obtained for the 2- charge state (100% sequence coverage). 
Interestingly, a very abundant product ion, y12
#*, is observed in Figure 7.2B and is 
attributed to the combined loss of phosphoric acid and ammonia from the y12 sequence 
ion. This product arises from the backbone cleavage adjacent (N-terminal side) to the 
phosphorylated serine residue, suggesting that the highly acidic phosphate group may 
promote an unusual specific charge dependent cleavage at phosphorylated residues. The 
same y-type ion with phosphoric acid and ammonia loss was observed for UVPD of the 
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phosphorylated VPQLEIVPNpSAEER peptide as well (data not shown). In this case, an 
abundant y5
#* was formed. This preferential pathway could be very useful in pinpointing 
phosphorylation sites in peptide anions.  
Each of the three charge states of the pp60c-src peptide, TSTEPQpYQPGENL, 
were also subjected to UVPD (Figure 7.4).  Each charge state yielded many abundant a- 
and x-type ions and high sequence coverage (92%, corresponding to 11/12 possible 
backbone cleavages) as summarized at the top of Figure 7.4. The site of phosphorylation 
could be readily pinpointed due to this high sequence coverage. A particularly salient 
feature of the UVPD spectrum of the 3- charge state is the decreased low mass cutoff 
(LMCO), which enables the detection of the abundant PO3
- and H2PO4
- ions. These 
phosphate reporter anions are important since they permit easy differentiation between 
phosphorylated and unphosphorylated peptides in complex mixtures,24 and have recently 
been used for phosphopeptide mapping of melanoma cells.25 The singly charged peptide 
again shows preferential cleavage adjacent (N-terminal side) to the phosphorylated 
residue as noted by the presence of the y7
# ion. However, this cleavage is significantly 
less pronounced and is not accompanied by the neutral loss of ammonia as observed for 
the RQpSVELHSPQSLPR and VPQLEIVPNpSAEER peptides described above, an 
occurrence that may be attributed to the differences in fragmentation behavior between 
phosphorylated serine and tyrosine residues upon UVPD. From these 
TSTEPQpYQPGENL spectra, it is concluded that significant sequence information and 
predictable dissociation patterns can be achieved using 193 nm photodissociation for a 












































































































































Figure 7.4 UVPD (193 nm) spectra of pp60c-src peptide (a) TSTEPQpYQPGENL, 
3-, (b) TSTEPQpYQPGENL, 2-, and (c) TSTEPQpYQPGENL, 1-. A q-
value of 0.1 and an activation of 9 pulses (in a 18 ms activation period), 1 
mJ/pulse, 500 Hz were used for each spectrum. Neutral losses of 
phosphoric acid and CO2 are denoted by 
# and “, respectively. The legend 
in the upper right corner represents sequence ion coverage from the 3-, 2-, 





7.4.2 193 nm UVPD Sequence Coverage Distribution 
The production of high abundance sequence ions across the backbone of a peptide 
is vital for any MS/MS strategy that will be applied to the analysis of complex mixtures. 
Sequence coverage distribution is defined as the distribution of backbone cleavages based 
on the relative abundances of complementary a/x ions, and it was compared for five 
peptides in the 2- charge state (Figure 7.5). Moreover, we also wanted to assess the 
sequence coverage distribution obtained using a single UV pulse (8 mJ) versus multiple 
UV pulses (9 pulses, 1 mJ/pulse) for photodissociation, the latter which would be 
anticipated to cause more extensive dissociation of both precursor and product ions. The 
sequence coverage distribution is shown in Figure 7.5 for multiple pulse UVPD (Figure 
7.5A) and single pulse UVPD (Figure 7.5B). For each peptide (RQpSVELHSPQSLPR, 
HQGLPQEVLNENLLR, TSTEPQpYQPGENL, DRVYIHPFHLVIH, and 
FFVAPFPEVFGK), the sequence coverage distribution was normalized to the most 
abundance a/x pair obtained by any of the two activation methods.  Because peptides 
containing aromatic groups have higher photoabsorptivities at 193 nm and thus typically 
yield the highest photodissociation efficiencies,22 the peptides were arranged from the 
least aromatic (top of figure) to the most aromatic (bottom of figure). Comparison of the 
distributions in Figure 7.5A and Figure 7.5B illustrate that activation using a singly high 
energy UV pulse generates similar or often better sequence coverage distribution 
compared to that obtained upon multiple lower energy laser pulses. An example spectrum 
using a single 5 ns (8 mJ) pulse for UVPD activation can be seen in Figure 7.6 for the 
peptide FFVAPFPEVFGK (2-). The relative abundances of the surviving precursor ions 
were two to thirty times lower after nine 1 mJ UV pulses than after a single 8 mJ UV 
pulse. That is, while the most extensive dissociation of the precursor was always 
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achieved using multiple UV pulses, the highest sequence coverage distribution was in 
fact more often obtained using a single UV pulse, especially for the peptides that 
contained the greatest number of tyrosine and phenylalanine residues. Interestingly, the 
sequence distributions in both Figure 7.5A and Figure 7.5B also show an enhanced 
degree of backbone cleavage next to residues that have UV-absorbing aromatic groups in 
addition to preferential cleavage at histidine and proline residues. The distributions in 
Figure 7.5 indicate that the highest sequence coverage distribution is achieved using a 
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Figure 7.5 Sequence coverage distribution comparison between UVPD using 9 pulses 
(in a 18 ms period, 1 mJ/pulse) and UVPD using one 5 ns, 8 mJ pulse. The 
product ion signals were plotted for summed a/x pairs for each backbone 
cleavage. For each peptide (RQpSVELHSPQSLPR, 
HQGLPQEVLNENLLR, TSTEPQpYQPGENL, DRVYIHPFHLVIH, and 
FFVAPFPEVFGK), ion signals were normalized to the most abundant a/x 
pair between the three activation methods. Peptides are oriented from least 


























































Figure 7.6 UVPD (193 nm) spectra of the α-SI-casein peptide FFVAPFPEVFGK, 2-. 
A q-value of 0.1 and an activation of one 5 ns (8 mJ) pulse were used. 
Neutral losses of H2O and CO2 are denoted by ˚ and “, respectively. 
 
7.4.3 LC-MS/UVPD of Mitogen-Activated Protein Kinases 
The promising results summarized above motivated us to adapt UVPD for LC-
MS/MS applications, as demonstrated for a mixture of mitogen-activated protein kinases 
(MAPKs). Typical LC mobile phases used for peptide separations are acidic and limit the 
ionization efficiencies of acidic species analyzed under negative polarity ionization. Flora 
and Muddiman showed increased ionization of acidic peptides by adjusting directly 
infused, working solutions to a higher pH using piperidine.26 We have replicated these 
experiments and confirmed increased ion signals as well as a shift to higher charge states 
upon addition of piperidine to the solutions (data not shown). We were motivated to use 
piperidine as an organic modifier in the LC mobile phase to promote improved negative 
ionization after peptide separation to complement UVPD. An equimolar mixture of 
digested MAPKs, including c-Jun N-terminal kinase 2 (JNK2), mitogen-activated protein 
kinase kinase 7 (MKK7), mitogen-activated protein kinase 1 (ERK2), and p38 mitogen-
activated kinase 14 (p38MAPKα), was analyzed. The SDS PAGE gel of each MAPK is 
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shown in Figure 7.7. Mitogen-activated protein kinase pathways are well-defined cell 
signaling modules that regulate many diverse cellular events. These proteins essentially 
control all cellular processes and thus are thought to play key roles in cancer 
progression;27 they also yield many acidic peptides after trypsin digestion making them 
amenable to the proposed LC-MS/UVPD method. Figure 7.8A shows the base peak 
chromatogram obtained for the MAPK tryptic peptide mixture using a highly basic 
mobile phase (pH 11.5) consisting of 10 mM piperidine in each eluent. Good separation 
and satisfactory peak shapes are obtained using this protocol. The analogous data-
dependent UVPD acquisitions yielded high quality photodissociation spectra (i.e., high 
signal-to-noise) by averaging only 10 microscans using a single 5 ns UV pulse per scan 
as seen in Figure 7.8B and Figure 7.8C for the doubly charged p38MAPKα peptide, 
TLFPGTDHIDQLK, and the triply charged ERK2 peptide, LKELIFEETAR, 
respectively. Both spectra display mainly a/x sequence ions along with a few abundant d 
and w side-chain loss ions and other diagnostic ions (occasional Y, c, z, y, and b ions); 
high backbone sequence coverage (100% for both peptides) was derived from this rich 
fragmentation behavior. These examples illustrate the high sensitivity and sequence 







Figure 7.7 SDS PAGE gel of MAPK samples. 10% SDS-Polyacrylamide Gel in tris-
glycine running buffer using BenchMark™ Protein Ladder (Invitrogen), 
Catalog number:  10747-012 showing the degree of purity of active JNK2, 
p38 MAPKα, ERK2 and GST-MKK7-His6.  The purity of each protein is 
estimated to be >95%.  All purity levels were estimated visually by 
loading 10-20 μg of each protein. 
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Figure 7.8 LC-MS/UVPD analysis of a mitogen-activated protein kinase (MAPK) 
mixture; (a) base peak ion chromatogram from a separation using 10 mM 
piperidine spiked into LC eluents, (b) UVPD (193 nm) spectra of the 
p38MAPKα peptide TLFPGTDHIDQLK, 2-, and (c) UVPD (193 nm) 
spectra of the ERK2 peptide LKELIFEETAR, 3-. A q-value of 0.1 and an 
activation of one 5 ns (8 mJ) pulse were used for each 193 nm 
photodissociation spectrum. Neutral losses of H2O, NH3, and CO2 are 




In this chapter, we have illustrated the benefits and applicability of 193 
photodissociation for “bottom-up”, acidic proteome characterization. The relative ease 
and affordability of coupling a laser to a commercial mass spectrometer has accelerated 
our efforts to implement this MS/MS technique on other mass spectrometers (e.g., 
orbitraps, hybrid quadrupole time-of-flights, etc.) for various large scale and targeted 
proteomic applications. We are also currently writing script to manipulate the UVPD 
spectra to make them more applicable to commercial database searching algorithms, 
which were mainly developed for positive mode analysis using CID. Coupled with our 
previous work 20, the present findings establish a compelling benchmark for obtaining 
high sequence information of both acidic and basic peptides via alternating 
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Advancing the understanding of biological processes by developing novel tandem 
mass spectrometry techniques is the key to this dissertation. Tremendous progress has 
been made in proteomics research due to technological advances in mass spectrometric 
instrumentation and ion activation; however, there still remain many unresolved 
limitations in practical applications. One key problem is the inadequate activation of 
selected precursor ions to generate useful products that are needed to identify proteins 
and any possible protein modifications. Another important limitation is the high false 
positive rate in computer-guided interpretation of tandem mass spectra. Both of these 
problems cause huge limitations in the characterization of the full proteome by MS 
methods, and the research herein has sought to address these restrictions. 
In Chapter 3, precursor ions were supercharged with m-nitrobenzyl alcohol (m-
NBA) prior to IRMPD analysis. These highly charged species yielded significantly more 
diagnostic sequence ions when compared to the dissociation of lower charge states. CID 
of supercharged ions did not yield more sequence information, and in general CID 
yielded less diagnostic information when compared to IRMPD of high charge states. 
Chapter 4 showcased the utility of forming an almost exclusive series of z-type by 
combining electron transfer reactions and N-terminal sulfonation. The MSn simplification 




IRMPD was implemented onto a dual pressure linear ion trap, and afforded 
efficient dissociation of intact protein cations as discussed in Chapter 5.  Product ions 
from IRMPD yielded a high level of backbone cleavage specificity and low charge states 
thus enhancing “top-down” automated database searching using trapping instruments. 
The results in Chapter 6 illustrate the utility of applying ultrafast UVPD for high-
throughput proteomic workflows. LC-MS/UVPD combined with database searching via 
SEQUEST improved in silico searching results for complex fibrosarcoma cell samples. 
The benefits and applicability of 193 photodissociation for peptide anion 
sequencing and characterization was illustrated in Chapter 7. Upon dissociation by this 
method, prolific high-energy products (a-/x-type ions) were generated, often yielding 
100% sequence coverage and leaving labile modifications intact. With the use of a basic 
mobile phase, LC-MS/UVPD was implemented for anion analysis, and resulted in the 
successful characterization of mitogen-activated pathway kinases. 
In summary, this dissertation focused on developing and advancing new mass 
spectrometry techniques to better aid proteomic analysis. In particular, emphasis was 
placed on tandem mass spectrometry and MSn methods to enhance dissociation 
efficiencies and sequence ion distributions to further aid automated analysis by both 
database searching (in silico) and de novo algorithms. The work herein was undertaken 
on a variety of ion trapping instruments due to their compatibility with lasers for 
photodissociation and ion/ion reaction capabilities. However, applying these methods to 
other mass spectrometers with high performance mass analyzers such as quadrupole – 
time-of-flight and linear ion trap – orbitraps (staples in proteomic analysis) should yield 
even greater results due the high mass accuracy measurements that can be made. Being 
that these hybrid mass spectrometers all have trapping devices on the front end, huge 
hurdles in implementing the methods developed in this dissertation to these high mass 
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accuracy instruments are not foreseen. The benefits of high mass accuracy measurements 
would increase the selectivity of automated spectral interpretation by decreasing false 
positives and increasing true positives thus escalating the depth of analysis into the 
proteome. 
Future goals involve the development of new algorithms based on database 
searching and de novo sequencing to effectively automate spectral interpretation from 
data generated from the methods developed in this dissertation, those which often 
generate novel fragmentation behavior. For example, there are no available 
computational methods for the automated interpretation of anion MS/MS spectra. Using 
the framework established in Chapter 7, we have begun developing a new searching 
algorithm for the interpretation of 193 nm UVPD spectra of peptide anions. To start, we 
modified a recently introduced searching algorithm, MassMatrix,1 to allow database 
searching of negative polarity MS/MS files. The computational package uses a mass 
accuracy sensitive probability-based scoring scheme for both the total number of matched 
product ions and the total abundance of matched products, and also utilizes LC retention 
times to filter false positive peptide matches.2 We have begun to modify the algorithm to 
be specific to the fragmentation behavior generated from 193 nm UVPD of peptide 
anions, but also to have the flexibility to search spectra from other photon/electron-based 
MSn methods (e.g., NETD, EDD, a-EPD, etc.). To increase the speed and selectivity of 
the searches, we have incorporated a charge-state-filtering algorithm, which identifies the 
charge state of each MS/MS spectrum based off the fragmentation patterns, and encodes 
it into the given mzXML file, a general mass spectrometry data format, prior to 
searching. The new version of MassMatrix can not only analyze both positive and 
negative polarity LC-MS/MS files separately, but can combine files from different 
polarities and different dissociation methods into a single search, thus maximizing the  
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information content for a given proteomics experiment. MassMatrix will be available as a 
free search engine to the public and as open-source software at www.massmatrix.net. 
Very recently we have begun showcasing the utility of combining MassMatrix searching 
with +/- polarity MS/MS switching (e.g., data-dependent positive MS/MS and negative 
MS/MS during a single proteomic LC-MS/MS run). Figure 8.1 illustrates a +/- polarity 
MS/MS switching experiment in which positive mode ETD was combined with negative 
mode UVPD in a single LC-MS/MS run of a tryptic digestion of the cytosolic section of 
HeLa cells. Figure 8.1A and Figure 8.1B shows the negative and positive base peak 
chromatogram, respectively, extracted from the single LC-MS/MS file. Figure 8.1C 
illustrates the 193 nm UVPD spectrum of pyruvate kinase isozyme peptide 
GDLGIEIPAEK (2-) identified from the complex HeLa sample. Figure 8.1D shows the 
ETD spectrum of the triosephosphate isomerase peptide KQSLGELIGTLNAAK (3+) 
identified from the same LC-MS/MS run of the same HeLa sample. This example 
illustrates the potential of combining different polarity MS/MS methods in a high-
throughput fashion to increase the diagnostic content of a single proteomic analysis. 
ETD, for instance, has a bias towards yielding the best results for highly basic peptides, 
while negative UVPD works well with more acidic peptides. By combining the two, it 
may be possible to yield very high protein sequence coverage. There is also potential for 
+/- switching just using 193 nm UVPD alone. The fast activation times of UVPD (as low 
as 5 ns), which are significantly faster than any other activation technique, is an attractive 
option for elevating the information that can be obtained in a single experiment.  
To take advantage of the negative UVPD and/or +/- polarity MS/MS switching 
methods, the enzyme used for protein digestion is critical. Trypsin is considered the gold 
standard and generates Arg- or Lys-terminated peptides that have proven well-suited for 
characterization by CID. While collisional dissociation and tryptic peptides work well 
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together, negative UVPD would likely match better with other enzymes besides trypsin. 
For example, the use of Glu-C, which cleaves after acidic residues (D,E), and Asp-N, 
which cleaves only after aspartic acid (D), would generate peptides that contain acidic 
residues and thus should enhance negative ESI. Also, chymotrypsin results primarily in 
peptides terminated with an aromatic residue, a feature that also ensures the peptides will 
have enhanced UV photoabsorptivity.3 Coupling the use of these alternative proteases 
with UVPD and comparison to CID and ETD offers a way to enhance sequence coverage 
across the basic and acidic proteomes. A streamlined assessment of these alternative 

































































































Figure 8.1 Polarity switching LC-MS/MS for simultaneous sequencing of cation 
(ETD) and anion (193 nm UVPD) tryptic peptides from the cytosolic 
section of HeLa cells. (a) Extracted negative polarity base peak 
chromatogram. (b) Extracted positive polarity base peak chromatogram. c) 
193 nm UVPD of pyruvate kinase isozyme peptide GDLGIEIPAEK, 2-. d) 
ETD of triosephosphate isomerase peptide KQSLGELIGTLNAAK, 3+.  
 
Another goal for the future also involves expanding the work developed in 
Chapter 7 of this dissertation, but for intact protein characterization (i.e., top-down 
analysis). That is, intact proteins would be ionized in the negative mode, subjected to 193 
nm UVPD, and then the resulting fragmentation patterns analyzed by search algorithms. 
Typically, top-down analysis is undertaken in positive MS mode; however, we have 
recently shown that proteins can be ionized in the negative mode with ion signals on par 
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with the traditional positive mode analysis. The formation of negative ions is aided by 
adding approximately 10 – 20 mM of piperidine to working solutions in order to shift the 
pH to between 11 – 12, thus enhancing deprotonation. A full ESI negative mass spectrum 
of the protein ubiquitin is shown in Figure 8.2, and illustrates the clean and highly 



























Dissociation of the individual intact protein anion charge states would be 
performed by 193 nm UVPD to produce diagnostic ions. As mentioned previously, 
although top-down analysis is more challenging and less developed compared to bottom- 
up strategies, dissociation of intact proteins offer certain benefits including the 
elimination of enzymatic digestion procedures, access to contextual post-translational 
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modification information, and direct knowledge about the molecular weights of the intact 
proteins.4, 5 One of the challenges of top-down analysis is generating enough diagnostic 
information after dissociation. Figure 8.3A shows the MS/MS spectrum of intact 
ubiquitin (7- charge state). As observed in Chapter 7, electron photodetachment, which 
creates charge-reduced, radical species, is a prominent pathway during UVPD. The 
sequence ions are generally observed at lower abundance compared to the 
photodetachment products. Figure 8.3B illustrates a zoomed in section from 
approximately m/z 870 – 1180 showing the product ion types matched to peaks in the 
MS/MS spectrum, and demonstrates the rich information that can be obtained from top-
down analysis using 193 nm photons. The sequence information obtained from the 
negative UVPD dissociation of the intact ubiquitin protein (7- charge state) is shown in 
Figure 8.3C. The colored markers represent cleavage sites along the protein backbone, 
and are matched to the product ion type by the legend at the right of the figure. As seen in 
this distribution map, these initial experiments show that high sequence coverage can be 
obtained by the top-down negative UVPD method. Furthermore, the initial analysis was 
performed on a fairly low resolution ion trap mass spectrometer limiting the resolving 
power to approximately five charges on a product ion. If the dissociation technique was 
implemented on a higher performing instrument such as a q-TOF or orbitrap instrument, 
a near future goal, a significantly gain in diagnostic information would be predicted. 
Future goals of this method would be to extend it to higher performing instruments, as 
described previously, develop automated searching techniques to interpret the 
fragmentation behavior (likely based off our modified MassMatrix algorithm), and to 
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Figure 8.3 Negative polarity top-down analysis of ubiquitin (7- charge state) by 193 
nm UVPD. (a) The MS/MS spectrum illustrating the electron 
photodetachment, radical products (labeled) and the sequence ions at 
lower abundance. (b) A zoomed in section from approximately m/z 870 – 
1180 showing the product ion types for peaks in the spectrum. (c) 
Sequence coverage from the various products observed in the MS/MS 
spectrum. The legend at the right side of the figure matches the colored 
backbone cleavage markers with their associated product ion type. The ion 
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